US8299100B2	NNP	O
-	:	O
Potent	NN	O
and	CC	O
selective	JJ	O
neuronal	JJ	O
nitric	JJ	O
oxide	IN	O
synthase	NN	O
inhibitors	NNS	O
with	IN	O
improved	JJ	O
membrane	NN	O
permeability	NN	O
-	:	O
Google	NN	O
Patents	NNS	O
Info	NNP	O
Links	NNP	O
Images	NNP	O
Classifications	NNP	O
Abstract	NNP	O
Description	NNP	O
This	DT	O
application	NN	O
claims	VBZ	O
priority	NN	O
benefit	NN	O
from	IN	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
61/205,770	CD	O
filed	VBD	O
Jan.	NNP	O
23	CD	O
,	,	O
2009	CD	O
,	,	O
the	DT	O
entirety	NN	O
of	IN	O
which	WDT	O
is	VBZ	O
incorporated	VBN	O
herein	NN	O
by	IN	O
reference	NN	O
.	.	O
This	DT	O
invention	NN	O
was	VBD	O
made	VBN	O
with	IN	O
government	NN	O
support	NN	O
under	IN	O
Grant	NNP	O
No	NNP	O
.	.	O
R01	NNP	O
GM49725	NNP	O
awarded	VBN	O
by	IN	O
the	DT	O
National	NNP	O
Institutes	NNPS	O
of	IN	O
Health	NNP	O
to	TO	O
Northwestern	NNP	O
University	NNP	O
.	.	O
The	DT	O
government	NN	O
has	VBZ	O
certain	JJ	O
rights	NNS	O
in	IN	O
the	DT	O
invention	NN	O
.	.	O
BACKGROUND	NNP	O
OF	IN	O
THE	NNP	O
INVENTION	NNP	O
Neuronal	NNP	O
nitric	JJ	O
oxide	NN	O
synthase	NN	O
(	(	O
nNOS	JJ	O
)	)	O
catalyzes	VBZ	O
the	DT	O
oxidation	NN	O
of	IN	O
L-arginine	NNP	O
to	TO	O
L-citrulline	NNP	O
in	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
,	,	O
generating	VBG	O
nitric	JJ	O
oxide	NN	O
(	(	O
NO	NNP	O
)	)	O
,	,	O
a	DT	O
critical	JJ	O
neurotransmitter	NN	O
.	.	O
Significant	NNP	O
research	NN	O
has	VBZ	O
implicated	VBN	O
the	DT	O
overexpression	NN	O
of	IN	O
nNOS—and	JJ	O
overproduction	NN	O
of	IN	O
NO—in	NNP	O
various	JJ	O
neurological	JJ	O
diseases	NNS	O
,	,	O
including	VBG	O
Parkinson	NNP	O
's	POS	O
,	,	O
Alzheimer	NNP	O
's	POS	O
,	,	O
and	CC	O
Huntington	NNP	O
's	POS	O
diseases	NNS	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
neuronal	JJ	O
damage	NN	O
due	JJ	O
to	TO	O
stroke	VB	O
Inhibiting	NNP	O
endothelial	JJ	O
nitric	JJ	O
oxide	NN	O
synthase	NN	O
(	(	O
eNOS	NN	O
)	)	O
and	CC	O
inducible	JJ	O
nitric	JJ	O
oxide	NN	O
synthase	NN	O
(	(	O
iNOS	NN	O
)	)	O
is	VBZ	O
,	,	O
however	RB	O
,	,	O
undesirable	JJ	O
,	,	O
because	IN	O
these	DT	O
isozymes	NNS	O
are	VBP	O
responsible	JJ	O
for	IN	O
maintaining	VBG	O
crucial	JJ	O
body	NN	O
function	NN	O
.	.	O
Thus	RB	O
,	,	O
selective	JJ	O
inhibition	NN	O
of	IN	O
nNOS	NN	O
over	IN	O
its	PRP$	O
closely	RB	O
related	JJ	O
isoforms	NNS	O
,	,	O
eNOS	NN	O
and	CC	O
iNOS	NN	O
,	,	O
can	MD	O
provide	VB	O
a	DT	O
promising	JJ	O
strategy	NN	O
in	IN	O
developing	VBG	O
therapeutics	NNS	O
for	IN	O
the	DT	O
treatment	NN	O
of	IN	O
neurodegenerative	JJ	O
diseases	NNS	O
.	.	O
Through	IN	O
on-going	JJ	O
research	NN	O
of	IN	O
nNOS	JJ	O
selective	JJ	O
inhibitors	NNS	O
,	,	O
a	DT	O
pyrrolidine-based	JJ	O
compound	NN	O
(	(	O
1	CD	O
,	,	O
FIG	NNP	O
.	.	O
1	CD	O
)	)	O
,	,	O
was	VBD	O
found	VBN	O
to	TO	O
provide	VB	O
great	JJ	O
potency	NN	O
(	(	O
Ki=15	NNP	O
nM	RB	O
)	)	O
and	CC	O
very	RB	O
high	JJ	O
selectivity	NN	O
for	IN	O
nNOS	NN	O
over	IN	O
eNOS	NN	O
(	(	O
2100	CD	O
fold	NN	O
)	)	O
and	CC	O
iNOS	NN	O
(	(	O
630	CD	O
fold	NN	O
)	)	O
.	.	O
However	RB	O
,	,	O
despite	IN	O
the	DT	O
promising	JJ	O
inhibitory	JJ	O
activity	NN	O
of	IN	O
1	CD	O
,	,	O
further	JJ	O
application	NN	O
to	TO	O
neurodegenerative	JJ	O
therapeutics	NNS	O
has	VBZ	O
been	VBN	O
impeded	VBN	O
by	IN	O
several	JJ	O
structural	JJ	O
characteristics	NNS	O
.	.	O
First	RB	O
,	,	O
the	DT	O
flexible	JJ	O
m-fluorophenyl	JJ	O
ethanamino	NN	O
tail	NN	O
brought	VBD	O
multiple	JJ	O
rotatable	JJ	O
bonds	NNS	O
to	TO	O
the	DT	O
inhibitor	NN	O
,	,	O
limits	VBZ	O
the	DT	O
potency	NN	O
and	CC	O
selectivity	NN	O
of	IN	O
1	CD	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
the	DT	O
benzylic	JJ	O
position	NN	O
of	IN	O
the	DT	O
m-fluorophenyl	JJ	O
ring	NN	O
is	VBZ	O
highly	RB	O
susceptible	JJ	O
to	TO	O
metabolic	JJ	O
oxidation	NN	O
reactions	NNS	O
.	.	O
More	RBR	O
importantly	RB	O
,	,	O
the	DT	O
two	CD	O
positive	JJ	O
charges	NNS	O
of	IN	O
1	CD	O
at	IN	O
physiological	JJ	O
pH	NN	O
,	,	O
derived	VBN	O
from	IN	O
the	DT	O
two	CD	O
amino	NN	O
groups	NNS	O
,	,	O
decreases	VBZ	O
the	DT	O
chance	NN	O
of	IN	O
1	CD	O
to	TO	O
penetrate	VB	O
the	DT	O
blood	NN	O
brain	NN	O
barrier	NN	O
(	(	O
BBB	NNP	O
)	)	O
.	.	O
SUMMARY	NN	O
OF	IN	O
THE	DT	O
INVENTION	NNP	O
In	IN	O
light	NN	O
of	IN	O
the	DT	O
foregoing	NN	O
,	,	O
it	PRP	O
is	VBZ	O
an	DT	O
object	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
compounds	NNS	O
,	,	O
compositions	NNS	O
and	CC	O
related	JJ	O
methods	NNS	O
of	IN	O
use	NN	O
for	IN	O
the	DT	O
selective	JJ	O
inhibition	NN	O
of	IN	O
neuronal	JJ	O
nitric	JJ	O
oxide	NN	O
synthase	NN	O
,	,	O
thereby	RB	O
overcoming	VBG	O
various	JJ	O
deficiencies	NNS	O
and	CC	O
shortcomings	NNS	O
of	IN	O
the	DT	O
prior	JJ	O
art	NN	O
including	VBG	O
those	DT	O
outlined	VBN	O
above	IN	O
.	.	O
It	PRP	O
would	MD	O
be	VB	O
understood	VBN	O
by	IN	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
that	WDT	O
one	CD	O
or	CC	O
more	JJR	O
aspects	NNS	O
of	IN	O
this	DT	O
invention	NN	O
can	MD	O
meet	VB	O
certain	JJ	O
objectives	NNS	O
,	,	O
while	IN	O
one	CD	O
or	CC	O
more	JJR	O
other	JJ	O
aspects	NNS	O
can	MD	O
meet	VB	O
certain	JJ	O
other	JJ	O
objectives	NNS	O
.	.	O
Each	DT	O
objective	NN	O
may	MD	O
not	RB	O
apply	VB	O
equally	RB	O
,	,	O
in	IN	O
all	DT	O
its	PRP$	O
respects	NNS	O
,	,	O
to	TO	O
every	DT	O
aspect	NN	O
of	IN	O
this	DT	O
invention	NN	O
.	.	O
As	IN	O
such	JJ	O
,	,	O
the	DT	O
following	JJ	O
objects	NNS	O
can	MD	O
be	VB	O
viewed	VBN	O
in	IN	O
the	DT	O
alternative	NN	O
with	IN	O
respect	NN	O
to	TO	O
any	DT	O
one	CD	O
aspect	NN	O
of	IN	O
this	DT	O
invention	NN	O
.	.	O
It	PRP	O
is	VBZ	O
an	DT	O
object	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
one	CD	O
or	CC	O
more	JJR	O
small	JJ	O
molecule	NN	O
and/or	IN	O
non-peptide	JJ	O
compounds	NNS	O
exhibiting	VBG	O
selective	JJ	O
nNOS	JJ	O
inhibition	NN	O
over	IN	O
other	JJ	O
enzyme	JJ	O
isoforms	NNS	O
and	CC	O
providing	VBG	O
improved	VBN	O
membrane	JJ	O
permeability	NN	O
and	CC	O
bioavailability	NN	O
.	.	O
It	PRP	O
can	MD	O
be	VB	O
another	DT	O
object	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
an	DT	O
enantiomerically-pure	JJ	O
compound	NN	O
to	TO	O
affect	VB	O
binding	VBG	O
orientation	NN	O
and	CC	O
improved	JJ	O
potency	NN	O
and	CC	O
selectivity	NN	O
over	IN	O
the	DT	O
corresponding	JJ	O
racemic	JJ	O
mixtures	NNS	O
.	.	O
It	PRP	O
can	MD	O
be	VB	O
another	DT	O
object	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
,	,	O
alone	RB	O
or	CC	O
in	IN	O
conjunction	NN	O
with	IN	O
one	CD	O
or	CC	O
more	JJR	O
of	IN	O
the	DT	O
preceding	VBG	O
objectives	NNS	O
,	,	O
to	TO	O
reduce	VB	O
basicity	NN	O
of	IN	O
an	DT	O
ethanamino	NN	O
nitrogen	NN	O
center	NN	O
,	,	O
as	IN	O
can	MD	O
be	VB	O
accomplished	VBN	O
by	IN	O
incorporation	NN	O
of	IN	O
an	DT	O
electron-withdrawing	JJ	O
moiety	NN	O
adjacent	NN	O
or	CC	O
proximate	NN	O
thereto	NN	O
,	,	O
to	TO	O
reduce	VB	O
molecular	JJ	O
cationic	JJ	O
character	NN	O
at	IN	O
physiological	JJ	O
pH	NN	O
and	CC	O
to	TO	O
enhance	VB	O
bioavailability	NN	O
by	IN	O
improved	JJ	O
penetration	NN	O
of	IN	O
the	DT	O
BBB	NNP	O
.	.	O
It	PRP	O
can	MD	O
be	VB	O
another	DT	O
object	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
one	CD	O
or	CC	O
more	JJR	O
such	JJ	O
non-peptide	JJ	O
compounds	NNS	O
for	IN	O
in	IN	O
vitro	NN	O
use	NN	O
and	CC	O
study	NN	O
under	IN	O
conditions	NNS	O
promoting	VBG	O
nitric	JJ	O
oxide	JJ	O
production	NN	O
,	,	O
indicative	NN	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
mammalian	JJ	O
disease	NN	O
states	NNS	O
.	.	O
Alternatively	RB	O
,	,	O
it	PRP	O
can	MD	O
also	RB	O
be	VB	O
an	DT	O
object	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
one	CD	O
or	CC	O
more	JJR	O
such	JJ	O
compounds	NNS	O
enabling	VBG	O
in	IN	O
vivo	JJ	O
treatment	NN	O
of	IN	O
such	JJ	O
disease	NN	O
states	NNS	O
.	.	O
Other	JJ	O
objects	NNS	O
,	,	O
features	NNS	O
,	,	O
benefits	NNS	O
and	CC	O
advantages	NNS	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
will	MD	O
be	VB	O
apparent	JJ	O
from	IN	O
this	DT	O
summary	JJ	O
and	CC	O
the	DT	O
following	JJ	O
descriptions	NNS	O
of	IN	O
certain	JJ	O
embodiments	NNS	O
of	IN	O
such	JJ	O
compounds	NNS	O
,	,	O
compositions	NNS	O
and/or	VBP	O
methods	NNS	O
and	CC	O
will	MD	O
be	VB	O
readily	RB	O
apparent	JJ	O
to	TO	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
having	VBG	O
knowledge	NN	O
of	IN	O
the	DT	O
synthetic	JJ	O
techniques	NNS	O
described	VBN	O
herein	RB	O
.	.	O
Such	JJ	O
objectives	NNS	O
,	,	O
features	NNS	O
,	,	O
benefits	NNS	O
and	CC	O
advantages	NNS	O
will	MD	O
be	VB	O
apparent	JJ	O
from	IN	O
the	DT	O
above	NN	O
as	IN	O
taken	VBN	O
into	IN	O
conjunction	NN	O
with	IN	O
the	DT	O
accompanying	VBG	O
examples	NNS	O
,	,	O
data	NNS	O
,	,	O
figures	NNS	O
and	CC	O
references	NNS	O
incorporated	VBN	O
herein	NN	O
,	,	O
together	RB	O
with	IN	O
all	DT	O
reasonable	JJ	O
inferences	NNS	O
to	TO	O
be	VB	O
drawn	VBN	O
therefrom	NN	O
.	.	O
Accordingly	RB	O
,	,	O
in	IN	O
part	NN	O
,	,	O
the	DT	O
present	JJ	O
invention	NN	O
can	MD	O
relate	VB	O
to	TO	O
compounds	NNS	O
of	IN	O
a	DT	O
formula	NN	O
wherein	NN	O
X	NN	O
can	MD	O
be	VB	O
selected	VBN	O
from	IN	O
divalent	JJ	O
electron-withdrawing	JJ	O
moieties	NNS	O
or	CC	O
groups	NNS	O
and/or	JJ	O
substituents	NNS	O
thereof	NN	O
,	,	O
together	RB	O
with	IN	O
salts	NNS	O
,	,	O
hydrates	NNS	O
and/or	VBP	O
solvates	NNS	O
of	IN	O
such	JJ	O
compounds	NNS	O
;	:	O
and	CC	O
to	TO	O
pharmaceutical	JJ	O
compositions	NNS	O
comprising	VBG	O
one	CD	O
or	CC	O
more	JJR	O
such	JJ	O
compounds	NNS	O
,	,	O
optionally	RB	O
together	RB	O
with	IN	O
an	DT	O
acceptable	JJ	O
carrier	NN	O
component	NN	O
.	.	O
In	IN	O
certain	JJ	O
embodiments	NNS	O
,	,	O
without	IN	O
limitation	NN	O
,	,	O
such	JJ	O
moieties/groups	NNS	O
can	MD	O
be	VB	O
selected	VBN	O
from	IN	O
ether	NN	O
,	,	O
cyclopropyl	NN	O
,	,	O
monofluoroethylene	NN	O
and	CC	O
difluoroethylene	NN	O
,	,	O
such	JJ	O
groups/moieties	NNS	O
as	IN	O
are	VBP	O
illustrated	VBN	O
below	IN	O
and	CC	O
discussed	VBD	O
more	RBR	O
fully	RB	O
elsewhere	RB	O
herein	NN	O
.	.	O
More	RBR	O
generally	RB	O
,	,	O
such	JJ	O
groups/moieties	NNS	O
and	CC	O
substituents	NNS	O
thereof	NNS	O
are	VBP	O
limited	VBN	O
only	RB	O
by	IN	O
electron-withdrawing	JJ	O
function	NN	O
,	,	O
as	IN	O
can	MD	O
be	VB	O
considered	VBN	O
in	IN	O
the	DT	O
context	NN	O
of	IN	O
mitigation	NN	O
or	CC	O
partial	JJ	O
removal	NN	O
of	IN	O
a	DT	O
degree	NN	O
of	IN	O
positive	JJ	O
charge	NN	O
from	IN	O
an	DT	O
amine	JJ	O
functionality	NN	O
,	,	O
such	JJ	O
as	IN	O
at	IN	O
physiological	JJ	O
pH	NN	O
.	.	O
Accordingly	RB	O
,	,	O
without	IN	O
limitation	NN	O
,	,	O
in	IN	O
certain	JJ	O
such	JJ	O
embodiments	NNS	O
,	,	O
such	PDT	O
a	DT	O
compound	NN	O
can	MD	O
be	VB	O
present	JJ	O
as	IN	O
an	DT	O
acid	NN	O
salt	NN	O
,	,	O
either	CC	O
partially	RB	O
or	CC	O
fully	RB	O
protonated	VBN	O
.	.	O
In	IN	O
certain	JJ	O
such	JJ	O
embodiments	NNS	O
,	,	O
the	DT	O
counter	NN	O
ion	NN	O
(	(	O
s	PRP	O
)	)	O
can	MD	O
be	VB	O
a	DT	O
conjugate	JJ	O
base	NN	O
of	IN	O
a	DT	O
protic	JJ	O
acid	NN	O
.	.	O
Regardless	RB	O
,	,	O
Φ	NNS	O
can	MD	O
be	VB	O
selected	VBN	O
from	IN	O
moieties	NNS	O
capable	JJ	O
of	IN	O
contribution	NN	O
to	TO	O
or	CC	O
affect	VB	O
on	IN	O
enzyme	JJ	O
binding	NN	O
or	CC	O
interaction	NN	O
.	.	O
Without	IN	O
limitation	NN	O
,	,	O
Φ	WP	O
can	MD	O
be	VB	O
as	IN	O
discussed	JJ	O
below	IN	O
.	.	O
More	RBR	O
generally	RB	O
,	,	O
as	IN	O
demonstrated	VBN	O
below	IN	O
,	,	O
the	DT	O
structure	NN	O
of	IN	O
such	JJ	O
a	DT	O
compound	NN	O
is	VBZ	O
limited	VBN	O
only	RB	O
by	IN	O
choice	NN	O
of	IN	O
starting	VBG	O
material	NN	O
or	CC	O
reagent	NN	O
,	,	O
enroute	NN	O
to	TO	O
a	DT	O
pyridine	JJ	O
substructure	NN	O
(	(	O
I	PRP	O
)	)	O
,	,	O
pyrrolidine	JJ	O
substructure	NN	O
(	(	O
II	NNP	O
)	)	O
and/or	VBZ	O
lipophilic	JJ	O
tail	NN	O
substructure	NN	O
(	(	O
III	NNP	O
)	)	O
,	,	O
such	JJ	O
substructures	NNS	O
as	IN	O
are	VBP	O
discussed	VBN	O
more	RBR	O
fully	RB	O
below	IN	O
and/or	NNS	O
in	IN	O
co-pending	JJ	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
11/906,283	CD	O
and	CC	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
7,470,790	CD	O
,	,	O
each	DT	O
of	IN	O
which	WDT	O
is	VBZ	O
incorporated	VBN	O
herein	NN	O
by	IN	O
reference	NN	O
in	IN	O
its	PRP$	O
entirety	NN	O
.	.	O
Accordingly	RB	O
,	,	O
various	JJ	O
compounds	NNS	O
of	IN	O
this	DT	O
invention	NN	O
can	MD	O
,	,	O
optionally	RB	O
,	,	O
comprise	VBP	O
various	JJ	O
other	JJ	O
substructures	NNS	O
I	PRP	O
,	,	O
II	NNP	O
and/or	VBZ	O
III	NNP	O
or	CC	O
other	JJ	O
moieties	NNS	O
and/or	VBP	O
substituents	NNS	O
thereof	VB	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
substructures	NNS	O
,	,	O
moieties	NNS	O
and/or	VBP	O
groups	NNS	O
described	VBN	O
in	IN	O
the	DT	O
aforementioned	JJ	O
incorporated	JJ	O
references	NNS	O
.	.	O
As	IN	O
such	JJ	O
,	,	O
with	IN	O
respect	NN	O
to	TO	O
the	DT	O
broader	JJR	O
aspects	NNS	O
of	IN	O
this	DT	O
invention	NN	O
,	,	O
the	DT	O
present	JJ	O
compounds	NNS	O
are	VBP	O
without	IN	O
stereochemical	JJ	O
limitation	NN	O
.	.	O
Where	WRB	O
such	JJ	O
compounds	NNS	O
and/or	VBP	O
their	PRP$	O
intermediates	NNS	O
are	VBP	O
available	JJ	O
as	IN	O
racemic	JJ	O
mixtures	NNS	O
,	,	O
the	DT	O
respective	JJ	O
isomers	NNS	O
can	MD	O
be	VB	O
resolved	VBN	O
.	.	O
Likewise	RB	O
,	,	O
as	IN	O
such	JJ	O
compounds	NNS	O
are	VBP	O
diastereomers	NNS	O
,	,	O
the	DT	O
corresponding	JJ	O
enantiomers	NNS	O
can	MD	O
be	VB	O
separated	VBN	O
.	.	O
Accordingly	RB	O
,	,	O
any	DT	O
such	JJ	O
stereocenter	NN	O
can	MD	O
be	VB	O
(	(	O
S	NNP	O
)	)	O
or	CC	O
(	(	O
R	NNP	O
)	)	O
with	IN	O
respect	NN	O
to	TO	O
any	DT	O
other	JJ	O
stereocenter	NN	O
(	(	O
s	NN	O
)	)	O
,	,	O
whether	IN	O
such	PDT	O
a	DT	O
compound	NN	O
is	VBZ	O
present	JJ	O
as	IN	O
a	DT	O
salt	NN	O
,	,	O
hydrate	NN	O
and/or	NN	O
solvate	NN	O
thereof	NN	O
.	.	O
In	IN	O
part	NN	O
,	,	O
the	DT	O
present	JJ	O
invention	NN	O
can	MD	O
also	RB	O
provide	VB	O
a	DT	O
method	NN	O
of	IN	O
inhibiting	VBG	O
a	DT	O
nitric	JJ	O
oxide	NN	O
synthase	NN	O
,	,	O
such	PDT	O
a	DT	O
method	NN	O
comprising	VBG	O
contacting	VBG	O
a	DT	O
nitric	JJ	O
oxide	NN	O
synthase	NN	O
with	IN	O
an	DT	O
effective	JJ	O
amount	NN	O
of	IN	O
any	DT	O
one	CD	O
or	CC	O
more	JJR	O
of	IN	O
the	DT	O
present	JJ	O
compounds	NNS	O
,	,	O
including	VBG	O
,	,	O
but	CC	O
not	RB	O
limited	JJ	O
to	TO	O
those	DT	O
illustrated	VBN	O
by	IN	O
the	DT	O
following	JJ	O
examples	NNS	O
,	,	O
referenced	VBD	O
figures	NNS	O
and/or	RP	O
accompanying	VBG	O
synthetic	JJ	O
schemes	NNS	O
.	.	O
More	RBR	O
specifically	RB	O
,	,	O
as	IN	O
also	RB	O
supported	VBN	O
herein	NN	O
,	,	O
the	DT	O
present	JJ	O
invention	NN	O
can	MD	O
provide	VB	O
a	DT	O
method	NN	O
of	IN	O
using	VBG	O
an	DT	O
electron	NN	O
withdrawing	VBG	O
moiety	NN	O
to	TO	O
inhibit	VB	O
such	JJ	O
a	DT	O
nitric	JJ	O
oxide	NN	O
synthase	NN	O
and/or	NN	O
for	IN	O
selective	JJ	O
inhibition	NN	O
of	IN	O
neuronal	JJ	O
nitric	JJ	O
oxide	NN	O
synthase	NN	O
.	.	O
Such	JJ	O
a	DT	O
method	NN	O
can	MD	O
comprise	VB	O
providing	VBG	O
a	DT	O
compound	NN	O
or	CC	O
a	DT	O
related	JJ	O
composition	NN	O
of	IN	O
this	DT	O
invention	NN	O
;	:	O
and	CC	O
contacting	VBG	O
a	DT	O
nitric	JJ	O
oxide	NN	O
synthase	NN	O
enzyme	NN	O
with	IN	O
such	PDT	O
a	DT	O
compound/composition	NN	O
,	,	O
such	JJ	O
contact	NN	O
as	IN	O
can	MD	O
selectively	RB	O
inhibit	VB	O
neuronal	JJ	O
nitric	JJ	O
oxide	NN	O
synthase	NN	O
over	IN	O
inducible	JJ	O
and/or	JJ	O
endothelial	JJ	O
isoforms	NNS	O
.	.	O
BRIEF	JJ	O
DESCRIPTION	NNP	O
OF	IN	O
THE	NNP	O
DRAWINGS	NNP	O
FIG	NNP	O
.	.	O
1	CD	O
shows	NNS	O
development	NN	O
and	CC	O
design	NN	O
of	IN	O
several	JJ	O
non-limiting	JJ	O
compounds	NNS	O
of	IN	O
this	DT	O
invention	NN	O
from	IN	O
prior	JJ	O
art	NN	O
compound	NN	O
1	CD	O
.	.	O
FIGS	NNP	O
.	.	O
2	CD	O
A-B	JJ	O
.	.	O
The	DT	O
nNOS	JJ	O
active	JJ	O
site	NN	O
with	IN	O
inhibitor	NN	O
2da	CD	O
(	(	O
A	DT	O
)	)	O
or	CC	O
2db	CD	O
(	(	O
B	NNP	O
)	)	O
bound	NN	O
.	.	O
The	DT	O
sigmaA	NN	O
weighted	VBD	O
2Fo−Fc	CD	O
density	NN	O
for	IN	O
inhibitor	NN	O
is	VBZ	O
also	RB	O
shown	VBN	O
at	IN	O
contour	JJ	O
level	NN	O
of	IN	O
1	CD	O
σ.	JJ	O
Hydrogen	NNP	O
bonds	NNS	O
are	VBP	O
depicted	VBN	O
with	IN	O
dashed	JJ	O
lines	NNS	O
.	.	O
Alternate	NNP	O
conformations	NNS	O
for	IN	O
2db	CD	O
and	CC	O
E592	NNP	O
were	VBD	O
observed	VBN	O
.	.	O
FIGS	NNP	O
.	.	O
2	CD	O
,	,	O
3	CD	O
,	,	O
and	CC	O
4	CD	O
were	VBD	O
prepared	VBN	O
with	IN	O
PyMol	NNP	O
,	,	O
an	DT	O
open-source	JJ	O
,	,	O
user-sponsored	JJ	O
molecular	JJ	O
visualization	NN	O
system	NN	O
well-known	JJ	O
to	TO	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
FIGS	NNP	O
.	.	O
3A-D	CD	O
The	DT	O
nNOS	NN	O
active	JJ	O
site	NN	O
with	IN	O
2dc	CD	O
(	(	O
A	DT	O
)	)	O
,	,	O
2dd	CD	O
(	(	O
B	NNP	O
)	)	O
,	,	O
2e	CD	O
(	(	O
C	NNP	O
)	)	O
,	,	O
or	CC	O
2f	CD	O
(	(	O
D	NNP	O
)	)	O
bound	NN	O
.	.	O
Around	IN	O
each	DT	O
inhibitor	NN	O
is	VBZ	O
the	DT	O
sigmaA	NN	O
weighted	VBD	O
2Fo−Fc	CD	O
density	NN	O
contoured	VBN	O
at	IN	O
1	CD	O
σ	NN	O
.	.	O
Major	JJ	O
hydrogen	NN	O
bonds	NNS	O
are	VBP	O
depicted	VBN	O
with	IN	O
dashed	JJ	O
lines	NNS	O
.	.	O
Note	VB	O
the	DT	O
alternate	NN	O
conformations	NNS	O
for	IN	O
E592	NNP	O
occur	NN	O
when	WRB	O
the	DT	O
inhibitor	NN	O
shows	VBZ	O
multiple	JJ	O
conformations	NNS	O
in	IN	O
the	DT	O
nNOS-2dd	JJ	O
or	CC	O
nNOS-2e	JJ	O
structure	NN	O
.	.	O
FIGS	NNP	O
.	.	O
4A-B	JJ	O
.	.	O
The	DT	O
eNOS	NN	O
active	JJ	O
site	NN	O
with	IN	O
2db	CD	O
(	(	O
A	DT	O
)	)	O
and	CC	O
2f	CD	O
(	(	O
B	NNP	O
)	)	O
bound	NN	O
.	.	O
Around	IN	O
each	DT	O
inhibitor	NN	O
is	VBZ	O
the	DT	O
sigmaA	NN	O
weighted	VBD	O
2Fo−Fc	CD	O
density	NN	O
contoured	VBN	O
at	IN	O
1	CD	O
σ	NN	O
.	.	O
Major	JJ	O
hydrogen	NN	O
bonds	NNS	O
are	VBP	O
depicted	VBN	O
with	IN	O
dashed	JJ	O
lines	NNS	O
.	.	O
As	IN	O
observed	VBN	O
with	IN	O
nNOS	NN	O
,	,	O
alternate	JJ	O
conformations	NNS	O
for	IN	O
Glu363	NNP	O
occur	NN	O
in	IN	O
the	DT	O
eNOS-2db	JJ	O
structure	NN	O
.	.	O
DETAILED	JJ	O
DESCRIPTION	NNP	O
OF	NNP	O
CERTAIN	NNP	O
EMBODIMENTS	NNP	O
To	TO	O
address	VB	O
permeability	NN	O
problems	NNS	O
of	IN	O
the	DT	O
sort	NN	O
discussed	VBD	O
above	IN	O
,	,	O
different	JJ	O
strategies	NNS	O
have	VBP	O
been	VBN	O
applied	VBN	O
to	TO	O
improve	VB	O
the	DT	O
bioavailability	NN	O
of	IN	O
the	DT	O
prior	JJ	O
art	NN	O
compounds—including	NN	O
,	,	O
without	IN	O
limitation	NN	O
,	,	O
the	DT	O
design	NN	O
,	,	O
synthesis	NN	O
,	,	O
and	CC	O
biological	JJ	O
evaluation	NN	O
of	IN	O
a	DT	O
new	JJ	O
series	NN	O
of	IN	O
low	JJ	O
pKa	NN	O
inhibitors	NNS	O
(	(	O
e.g.	NN	O
,	,	O
compounds	VBZ	O
2a-d	CD	O
of	IN	O
FIG	NNP	O
.	.	O
1	CD	O
)	)	O
.	.	O
In	IN	O
representative	JJ	O
such	JJ	O
embodiments	NNS	O
,	,	O
different	JJ	O
electron	NN	O
withdrawing	VBG	O
groups	NNS	O
,	,	O
including	VBG	O
ether	NN	O
(	(	O
2a	CD	O
)	)	O
,	,	O
cyclopropyl	NN	O
(	(	O
2b	CD	O
)	)	O
,	,	O
monofluoromethylene	NN	O
(	(	O
2c	CD	O
)	)	O
,	,	O
and	CC	O
difluoromethylene	NN	O
(	(	O
2d	CD	O
)	)	O
,	,	O
were	VBD	O
introduced	VBN	O
at	IN	O
the	DT	O
position	NN	O
adjacent	NN	O
or	CC	O
proximate	NN	O
to	TO	O
the	DT	O
pendent	JJ	O
amine	NN	O
group	NN	O
in	IN	O
the	DT	O
lipophilic	JJ	O
tail	NN	O
of	IN	O
1	CD	O
(	(	O
FIG	NNP	O
.	.	O
1	CD	O
)	)	O
.	.	O
While	IN	O
the	DT	O
chemical	JJ	O
structures	NNS	O
of	IN	O
these	DT	O
inhibitors	NNS	O
are	VBP	O
related	VBN	O
to	TO	O
that	DT	O
of	IN	O
1	CD	O
,	,	O
the	DT	O
predicted	JJ	O
pKa	NN	O
values	NNS	O
of	IN	O
these	DT	O
compounds	NNS	O
are	VBP	O
significantly	RB	O
and	CC	O
unexpectedly	RB	O
lower	JJR	O
than	IN	O
1	CD	O
(	(	O
Table	JJ	O
1	CD	O
)	)	O
:	:	O
supporting	VBG	O
the	DT	O
hypothesis	NN	O
was	VBD	O
that	IN	O
an	DT	O
additional	JJ	O
electron	NN	O
withdrawing	VBG	O
group	NN	O
,	,	O
which	WDT	O
can	MD	O
be	VB	O
considered	VBN	O
to	TO	O
mitigate	VB	O
or	CC	O
partially	RB	O
remove	VB	O
the	DT	O
positive	JJ	O
charge	NN	O
from	IN	O
the	DT	O
amine	NN	O
functionality	NN	O
through	IN	O
electronegative	JJ	O
induction	NN	O
,	,	O
would	MD	O
decrease	VB	O
cationic	JJ	O
character	NN	O
of	IN	O
inhibitors	NNS	O
2a-d	JJ	O
compared	VBN	O
to	TO	O
1	CD	O
,	,	O
and	CC	O
therefore	RB	O
,	,	O
improve	VB	O
membrane	NN	O
permeability	NN	O
of	IN	O
the	DT	O
inhibitors	NNS	O
.	.	O
Illustrating	VBG	O
various	JJ	O
such	JJ	O
embodiments	NNS	O
of	IN	O
this	DT	O
invention	NN	O
,	,	O
a	DT	O
series	NN	O
of	IN	O
nNOS	JJ	O
inhibitors	NNS	O
(	(	O
2	CD	O
)	)	O
provides	VBZ	O
a	DT	O
structurally	RB	O
constrained	VBN	O
cyclopropyl	NN	O
ring	VBG	O
inserted	VBN	O
in	IN	O
the	DT	O
position	NN	O
adjacent	NN	O
to	TO	O
the	DT	O
amine	JJ	O
group	NN	O
of	IN	O
the	DT	O
ethanamino	NN	O
tail	NN	O
.	.	O
The	DT	O
introduction	NN	O
of	IN	O
the	DT	O
cyclopropyl	NN	O
group	NN	O
of	IN	O
the	DT	O
new	JJ	O
inhibitors	NNS	O
(	(	O
2	CD	O
)	)	O
can	MD	O
potentially	RB	O
enhance	VB	O
the	DT	O
inhibitory	NN	O
activity	NN	O
by	IN	O
stabilizing	VBG	O
a	DT	O
biologically	RB	O
active	JJ	O
conformer	NN	O
(	(	O
therefore	IN	O
reducing	VBG	O
the	DT	O
energetic	JJ	O
penalty	NN	O
on	IN	O
binding	VBG	O
to	TO	O
the	DT	O
enzyme	NN	O
)	)	O
,	,	O
and	CC	O
improve	VB	O
selectivity	NN	O
by	IN	O
eliminating	VBG	O
bioactive	JJ	O
conformers	NNS	O
that	WDT	O
give	VBP	O
undesired	JJ	O
biological	JJ	O
responses	NNS	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
the	DT	O
insertion	NN	O
of	IN	O
a	DT	O
cyclopropyl	JJ	O
fragment	NN	O
can	MD	O
block	VB	O
the	DT	O
potential	JJ	O
metabolic	JJ	O
oxidation	NN	O
at	IN	O
the	DT	O
benzylic	JJ	O
position	NN	O
of	IN	O
the	DT	O
m-fluorophenyl	JJ	O
ring	NN	O
.	.	O
Furthermore	RB	O
,	,	O
the	DT	O
electro-withdrawing	JJ	O
character	NN	O
of	IN	O
the	DT	O
cyclopropyl	NN	O
ring	NN	O
decreases	VBZ	O
the	DT	O
basicity	NN	O
of	IN	O
the	DT	O
adjacent	JJ	O
amino	NN	O
group	NN	O
.	.	O
The	DT	O
calculated	JJ	O
pKa	NN	O
value	NN	O
of	IN	O
the	DT	O
amino	NN	O
group	NN	O
in	IN	O
the	DT	O
lipophilic	JJ	O
tail	NN	O
of	IN	O
such	JJ	O
embodiments	NNS	O
of	IN	O
inhibitor	NN	O
2	CD	O
was	VBD	O
˜7.4	NNP	O
,	,	O
which	WDT	O
was	VBD	O
significantly	RB	O
lower	JJR	O
than	IN	O
that	DT	O
of	IN	O
1	CD	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
pseudo-monocationic	JJ	O
cyclopropyl	NN	O
variations	NNS	O
of	IN	O
inhibitor	NN	O
2	CD	O
should	MD	O
have	VB	O
improved	VBN	O
BBB	NNP	O
permeability	NN	O
.	.	O
Generally	RB	O
,	,	O
a	DT	O
representative	JJ	O
synthesis	NN	O
of	IN	O
4b	CD	O
is	VBZ	O
detailed	VBN	O
in	IN	O
Scheme	NNP	O
1a	CD	O
,	,	O
below	NN	O
.	.	O
Acid-catalyzed	JJ	O
esterification	NN	O
of	IN	O
carboxylic	JJ	O
acid	NN	O
5	CD	O
provided	VBD	O
methyl	NN	O
ester	NN	O
6	CD	O
,	,	O
which	WDT	O
was	VBD	O
treated	VBN	O
with	IN	O
diazomethane	NN	O
(	(	O
CH2N2	NNP	O
)	)	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
catalytic	JJ	O
amount	NN	O
of	IN	O
Pd	NNP	O
(	(	O
OAc	NNP	O
)	)	O
2	CD	O
to	TO	O
generate	VB	O
cyclopropyl	NN	O
methyl	NN	O
ester	NN	O
7	CD	O
in	IN	O
excellent	JJ	O
yields	NNS	O
.	.	O
Saponification	NN	O
of	IN	O
7	CD	O
in	IN	O
aqueous	JJ	O
NaOH	NNP	O
(	(	O
2N	CD	O
)	)	O
gave	VBD	O
carboxylic	JJ	O
acid	NN	O
8	CD	O
,	,	O
which	WDT	O
was	VBD	O
converted	VBN	O
to	TO	O
a	DT	O
Boc-protected	JJ	O
amine	NN	O
9	CD	O
through	IN	O
a	DT	O
Curtius	NNP	O
rearrangement	NN	O
.	.	O
(	(	O
Tchilibon	NNP	B
,	,	I
S.	NNP	I
;	:	I
Kim	NNP	I
,	,	I
S.-K.	NNP	I
;	:	I
Gao	NNP	I
,	,	I
Z.-G.	NNP	I
;	:	I
Harris	NNP	I
,	,	I
B	NNP	I
.	.	I
A.	NN	I
;	:	I
Blaustein	NNP	I
,	,	I
J	NNP	I
.	.	I
B.	NNP	I
;	:	I
Gross	NNP	I
,	,	I
A.	NNP	I
S.	NNP	I
;	:	I
Duong	NNP	I
,	,	I
H.	NNP	I
T.	NNP	I
;	:	I
Melman	NNP	I
,	,	I
N.	NNP	I
;	:	I
Jacobson	NNP	I
,	,	I
K.	NNP	I
A	NNP	I
.	.	I
Exploring	VBG	I
distal	JJ	I
regions	NNS	I
of	IN	I
the	DT	I
A3	NNP	I
adenosine	NN	I
receptor	NN	I
binding	VBG	I
site	NN	I
:	:	I
sterically	RB	I
constrained	VBN	I
N6-	NNP	I
(	(	I
2-phenylethyl	JJ	I
)	)	I
adenosine	NN	I
derivatives	NNS	I
as	IN	I
potent	JJ	I
ligands	NNS	I
.	.	I
Bioorg	NNP	I
.	.	I
Med	NNP	I
.	.	I
Chem	NNP	I
.	.	I
2004	CD	I
,	,	I
12	CD	I
,	,	I
2021-2034	JJ	I
.	.	O
)	)	O
Finally	RB	O
,	,	O
the	DT	O
Boc-protecting	NNP	O
group	NN	O
of	IN	O
9	CD	O
was	VBD	O
removed	VBN	O
with	IN	O
TFA	NNP	O
to	TO	O
provide	VB	O
4b	CD	O
as	IN	O
a	DT	O
TFA	NNP	O
salt	NN	O
in	IN	O
high	JJ	O
yields	NNS	O
.	.	O
Alternatively	RB	O
,	,	O
illustrating	VBG	O
another	DT	O
synthetic	JJ	O
route	NN	O
,	,	O
consider	VB	O
the	DT	O
preparation	NN	O
of	IN	O
3a-c	JJ	O
shown	VBN	O
in	IN	O
Scheme	NNP	O
1b	CD	O
.	.	O
(	(	O
As	IN	O
a	DT	O
departure	NN	O
from	IN	O
the	DT	O
aforementioned	JJ	O
general	JJ	O
numbering	NN	O
format	NN	O
,	,	O
the	DT	O
following	JJ	O
compounds	NNS	O
4-9	JJ	O
are	VBP	O
illustrated	VBN	O
in	IN	O
Schemes	NNP	O
1b-e	JJ	O
(	(	O
and	CC	O
described	VBN	O
in	IN	O
examples	NNS	O
5-29	JJ	O
)	)	O
en	FW	O
route	NN	O
to	TO	O
several	JJ	O
non-limiting	JJ	O
representative	JJ	O
variations	NNS	O
of	IN	O
inhibitor	NN	O
compound	NN	O
2b	CD	O
:	:	O
for	IN	O
instance	NN	O
,	,	O
cyclopropyl	JJ	O
inhibitors	NNS	O
2ba-2bd	JJ	O
,	,	O
in	IN	O
Scheme	NNP	O
1d	CD	O
,	,	O
below	IN	O
)	)	O
.	.	O
Rhodium	NNP	O
(	(	O
II	NNP	O
)	)	O
-catalyzed	VBD	O
cyclopropanation	NN	O
of	IN	O
1-substituted-3-vinylbenzene	JJ	O
(	(	O
4a-c	JJ	O
)	)	O
provided	VBD	O
5a-c	JJ	O
as	IN	O
a	DT	O
cis/trans	JJ	O
mixture	NN	O
in	IN	O
good	JJ	O
yields	NNS	O
.	.	O
Next	JJ	O
,	,	O
ethyl	JJ	O
ester	NN	O
5a-c	JJ	O
were	VBD	O
treated	VBN	O
with	IN	O
NaOMe	NNP	O
in	IN	O
refluxing	VBG	O
EtOH	NNP	O
to	TO	O
induce	VB	O
the	DT	O
epimerization	NN	O
reaction	NN	O
,	,	O
generating	VBG	O
the	DT	O
thermodynamically	RB	O
more	RBR	O
stable	JJ	O
trans	NNS	O
isomers	NNS	O
,	,	O
which	WDT	O
were	VBD	O
hydrolyzed	VBN	O
in	IN	O
aqueous	JJ	O
LiOH	NNP	O
to	TO	O
provide	VB	O
6a-c	JJ	O
in	IN	O
good	JJ	O
yields	NNS	O
.	.	O
(	(	O
See	VB	O
,	,	O
Pryde	NNP	B
,	,	I
D.	NNP	I
C.	NNP	I
;	:	I
Cook	NNP	I
,	,	I
A.	NNP	I
S.	NNP	I
;	:	I
Burring	NNP	I
,	,	I
D.	NNP	I
J.	NNP	I
;	:	I
Jones	NNP	I
,	,	I
L.	NNP	I
H.	NNP	I
;	:	I
Foll	NNP	I
,	,	I
S.	NNP	I
;	:	I
Platts	NNP	I
,	,	I
M.	NNP	I
Y.	NNP	I
;	:	I
Sanderson	NNP	I
,	,	I
V.	NNP	I
;	:	I
Corless	NNP	I
,	,	I
M.	NNP	I
;	:	I
Stobie	NNP	I
,	,	I
A.	NNP	I
;	:	I
Middleton	NNP	I
,	,	I
D.	NNP	I
S.	NNP	I
;	:	I
Foster	NNP	I
,	,	I
L.	NNP	I
;	:	I
Barker	NNP	I
,	,	I
L.	NNP	I
;	:	I
Graaf	NNP	I
,	,	I
P.	NNP	I
V.	NNP	I
D.	NNP	I
;	:	I
Stacey	NNP	I
,	,	I
P.	NNP	I
;	:	I
Kohl	NNP	I
,	,	I
C.	NNP	I
;	:	I
Coggon	NNP	I
,	,	I
S.	NNP	I
;	:	I
Beaumont	NNP	I
,	,	I
K.	NNP	I
“	NNP	I
Novel	NNP	I
Selective	NNP	I
Inhibitors	NNP	I
of	IN	I
Neutral	NNP	I
Endopeptidase	NNP	I
for	IN	I
the	DT	I
Treatment	NNP	I
of	IN	I
Female	NNP	I
Sexual	NNP	I
Arousal	NNP	I
Disorder.	NNP	I
”	NNP	I
Bioor	NNP	I
.	.	I
Med	NNP	I
.	.	I
Chem	NNP	I
.	.	I
2007	CD	I
,	,	I
15	CD	I
,	,	I
142	CD	I
.	.	O
)	)	O
Carboxylic	JJ	O
acids	NNS	O
6a-c	CD	O
were	VBD	O
converted	VBN	O
to	TO	O
Boc-protected	JJ	O
amines	NNS	O
(	(	O
7a-c	JJ	O
)	)	O
through	IN	O
Curtius	NNP	O
rearrangement	JJ	O
reactions	NNS	O
in	IN	O
reasonable	JJ	O
yields	NNS	O
.	.	O
(	(	O
See	VB	O
,	,	O
Tchilibon	NNP	B
,	,	I
S.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
supra	NN	I
.	.	I
)	)	O
Finally	RB	O
,	,	O
the	DT	O
Boc-protecting	NNP	O
groups	NNS	O
of	IN	O
7a-c	JJ	O
were	VBD	O
removed	VBN	O
in	IN	O
trifluoroacetic	JJ	O
acid	NN	O
(	(	O
TFA	NNP	O
)	)	O
to	TO	O
provide	VB	O
3a-c	JJ	O
as	IN	O
TFA	NNP	O
salts	NNS	O
in	IN	O
high	JJ	O
yields	NNS	O
.	.	O
The	DT	O
two	CD	O
enantiomers	NNS	O
of	IN	O
3c	CD	O
were	VBD	O
resolved	VBN	O
through	IN	O
their	PRP$	O
camphanic	JJ	O
amides	NNS	O
(	(	O
Scheme	NNP	O
1c	CD	O
)	)	O
.	.	O
First	RB	O
the	DT	O
racemic	JJ	O
mixture	NN	O
of	IN	O
3c	CD	O
was	VBD	O
treated	VBN	O
with	IN	O
(	(	O
S	NNP	O
)	)	O
-	:	O
(	(	O
−	NN	O
)	)	O
camphanic	NN	O
chloride	NN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
triethylamine	NN	O
(	(	O
TEA	NNP	O
)	)	O
to	TO	O
generate	VB	O
two	CD	O
separable	JJ	O
diastereomers	NNS	O
8a	CD	O
and	CC	O
8b	CD	O
in	IN	O
high	JJ	O
yields	NNS	O
.	.	O
Next	RB	O
,	,	O
the	DT	O
amide	JJ	O
bonds	NNS	O
of	IN	O
8a	CD	O
and	CC	O
8b	CD	O
were	VBD	O
hydrolyzed	VBN	O
in	IN	O
concentrated	JJ	O
HCl	NNP	O
to	TO	O
provide	VB	O
single	JJ	O
enantiomers	NNS	O
3d	CD	O
and	CC	O
3e	CD	O
in	IN	O
good	JJ	O
yields	NNS	O
.	.	O
As	IN	O
illustrated	VBN	O
in	IN	O
Scheme	NNP	O
1d	CD	O
,	,	O
reductive	JJ	O
amination	NN	O
of	IN	O
aldehyde	JJ	O
8	CD	O
with	IN	O
amines	NNS	O
3a-d	CD	O
using	VBG	O
NaHB	NNP	O
(	(	O
OAc	NNP	O
)	)	O
3	CD	O
as	IN	O
a	DT	O
reducing	VBG	O
reagent	NN	O
gave	VBD	O
9a-d	CD	O
in	IN	O
high	JJ	O
yields	NNS	O
.	.	O
Next	RB	O
,	,	O
the	DT	O
three	CD	O
Boc-protecting	JJ	O
groups	NNS	O
of	IN	O
9a-d	CD	O
were	VBD	O
removed	VBN	O
in	IN	O
HCl	NNP	O
to	TO	O
yield	VB	O
the	DT	O
final	JJ	O
inhibitors	NNS	O
(	(	O
2ba-bd	JJ	O
)	)	O
in	IN	O
excellent	JJ	O
yields	NNS	O
.	.	O
For	IN	O
purpose	NN	O
of	IN	O
comparison	NN	O
and	CC	O
to	TO	O
demonstrate	VB	O
the	DT	O
relative	JJ	O
effectiveness	NN	O
of	IN	O
inhibitors	NNS	O
2a-d	JJ	O
,	,	O
compound	VBD	O
10	CD	O
was	VBD	O
synthesized	VBN	O
as	IN	O
shown	VBN	O
in	IN	O
Scheme	NNP	O
1e	CD	O
.	.	O
Reductive	JJ	O
amination	NN	O
of	IN	O
aldehyde	JJ	O
11	CD	O
with	IN	O
amine	JJ	O
3e	CD	O
provided	VBD	O
the	DT	O
corresponding	JJ	O
secondary	JJ	O
amine	NN	O
,	,	O
which	WDT	O
was	VBD	O
then	RB	O
protected	VBN	O
by	IN	O
a	DT	O
Boc-protecting	NNP	O
group	NN	O
to	TO	O
give	VB	O
12	CD	O
in	IN	O
reasonable	JJ	O
yields	NNS	O
.	.	O
Catalytic	JJ	O
hydrogenation	NN	O
of	IN	O
12	CD	O
using	VBG	O
Pd	NNP	O
(	(	O
OH	NNP	O
)	)	O
2/C	CD	O
as	IN	O
a	DT	O
catalyst	NN	O
at	IN	O
60°	CD	O
C.	NNP	O
removed	VBD	O
the	DT	O
Bn-protecting	NNP	O
group	NN	O
.	.	O
At	IN	O
the	DT	O
same	JJ	O
time	NN	O
,	,	O
the	DT	O
cyclopropyl	NN	O
group	NN	O
was	VBD	O
reduced	VBN	O
to	TO	O
generate	VB	O
compound	NN	O
13	CD	O
as	IN	O
a	DT	O
single	JJ	O
enantiomer	NN	O
.	.	O
Finally	RB	O
,	,	O
the	DT	O
three	CD	O
Boc-protecting	JJ	O
groups	NNS	O
were	VBD	O
removed	VBN	O
in	IN	O
HCl	NNP	O
to	TO	O
provide	VB	O
inhibitor	NN	O
10	CD	O
as	IN	O
an	DT	O
HCl	NNP	O
salt	NN	O
in	IN	O
good	JJ	O
yields	NNS	O
.	.	O
As	IN	O
shown	VBN	O
in	IN	O
Scheme	NNP	O
2	CD	O
,	,	O
the	DT	O
synthesis	NN	O
of	IN	O
4c	CD	O
began	VBD	O
with	IN	O
3-fluorostyrene	JJ	O
10	CD	O
.	.	O
Bromofluorination	NN	O
of	IN	O
10	CD	O
using	VBG	O
NBS	NNP	O
and	CC	O
Et3N.3HF	NNP	O
generated	VBD	O
1-	JJ	O
(	(	O
2-bromo-1-fluoroethyl	JJ	O
)	)	O
-3-fluorobenzene	VBZ	O
11	CD	O
in	IN	O
a	DT	O
high	JJ	O
yield	NN	O
.	.	O
(	(	O
See	VB	O
,	,	O
Rosen	NNP	B
,	,	I
T.	NNP	I
C.	NNP	I
;	:	I
Yoshida	NNP	I
,	,	I
S.	NNP	I
;	:	I
Fröhlich	NNP	I
,	,	I
R.	NNP	I
;	:	I
Kirk	NNP	I
,	,	I
K.	NNP	I
L.	NNP	I
;	:	I
Haufe	NNP	I
,	,	I
G.	NNP	I
Fluorinated	NNP	I
phenylcyclopropylamines	NNS	I
.	.	I
2	CD	I
.	.	I
Effects	NNS	I
of	IN	I
aromatic	JJ	I
ring	NN	I
substitution	NN	I
and	CC	I
of	IN	I
absolute	JJ	I
configuration	NN	I
on	IN	I
inhibition	NN	I
of	IN	I
microbial	JJ	I
tyramine	NN	I
oxidase	NN	I
.	.	I
J.	NNP	I
Med	NNP	I
.	.	I
Chem	NNP	I
.	.	I
2004	CD	I
,	,	I
47	CD	I
,	,	I
5860-5871	JJ	I
.	.	I
)	)	O
Next	JJ	O
,	,	O
11	CD	O
was	VBD	O
converted	VBN	O
to	TO	O
azide	VB	O
(	(	O
12	CD	O
)	)	O
using	VBG	O
NaN3	NNP	O
in	IN	O
DMSO	NNP	O
at	IN	O
65°	CD	O
C.	NNP	O
in	IN	O
a	DT	O
good	JJ	O
yield	NN	O
.	.	O
(	(	O
Other	JJ	O
solvents	NNS	O
such	JJ	O
as	IN	O
THF	NNP	O
and	CC	O
DMF	NNP	O
did	VBD	O
not	RB	O
give	VB	O
satisfactory	JJ	O
yields	NNS	O
.	.	O
)	)	O
Finally	RB	O
,	,	O
catalytic	JJ	O
hydrogenation	NN	O
of	IN	O
12	CD	O
in	IN	O
a	DT	O
mixture	NN	O
of	IN	O
EtOH	NNP	O
and	CC	O
1	CD	O
N	NNP	O
HCl	NNP	O
(	(	O
2:1	CD	O
)	)	O
provided	VBD	O
4c	CD	O
as	IN	O
a	DT	O
HCl	NNP	O
salt	NN	O
in	IN	O
an	DT	O
excellent	JJ	O
yield	NN	O
.	.	O
Generally	RB	O
,	,	O
a	DT	O
representative	JJ	O
synthesis	NN	O
of	IN	O
a	DT	O
difluoroethanamine	NN	O
is	VBZ	O
as	IN	O
shown	VBN	O
in	IN	O
Scheme	NNP	O
3	CD	O
.	.	O
2-Bromo-3′-fluoroacetophenone	CD	O
13	CD	O
was	VBD	O
treated	VBN	O
with	IN	O
diethylaminosulfur	JJ	O
trifluoride	NN	O
(	(	O
DAST	NNP	O
)	)	O
to	TO	O
give	VB	O
1-	JJ	O
(	(	O
2-bromo-1,1-difluoroethyl	JJ	O
)	)	O
-3-fluorobenzene	VBZ	O
14	CD	O
in	IN	O
good	JJ	O
yield	NN	O
.	.	O
(	(	O
See	VB	O
,	,	O
Lakshmipathi	NNP	B
,	,	I
P.	NNP	I
;	:	I
Crévisy	NNP	I
,	,	I
C.	NNP	I
;	:	I
Grée	NNP	I
,	,	I
R.	NNP	I
Reaction	NNP	I
monitoring	NN	I
in	IN	I
LPOS	NNP	I
by	IN	I
19F	CD	I
NMR	NNP	I
.	.	I
Study	NNP	I
of	IN	I
soluble	JJ	I
polymer	NN	I
supports	NNS	I
with	IN	I
fluorine	NN	I
in	IN	I
spacer	NN	I
or	CC	I
linker	NN	I
components	NNS	I
of	IN	I
supports	NNS	I
.	.	I
J.	NNP	I
Comb	NNP	I
.	.	I
Chem	NNP	I
.	.	I
2002	CD	I
,	,	I
4	CD	I
,	,	I
612-621	JJ	I
.	.	I
)	)	O
Next	JJ	O
,	,	O
14	CD	O
was	VBD	O
allowed	VBN	O
to	TO	O
react	VB	O
with	IN	O
NaN3	NNP	O
in	IN	O
DMSO	NNP	O
at	IN	O
110°	CD	O
C.	NNP	O
to	TO	O
give	VB	O
azide	NN	O
(	(	O
15	CD	O
)	)	O
in	IN	O
a	DT	O
good	JJ	O
yield	NN	O
.	.	O
Finally	RB	O
,	,	O
15	CD	O
was	VBD	O
subjected	VBN	O
to	TO	O
catalytic	JJ	O
hydrogenation	NN	O
under	IN	O
acidic	JJ	O
conditions	NNS	O
to	TO	O
give	VB	O
4d	CD	O
as	IN	O
an	DT	O
HCl	NNP	O
salt	NN	O
in	IN	O
a	DT	O
good	JJ	O
yield	NN	O
.	.	O
With	IN	O
4a-d	JJ	O
in	IN	O
hand	NN	O
,	,	O
the	DT	O
syntheses	NNS	O
of	IN	O
inhibitors	NNS	O
2a-d	JJ	O
were	VBD	O
completed	VBN	O
using	VBG	O
a	DT	O
three-step	JJ	O
procedure	NN	O
(	(	O
Scheme	NNP	O
4	CD	O
)	)	O
.	.	O
First	RB	O
,	,	O
reductive	JJ	O
amination	NN	O
between	IN	O
3	CD	O
and	CC	O
4a-d	JJ	O
using	VBG	O
NaHB	NNP	O
(	(	O
OAc	NNP	O
)	)	O
3	CD	O
gave	VBD	O
16a-d	CD	O
in	IN	O
modest	JJ	O
yields	NNS	O
.	.	O
To	TO	O
simplify	VB	O
the	DT	O
purification	NN	O
process	NN	O
,	,	O
the	DT	O
resulting	VBG	O
secondary	JJ	O
amines	NNS	O
(	(	O
16a-d	JJ	O
)	)	O
were	VBD	O
protected	VBN	O
with	IN	O
(	(	O
Boc	NNP	O
)	)	O
2O	CD	O
to	TO	O
give	VB	O
17a-d	JJ	O
.	.	O
Finally	RB	O
,	,	O
the	DT	O
Bn-protecting	NNP	O
group	NN	O
and	CC	O
the	DT	O
three	CD	O
Boc-protecting	JJ	O
groups	NNS	O
were	VBD	O
removed	VBN	O
at	IN	O
the	DT	O
same	JJ	O
time	NN	O
in	IN	O
a	DT	O
mixture	NN	O
of	IN	O
EtOH	NNP	O
and	CC	O
12	CD	O
N	NNP	O
HCl	NNP	O
(	(	O
2:1	CD	O
)	)	O
under	IN	O
high	JJ	O
pressure	NN	O
catalytic	JJ	O
hydrogenation	NN	O
conditions	NNS	O
to	TO	O
provide	VB	O
2a-d	JJ	O
as	IN	O
HCl	NNP	O
salts	NNS	O
in	IN	O
good	JJ	O
yields	NNS	O
.	.	O
Alternatively	RB	O
,	,	O
as	IN	O
a	DT	O
variation	NN	O
on	IN	O
the	DT	O
aforementioned	JJ	O
embodiments	NNS	O
,	,	O
enantiomerically-pure	JJ	O
inhibitors	NNS	O
can	MD	O
be	VB	O
prepared	VBN	O
,	,	O
examples	NNS	O
of	IN	O
which	WDT	O
are	VBP	O
shown	VBN	O
below	IN	O
.	.	O
(	(	O
As	IN	O
a	DT	O
departure	NN	O
from	IN	O
the	DT	O
aforementioned	JJ	O
general	JJ	O
numbering	NN	O
format	NN	O
,	,	O
the	DT	O
following	JJ	O
compounds	NNS	O
4-10	JJ	O
are	VBP	O
illustrated	VBN	O
in	IN	O
Schemes	NNP	O
5-8	JJ	O
(	(	O
and	CC	O
described	VBN	O
in	IN	O
examples	NNS	O
43-57	JJ	O
)	)	O
en	FW	O
route	NN	O
to	TO	O
several	JJ	O
non-limiting	JJ	O
representative	JJ	O
variations	NNS	O
of	IN	O
inhibitor	NN	O
compound	NN	O
2d	CD	O
;	:	O
for	IN	O
instance	NN	O
,	,	O
enantiomerically	RB	O
difluoromethylene	JJ	O
inhibitors	NNS	O
2da-2dd	JJ	O
in	IN	O
Scheme	NNP	O
6	CD	O
,	,	O
below	NN	O
.	.	O
Synthesis	NN	O
of	IN	O
enantiomerically	RB	O
pure	JJ	O
pyrrolidine	NN	O
core	NN	O
(	(	O
4a-b	JJ	O
)	)	O
is	VBZ	O
shown	VBN	O
in	IN	O
Scheme	NNP	O
5	CD	O
.	.	O
First	RB	O
,	,	O
the	DT	O
racemic	JJ	O
trans-alcohol	NN	O
5	CD	O
underwent	NN	O
a	DT	O
Mitsunobu	NNP	O
reaction	NN	O
using	VBG	O
(	(	O
S	NNP	O
)	)	O
-	:	O
(	(	O
−	NN	O
)	)	O
camphanic	NN	O
acid	NN	O
as	IN	O
a	DT	O
nucleophile	NN	O
to	TO	O
produce	VB	O
two	CD	O
separable	JJ	O
diastereomers	NNS	O
(	(	O
6a	CD	O
and	CC	O
6b	CD	O
)	)	O
in	IN	O
excellent	JJ	O
yields	NNS	O
.	.	O
Next	RB	O
,	,	O
the	DT	O
ester	NN	O
linkage	NN	O
in	IN	O
6a	CD	O
and	CC	O
6b	CD	O
was	VBD	O
hydrolyzed	VBN	O
in	IN	O
aqueous	JJ	O
Na2CO3	NNP	O
to	TO	O
generate	VB	O
4a	CD	O
and	CC	O
4b	CD	O
in	IN	O
high	JJ	O
yields	NNS	O
.	.	O
As	IN	O
shown	VBN	O
in	IN	O
Scheme	NNP	O
6	CD	O
,	,	O
single	JJ	O
enantiomer	NN	O
4a	CD	O
or	CC	O
4b	CD	O
was	VBD	O
treated	VBN	O
with	IN	O
NaH	NNP	O
,	,	O
and	CC	O
the	DT	O
resulting	VBG	O
anion	NN	O
was	VBD	O
allowed	VBN	O
to	TO	O
react	VB	O
with	IN	O
allyl	JJ	O
bromide	NN	O
to	TO	O
generate	VB	O
7a	CD	O
and	CC	O
7b	CD	O
in	IN	O
excellent	JJ	O
yields	NNS	O
.	.	O
Ozonolysis	NN	O
of	IN	O
7a	CD	O
and	CC	O
7b	CD	O
using	VBG	O
Zn	NNP	O
dust	NN	O
as	IN	O
reducing	VBG	O
reagent	NN	O
yielded	VBD	O
8a	CD	O
and	CC	O
8b	CD	O
in	IN	O
good	JJ	O
yields	NNS	O
.	.	O
Aldehydes	NNS	O
8a	CD	O
or	CC	O
8b	CD	O
were	VBD	O
subjected	VBN	O
to	TO	O
reductive	VB	O
amination	NN	O
reactions	NNS	O
with	IN	O
different	JJ	O
ethanamines	NNS	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
NaHB	NNP	O
(	(	O
OAc	NNP	O
)	)	O
3	CD	O
to	TO	O
generate	VB	O
secondary	JJ	O
amines	NNS	O
,	,	O
which	WDT	O
were	VBD	O
further	RBR	O
protected	VBN	O
by	IN	O
another	DT	O
Boc-protecting	NNP	O
group	NN	O
to	TO	O
produce	VB	O
the	DT	O
fully	RB	O
protected	JJ	O
inhibitors	NNS	O
9a-d	CD	O
in	IN	O
good	JJ	O
yields	NNS	O
.	.	O
Next	RB	O
,	,	O
the	DT	O
benzyl-protecting	JJ	O
group	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
a	DT	O
catalytic	JJ	O
hydrogenation	NN	O
reaction	NN	O
using	VBG	O
Pd	NNP	O
(	(	O
OH	NNP	O
)	)	O
2	CD	O
at	IN	O
60°	CD	O
C.	NNP	O
to	TO	O
provide	VB	O
10a-d	JJ	O
in	IN	O
modest	JJ	O
yields	NNS	O
.	.	O
Finally	RB	O
,	,	O
the	DT	O
three	CD	O
Boc-protecting	JJ	O
groups	NNS	O
were	VBD	O
removed	VBN	O
at	IN	O
the	DT	O
same	JJ	O
time	NN	O
in	IN	O
HCl	NNP	O
to	TO	O
generate	VB	O
inhibitors	NNS	O
2da-2dd	JJ	O
in	IN	O
high	JJ	O
yields	NNS	O
.	.	O
As	IN	O
relates	NNS	O
to	TO	O
the	DT	O
binding	NN	O
studies	NNS	O
discussed	VBN	O
below	IN	O
,	,	O
inhibitor	NN	O
compounds	NNS	O
2e-f	JJ	O
were	VBD	O
also	RB	O
prepared	VBN	O
.	.	O
The	DT	O
synthesis	NN	O
of	IN	O
inhibitor	NN	O
2e	CD	O
began	VBD	O
with	IN	O
9a	CD	O
(	(	O
Scheme	NNP	O
7	CD	O
)	)	O
.	.	O
Catalytic	JJ	O
hydrogenation	NN	O
of	IN	O
9a	CD	O
using	VBG	O
Pd	NNP	O
(	(	O
OH	NNP	O
)	)	O
2	CD	O
at	IN	O
accelerated	JJ	O
temperature	NN	O
removed	VBD	O
the	DT	O
benzyl-protecting	JJ	O
group	NN	O
,	,	O
and	CC	O
at	IN	O
the	DT	O
same	JJ	O
time	NN	O
,	,	O
the	DT	O
pyridinyl	NN	O
ring	NN	O
was	VBD	O
reduced	VBN	O
to	TO	O
generate	VB	O
10e	CD	O
in	IN	O
modest	JJ	O
yields	NNS	O
.	.	O
Then	RB	O
,	,	O
three	CD	O
Boc-protecting	JJ	O
groups	NNS	O
were	VBD	O
removed	VBN	O
in	IN	O
HCl	NNP	O
to	TO	O
generate	VB	O
inhibitor	NN	O
2e	CD	O
in	IN	O
high	JJ	O
yields	NNS	O
.	.	O
The	DT	O
synthesis	NN	O
of	IN	O
inhibitor	NN	O
2f	CD	O
is	VBZ	O
shown	VBN	O
in	IN	O
Scheme	NNP	O
8	CD	O
.	.	O
Reductive	JJ	O
amination	NN	O
of	IN	O
aldehyde	JJ	O
8b	CD	O
with	IN	O
2,2-difluoro-2-	JJ	O
(	(	O
pyridin-2-yl	JJ	O
)	)	O
ethanamine	NN	O
(	(	O
e.g.	JJ	O
,	,	O
as	RB	O
prepared	JJ	O
as	IN	O
described	VBN	O
above	IN	O
)	)	O
generated	VBD	O
a	DT	O
secondary	JJ	O
amine	NN	O
,	,	O
which	WDT	O
was	VBD	O
further	RBR	O
protected	VBN	O
by	IN	O
another	DT	O
Boc-protecting	NNP	O
group	NN	O
to	TO	O
provide	VB	O
9f	CD	O
in	IN	O
good	JJ	O
yields	NNS	O
.	.	O
Next	JJ	O
,	,	O
catalytic	JJ	O
hydrogenation	NN	O
of	IN	O
9f	CD	O
removed	VBD	O
the	DT	O
benzyl	NN	O
protecting	VBG	O
group	NN	O
,	,	O
and	CC	O
also	RB	O
reduced	VBD	O
the	DT	O
pyridinyl	NN	O
group	NN	O
adjacent	VBD	O
to	TO	O
the	DT	O
CF2	NNP	O
group	NN	O
to	TO	O
generate	VB	O
10f	CD	O
in	IN	O
modest	JJ	O
yields	NNS	O
.	.	O
Finally	RB	O
,	,	O
the	DT	O
three	CD	O
Boc-protecting	JJ	O
groups	NNS	O
were	VBD	O
removed	VBN	O
at	IN	O
the	DT	O
same	JJ	O
time	NN	O
in	IN	O
HCl	NNP	O
to	TO	O
generate	VB	O
the	DT	O
final	JJ	O
inhibitor	NN	O
2f	CD	O
in	IN	O
high	JJ	O
yields	NNS	O
.	.	O
Crystal	JJ	O
Structures	NNS	O
of	IN	O
nNOS	JJ	O
Bound	NNP	O
with	IN	O
Inhibitor	NNP	O
Compounds	NNP	O
2da-2dd	JJ	O
and	CC	O
2e-f	JJ	O
Consistent	NNP	O
with	IN	O
the	DT	O
binding	VBG	O
preference	NN	O
of	IN	O
the	DT	O
enantiomerically	JJ	O
pure	JJ	O
parental	JJ	O
compound	NN	O
1	CD	O
,	,	O
the	DT	O
binding	VBG	O
mode	NN	O
of	IN	O
these	DT	O
difluorine	JJ	O
derivatives	NNS	O
was	VBD	O
found	VBN	O
also	RB	O
to	TO	O
be	VB	O
dependent	JJ	O
on	IN	O
the	DT	O
configuration	NN	O
around	IN	O
the	DT	O
two	CD	O
chiral	JJ	O
centers	NNS	O
:	:	O
the	DT	O
3′	CD	O
and	CC	O
4′	CD	O
positions	NNS	O
of	IN	O
the	DT	O
pyrrolidine	NN	O
ring	NN	O
.	.	O
While	IN	O
the	DT	O
(	(	O
S	NNP	O
,	,	O
S	NNP	O
)	)	O
inhibitor	NN	O
2da	CD	O
was	VBD	O
found	VBN	O
to	TO	O
bind	VB	O
with	IN	O
its	PRP$	O
aminopyridine	NN	O
moiety	NN	O
hydrogen	NN	O
bonded	VBD	O
to	TO	O
the	DT	O
side	NN	O
chain	NN	O
of	IN	O
Glu592	NNP	O
in	IN	O
nNOS	NN	O
(	(	O
FIG	NNP	O
.	.	O
2A	CD	O
)	)	O
,	,	O
the	DT	O
(	(	O
R	NNP	O
,	,	O
R	NNP	O
)	)	O
inhibitor	NN	O
2db	CD	O
adopted	VBD	O
a	DT	O
‘	NN	O
flipped	VBD	O
’	NNP	O
binding	VBG	O
mode	NN	O
with	IN	O
its	PRP$	O
aminopyridine	NN	O
making	NN	O
bifurcated	VBD	O
hydrogen	JJ	O
bonds	NNS	O
with	IN	O
the	DT	O
heme	NN	O
propionate	VB	O
off	RP	O
pyrrole	JJ	O
ring	NN	O
D	NNP	O
(	(	O
FIG	NNP	O
.	.	O
2B	CD	O
)	)	O
.	.	O
To	TO	O
leave	VB	O
room	NN	O
for	IN	O
these	DT	O
new	JJ	O
hydrogen	NN	O
bonds	NNS	O
,	,	O
the	DT	O
Tyr706	NNP	O
side	NN	O
chain	NN	O
rotates	VBZ	O
away	RB	O
and	CC	O
stacks	NNS	O
against	IN	O
the	DT	O
aminopyridine	JJ	O
ring	NN	O
of	IN	O
inhibitor	NN	O
.	.	O
The	DT	O
pyrrolidine	NN	O
nitrogen	NN	O
in	IN	O
2db	CD	O
also	RB	O
makes	VBZ	O
favorable	JJ	O
hydrogen	JJ	O
bonds	NNS	O
with	IN	O
propionate	NN	O
A	NN	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
O4	NNP	O
atom	NN	O
of	IN	O
H4B	NNP	O
.	.	O
In	IN	O
comparison	NN	O
,	,	O
the	DT	O
pyrrolidine	NN	O
nitrogen	NN	O
in	IN	O
2da	CD	O
was	VBD	O
only	RB	O
loosely	RB	O
hydrogen	NN	O
bonded	VBD	O
to	TO	O
Glu592	NNP	O
.	.	O
The	DT	O
long	JJ	O
,	,	O
flexible	JJ	O
linker	NN	O
extending	VBG	O
from	IN	O
the	DT	O
pyrrolidine	NN	O
allowed	VBD	O
the	DT	O
tail	NN	O
fluorophenyl	NN	O
group	NN	O
in	IN	O
2db	CD	O
to	TO	O
reach	VB	O
the	DT	O
vicinity	NN	O
of	IN	O
Glu592	NNP	O
and	CC	O
to	TO	O
stack	VB	O
against	IN	O
the	DT	O
heme	NN	O
plane	NN	O
.	.	O
The	DT	O
amino	NN	O
group	NN	O
adjacent	VBD	O
to	TO	O
the	DT	O
CF2	NNP	O
moiety	NN	O
points	NNS	O
toward	IN	O
the	DT	O
Glu592	NNP	O
side	NN	O
chain	NN	O
,	,	O
causing	VBG	O
the	DT	O
formation	NN	O
of	IN	O
an	DT	O
alternate	JJ	O
conformation	NN	O
of	IN	O
the	DT	O
carboxylate	NN	O
to	TO	O
make	VB	O
a	DT	O
hydrogen	NN	O
bond	NN	O
between	IN	O
the	DT	O
amino	NN	O
nitrogen	NN	O
and	CC	O
the	DT	O
carboxylate	NN	O
oxygen	NN	O
(	(	O
FIG	NNP	O
.	.	O
2B	CD	O
)	)	O
.	.	O
This	DT	O
alternate	JJ	O
conformation	NN	O
of	IN	O
Glu592	NNP	O
was	VBD	O
not	RB	O
observed	VBN	O
in	IN	O
structure	NN	O
of	IN	O
nNOS	JJ	O
bound	NN	O
with	IN	O
2da	CD	O
because	IN	O
the	DT	O
tight	JJ	O
bifurcated	JJ	O
hydrogen	NN	O
bonds	NNS	O
from	IN	O
the	DT	O
inhibitor	NN	O
aminopyridine	NN	O
to	TO	O
the	DT	O
carboxylate	NN	O
of	IN	O
Glu592	NNP	O
made	VBD	O
a	DT	O
perfect	JJ	O
match	NN	O
to	TO	O
the	DT	O
original	JJ	O
conformation	NN	O
of	IN	O
the	DT	O
Glu	NNP	O
side	NN	O
chain	NN	O
.	.	O
The	DT	O
fit	NN	O
of	IN	O
the	DT	O
fluorophenyl	NN	O
group	NN	O
in	IN	O
2db	CD	O
to	TO	O
the	DT	O
site	NN	O
of	IN	O
Glu592	NNP	O
is	VBZ	O
not	RB	O
that	IN	O
ideal	NN	O
and	CC	O
in	IN	O
order	NN	O
to	TO	O
avoid	VB	O
close	JJ	O
van	JJ	O
der	NN	O
Waals	NNS	O
contacts	NNS	O
with	IN	O
the	DT	O
inhibitor	NN	O
,	,	O
Glu592	NNP	O
adopts	VBZ	O
an	DT	O
alternate	JJ	O
conformation	NN	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
the	DT	O
fluorophenyl	NN	O
tail	JJ	O
part	NN	O
of	IN	O
2db	CD	O
is	VBZ	O
disordered	VBN	O
as	IN	O
indicated	VBN	O
by	IN	O
the	DT	O
weak	JJ	O
electron	NN	O
density	NN	O
for	IN	O
this	DT	O
group	NN	O
.	.	O
When	WRB	O
only	RB	O
one	CD	O
conformation	NN	O
of	IN	O
the	DT	O
tail	NN	O
was	VBD	O
modeled	VBN	O
with	IN	O
the	DT	O
two	CD	O
fluorine	NN	O
atoms	NNS	O
pointing	VBG	O
away	RB	O
from	IN	O
the	DT	O
heme	NN	O
plane	NN	O
,	,	O
strong	JJ	O
negative	JJ	O
difference	NN	O
density	NN	O
was	VBD	O
clustered	VBN	O
around	IN	O
fluorine	NN	O
atoms	NNS	O
.	.	O
Also	RB	O
,	,	O
the	DT	O
electron	NN	O
density	NN	O
of	IN	O
the	DT	O
fluorophenyl	NN	O
ring	NN	O
could	MD	O
not	RB	O
be	VB	O
accounted	VBN	O
for	IN	O
with	IN	O
only	JJ	O
one	CD	O
ring	NN	O
orientation	NN	O
.	.	O
The	DT	O
tail	JJ	O
portion	NN	O
of	IN	O
2db	CD	O
was	VBD	O
,	,	O
therefore	RB	O
,	,	O
modeled	VBN	O
with	IN	O
two	CD	O
different	JJ	O
conformations	NNS	O
(	(	O
0.6	CD	O
and	CC	O
0.4	CD	O
occupancy	NN	O
)	)	O
as	IN	O
shown	VBN	O
in	IN	O
FIG	NNP	O
.	.	O
2B	CD	O
.	.	O
There	EX	O
is	VBZ	O
a	DT	O
partially	RB	O
occupied	JJ	O
water	NN	O
molecule	NN	O
bridging	VBG	O
between	IN	O
the	DT	O
heme	NN	O
propionate	NN	O
and	CC	O
the	DT	O
amino	NN	O
group	NN	O
in	IN	O
the	DT	O
tail	JJ	O
portion	NN	O
of	IN	O
2db	CD	O
in	IN	O
its	PRP$	O
minor	JJ	O
conformation	NN	O
.	.	O
In	IN	O
contrast	NN	O
,	,	O
the	DT	O
fluorophenyl	NN	O
ring	NN	O
in	IN	O
2da	CD	O
fit	NN	O
in	IN	O
a	DT	O
pocket	NN	O
surrounded	VBN	O
by	IN	O
Met336	NNP	O
,	,	O
Leu337	NNP	O
,	,	O
and	CC	O
Tyr706	NNP	O
(	(	O
FIG	NNP	O
.	.	O
2A	CD	O
)	)	O
,	,	O
but	CC	O
the	DT	O
density	NN	O
for	IN	O
2da	CD	O
was	VBD	O
clear	JJ	O
only	RB	O
up	RB	O
to	TO	O
the	DT	O
position	NN	O
of	IN	O
the	DT	O
two	CD	O
fluorine	NN	O
atoms	NNS	O
but	CC	O
too	RB	O
poor	JJ	O
toward	IN	O
the	DT	O
end	NN	O
to	TO	O
give	VB	O
a	DT	O
definite	JJ	O
fluorophenyl	NN	O
ring	VBG	O
orientation	NN	O
.	.	O
Inhibitor	NN	O
2dc	CD	O
has	VBZ	O
its	PRP$	O
fluorine	JJ	O
position	NN	O
in	IN	O
the	DT	O
phenyl	NN	O
ring	VBG	O
changed	VBN	O
from	IN	O
the	DT	O
meta-	NN	O
in	IN	O
2db	CD	O
to	TO	O
the	DT	O
para-position	NN	O
.	.	O
This	DT	O
new	JJ	O
position	NN	O
of	IN	O
fluorine	NN	O
makes	VBZ	O
the	DT	O
tail	JJ	O
portion	NN	O
a	DT	O
bit	NN	O
longer	RBR	O
in	IN	O
2dc	CD	O
than	IN	O
in	IN	O
2db	CD	O
,	,	O
which	WDT	O
resulted	VBD	O
in	IN	O
a	DT	O
conformation	NN	O
with	IN	O
the	DT	O
two	CD	O
fluorine	NN	O
atoms	NNS	O
pointing	VBG	O
downward	RB	O
to	TO	O
the	DT	O
heme	NN	O
plane	NN	O
(	(	O
FIG	NNP	O
.	.	O
3A	CD	O
)	)	O
.	.	O
This	DT	O
conformation	NN	O
disrupts	VBZ	O
the	DT	O
hydrogen	NN	O
bond	NN	O
between	IN	O
the	DT	O
inhibitor	NN	O
amino	NN	O
group	NN	O
and	CC	O
Glu	NNP	O
side	NN	O
chain	NN	O
seen	VBN	O
in	IN	O
the	DT	O
major	JJ	O
conformation	NN	O
in	IN	O
2db	CD	O
,	,	O
but	CC	O
similar	JJ	O
to	TO	O
its	PRP$	O
minor	JJ	O
conformation	NN	O
.	.	O
Inhibitor	NN	O
2dd	CD	O
is	VBZ	O
a	DT	O
derivative	JJ	O
of	IN	O
2db	CD	O
and	CC	O
differs	NNS	O
only	RB	O
by	IN	O
the	DT	O
absence	NN	O
of	IN	O
the	DT	O
fluorine	NN	O
on	IN	O
the	DT	O
phenyl	NN	O
ring	NN	O
.	.	O
Its	PRP$	O
binding	NN	O
mode	NN	O
to	TO	O
nNOS	NN	O
is	VBZ	O
,	,	O
therefore	RB	O
,	,	O
almost	RB	O
identical	JJ	O
to	TO	O
that	DT	O
of	IN	O
2db	CD	O
(	(	O
FIG	NNP	O
.	.	O
3B	CD	O
)	)	O
.	.	O
Without	IN	O
the	DT	O
fluoro	NN	O
group	NN	O
the	DT	O
phenyl	NN	O
ring	NN	O
makes	VBZ	O
a	DT	O
looser	JJR	O
contact	NN	O
with	IN	O
the	DT	O
hydrophobic	NN	O
pocket	NN	O
defined	VBN	O
by	IN	O
Pro565	NNP	O
,	,	O
Va1567	NNP	O
,	,	O
and	CC	O
Phe584	NNP	O
.	.	O
The	DT	O
phenyl	NN	O
tail	NN	O
portion	NN	O
in	IN	O
2db	CD	O
exhibits	NNS	O
two	CD	O
alternate	VBP	O
conformations	NNS	O
similar	JJ	O
to	TO	O
what	WP	O
is	VBZ	O
observed	VBN	O
for	IN	O
2db	CD	O
.	.	O
Inhibitor	NN	O
2e	CD	O
has	VBZ	O
its	PRP$	O
aminopyridine	JJ	O
ring	NN	O
partially	RB	O
reduced	VBN	O
from	IN	O
that	DT	O
in	IN	O
2dd	CD	O
,	,	O
which	WDT	O
has	VBZ	O
a	DT	O
negligible	JJ	O
impact	NN	O
on	IN	O
the	DT	O
binding	NN	O
mode	NN	O
of	IN	O
the	DT	O
inhibitor	NN	O
compared	VBN	O
to	TO	O
2dd	CD	O
(	(	O
FIG	NNP	O
.	.	O
3C	CD	O
)	)	O
.	.	O
The	DT	O
amino	NN	O
and	CC	O
the	DT	O
ring	NN	O
nitrogens	NNS	O
remain	VBP	O
planar	JJ	O
and	CC	O
are	VBP	O
still	RB	O
tightly	RB	O
hydrogen	NN	O
bonded	VBD	O
to	TO	O
the	DT	O
heme	NN	O
propionate	VB	O
off	RP	O
pyrrole	JJ	O
D	NNP	O
and	CC	O
the	DT	O
pyrrolidine	NN	O
nitrogen	NN	O
hydrogen	NN	O
bonded	VBD	O
to	TO	O
propionate	VB	O
A	NNP	O
and	CC	O
H4B	NNP	O
.	.	O
As	IN	O
in	IN	O
2db	CD	O
and	CC	O
2dd	CD	O
,	,	O
the	DT	O
phenyl	NN	O
tail	NN	O
in	IN	O
2e	CD	O
shows	NNS	O
two	CD	O
conformations	NNS	O
above	IN	O
the	DT	O
heme	NN	O
plane	NN	O
while	IN	O
the	DT	O
Glu592	NNP	O
side	NN	O
chain	NN	O
has	VBZ	O
two	CD	O
conformations	NNS	O
,	,	O
correspondingly	RB	O
.	.	O
Another	DT	O
(	(	O
S	NNP	O
,	,	O
S	NNP	O
)	)	O
inhibitor	NN	O
,	,	O
2f	CD	O
,	,	O
is	VBZ	O
similar	JJ	O
to	TO	O
2da	CD	O
except	IN	O
the	DT	O
fluorophenyl	NN	O
tail	NN	O
has	VBZ	O
been	VBN	O
replaced	VBN	O
by	IN	O
a	DT	O
piperidine	NN	O
ring	NN	O
.	.	O
The	DT	O
binding	NN	O
of	IN	O
2f	CD	O
is	VBZ	O
similar	JJ	O
to	TO	O
2da	CD	O
with	IN	O
its	PRP$	O
aminopyridine	NN	O
hydrogen	NN	O
bonded	VBD	O
to	TO	O
the	DT	O
Glu592	NNP	O
side	NN	O
chain	NN	O
while	IN	O
the	DT	O
piperidine	NN	O
ring	VBG	O
fits	NNS	O
to	TO	O
the	DT	O
pocket	NN	O
of	IN	O
Met336	NNP	O
,	,	O
Leu337	NNP	O
,	,	O
and	CC	O
Tyr706	NNP	O
(	(	O
FIG	NNP	O
.	.	O
3D	CD	O
)	)	O
.	.	O
The	DT	O
density	NN	O
for	IN	O
the	DT	O
tail	NN	O
portion	NN	O
is	VBZ	O
good	JJ	O
only	RB	O
up	RB	O
to	TO	O
the	DT	O
CF2	NNP	O
moiety	NN	O
with	IN	O
the	DT	O
piperidine	NN	O
partially	RB	O
disordered	VBD	O
.	.	O
Therefore	RB	O
,	,	O
the	DT	O
orientation	NN	O
of	IN	O
the	DT	O
ring	NN	O
(	(	O
position	NN	O
of	IN	O
nitrogen	NN	O
)	)	O
is	VBZ	O
not	RB	O
well	RB	O
defined	VBN	O
.	.	O
Crystal	JJ	O
Structures	NNS	O
of	IN	O
eNOS	NN	O
Bound	NNP	O
with	IN	O
Inhibitor	NNP	O
Compounds	NNP	O
2db	CD	O
and	CC	O
2f	CD	O
The	DT	O
eNOS	NN	O
structure	NN	O
bound	NN	O
with	IN	O
the	DT	O
(	(	O
R	NNP	O
,	,	O
R	NNP	O
)	)	O
inhibitor	NN	O
2db	CD	O
(	(	O
FIG	NNP	O
.	.	O
4A	CD	O
)	)	O
adopted	VBD	O
a	DT	O
‘	NN	O
flipped	VBD	O
’	NNP	O
binding	VBG	O
mode	NN	O
,	,	O
the	DT	O
same	JJ	O
orientation	NN	O
as	IN	O
in	IN	O
nNOS	NN	O
.	.	O
The	DT	O
Tyr477	NNP	O
side	NN	O
chain	NN	O
rotates	VBZ	O
out	RP	O
,	,	O
but	CC	O
is	VBZ	O
farther	RB	O
away	RB	O
in	IN	O
eNOS	NN	O
and	CC	O
therefore	RB	O
does	VBZ	O
not	RB	O
experience	VB	O
optimized	JJ	O
n-stacking	JJ	O
interactions	NNS	O
with	IN	O
the	DT	O
aminopyridine	NN	O
of	IN	O
inhibitor	NN	O
observed	VBN	O
in	IN	O
nNOS	NN	O
.	.	O
Similar	JJ	O
to	TO	O
what	WP	O
was	VBD	O
seen	VBN	O
in	IN	O
nNOS	NN	O
,	,	O
the	DT	O
aminopyridine	NN	O
in	IN	O
2db	CD	O
makes	VBZ	O
bifurcated	VBN	O
hydrogen	JJ	O
bonds	NNS	O
with	IN	O
the	DT	O
heme	NN	O
propionate	VB	O
off	RP	O
pyrrole	JJ	O
ring	NN	O
D	NNP	O
,	,	O
while	IN	O
the	DT	O
pyrrolidine	JJ	O
nitrogen	NN	O
makes	VBZ	O
favorable	JJ	O
hydrogen	JJ	O
bonds	NNS	O
with	IN	O
propionate	NN	O
A	NN	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
O4	NNP	O
atom	NN	O
of	IN	O
H4B	NNP	O
(	(	O
FIG	NNP	O
.	.	O
4A	CD	O
)	)	O
.	.	O
A	DT	O
hydrogen	NN	O
bond	NN	O
between	IN	O
the	DT	O
inhibitor	NN	O
amino	NN	O
group	NN	O
with	IN	O
alternate	JJ	O
conformations	NNS	O
for	IN	O
Glu363	NNP	O
also	RB	O
is	VBZ	O
observed	VBN	O
.	.	O
With	IN	O
the	DT	O
available	JJ	O
density	NN	O
at	IN	O
the	DT	O
limited	JJ	O
resolution	NN	O
only	RB	O
one	CD	O
conformation	NN	O
of	IN	O
the	DT	O
fluorophenyl	JJ	O
tail	NN	O
portion	NN	O
can	MD	O
be	VB	O
modeled	VBN	O
.	.	O
The	DT	O
binding	NN	O
of	IN	O
the	DT	O
(	(	O
S	NNP	O
,	,	O
S	NNP	O
)	)	O
inhibitor	NN	O
2f	CD	O
in	IN	O
eNOS	NN	O
is	VBZ	O
similar	JJ	O
to	TO	O
nNOS	VB	O
,	,	O
with	IN	O
its	PRP$	O
aminopyridine	NN	O
hydrogen	NN	O
bonded	VBD	O
to	TO	O
the	DT	O
Glu363	NNP	O
side	NN	O
chain	NN	O
(	(	O
FIG	NNP	O
.	.	O
4B	CD	O
)	)	O
in	IN	O
the	DT	O
standard	JJ	O
binding	NN	O
mode	NN	O
.	.	O
The	DT	O
pyrrolidine	NN	O
nitrogen	NN	O
also	RB	O
hydrogen	JJ	O
bonds	NNS	O
with	IN	O
the	DT	O
conserved	JJ	O
glutamate	NN	O
residue	NN	O
,	,	O
but	CC	O
the	DT	O
density	NN	O
for	IN	O
the	DT	O
tail	NN	O
portion	NN	O
is	VBZ	O
good	JJ	O
only	RB	O
up	RB	O
to	TO	O
the	DT	O
CF2	NNP	O
moiety	NN	O
with	IN	O
the	DT	O
piperidine	NN	O
partially	RB	O
disordered	VBD	O
.	.	O
Therefore	RB	O
,	,	O
the	DT	O
orientation	NN	O
of	IN	O
the	DT	O
ring	NN	O
(	(	O
position	NN	O
of	IN	O
nitrogen	NN	O
)	)	O
and	CC	O
the	DT	O
exact	JJ	O
configuration	NN	O
of	IN	O
the	DT	O
puckered	JJ	O
ring	NN	O
are	VBP	O
not	RB	O
clear	JJ	O
.	.	O
Inhibitors	NNS	O
2a-d	CD	O
were	VBD	O
evaluated	VBN	O
for	IN	O
in	IN	O
vitro	JJ	O
inhibition	NN	O
against	IN	O
three	CD	O
isozymes	NNS	O
of	IN	O
NOS	NNP	O
:	:	O
rat	NN	O
nNOS	NN	O
,	,	O
bovine	JJ	O
eNOS	NN	O
and	CC	O
murine	NN	O
iNOS	NN	O
using	VBG	O
known	VBN	O
methods	NNS	O
.	.	O
(	(	O
Hevel	NNP	B
,	,	I
J.	NNP	I
M.	NNP	I
;	:	I
Marletta	NNP	I
,	,	I
M.	NNP	I
A.	NNP	I
Nitric-oxide	NNP	I
synthase	NN	I
assays	NNS	I
.	.	I
Method	NNP	I
Enzymol	NNP	I
.	.	I
1994	CD	I
,	,	I
233	CD	I
,	,	I
250-258	JJ	I
)	)	O
Inhibitor	NNP	O
2a	CD	O
,	,	O
with	IN	O
an	DT	O
electronegative	JJ	O
oxygen	NN	O
atom	NN	O
inserted	VBN	O
into	IN	O
the	DT	O
lipophilic	JJ	O
tail	NN	O
of	IN	O
1	CD	O
,	,	O
has	VBZ	O
K	NNP	O
,	,	O
values	NNS	O
of	IN	O
86	CD	O
nM	NNS	O
,	,	O
21	CD	O
μM	NN	O
,	,	O
and	CC	O
18	CD	O
μM	NN	O
for	IN	O
nNOS	NN	O
,	,	O
eNOS	NN	O
,	,	O
and	CC	O
iNOS	NN	O
,	,	O
respectively	RB	O
(	(	O
Table	JJ	O
2	CD	O
)	)	O
.	.	O
Compared	VBN	O
to	TO	O
the	DT	O
lead	NN	O
compound	NN	O
(	(	O
I	PRP	O
)	)	O
,	,	O
inhibitor	JJ	O
2a	CD	O
is	VBZ	O
almost	RB	O
six-fold	JJ	O
less	RBR	O
potent	JJ	O
,	,	O
while	IN	O
the	DT	O
selectivity	NN	O
of	IN	O
this	DT	O
inhibitor	NN	O
for	IN	O
nNOS	NN	O
over	IN	O
eNOS	NN	O
and	CC	O
iNOS	NN	O
decreases	NNS	O
by	IN	O
ten	JJ	O
fold	NN	O
and	CC	O
three	CD	O
fold	NN	O
,	,	O
respectively	RB	O
.	.	O
There	EX	O
may	MD	O
be	VB	O
two	CD	O
considerations	NNS	O
with	IN	O
respect	NN	O
to	TO	O
these	DT	O
results	NNS	O
.	.	O
First	RB	O
,	,	O
compound	NN	O
2a	CD	O
is	VBZ	O
one	CD	O
atom	NN	O
longer	JJR	O
than	IN	O
1	CD	O
,	,	O
which	WDT	O
probably	RB	O
makes	VBZ	O
it	PRP	O
too	RB	O
long	RB	O
to	TO	O
fit	VB	O
snugly	RB	O
into	IN	O
the	DT	O
active	JJ	O
site	NN	O
of	IN	O
nNOS	NN	O
.	.	O
Moreover	RB	O
,	,	O
it	PRP	O
has	VBZ	O
been	VBN	O
shown	VBN	O
previously	RB	O
that	IN	O
the	DT	O
positively	RB	O
charged	VBN	O
amine	JJ	O
functionality	NN	O
in	IN	O
the	DT	O
lipophilic	JJ	O
tail	NN	O
plays	VBZ	O
an	DT	O
important	JJ	O
role	NN	O
for	IN	O
tight	JJ	O
binding	NN	O
of	IN	O
1	CD	O
to	TO	O
nNOS	VB	O
,	,	O
therefore	RB	O
,	,	O
partial	JJ	O
removal	NN	O
of	IN	O
the	DT	O
positive	JJ	O
charge	NN	O
from	IN	O
this	DT	O
group	NN	O
may	MD	O
impair	VB	O
the	DT	O
activity	NN	O
of	IN	O
inhibitors	NNS	O
Inhibitor	NNP	O
2b	CD	O
,	,	O
with	IN	O
a	DT	O
cyclopropyl	NN	O
functionality	NN	O
in	IN	O
the	DT	O
lipophilic	JJ	O
tail	NN	O
is	VBZ	O
more	RBR	O
potent	JJ	O
and	CC	O
selective	JJ	O
than	IN	O
2a	CD	O
,	,	O
retaining	VBG	O
the	DT	O
high	JJ	O
potency	NN	O
and	CC	O
selectivity	NN	O
of	IN	O
1	CD	O
.	.	O
Inhibitor	NN	O
2c	CD	O
,	,	O
with	IN	O
monofluoromethylene	JJ	O
adjacent	NN	O
to	TO	O
the	DT	O
basic	JJ	O
amino	NN	O
group	NN	O
,	,	O
shows	VBZ	O
even	RB	O
better	RBR	O
potency	NN	O
for	IN	O
nNOS	NN	O
and	CC	O
excellent	JJ	O
selectivity	NN	O
for	IN	O
nNOS	NN	O
over	IN	O
eNOS	NN	O
and	CC	O
iNOS	NN	O
.	.	O
Finally	RB	O
,	,	O
inhibitor	NN	O
2d	CD	O
,	,	O
with	IN	O
a	DT	O
difluoromethylene	NN	O
in	IN	O
the	DT	O
lipophilic	JJ	O
tail	NN	O
of	IN	O
1	CD	O
,	,	O
exhibited	VBD	O
a	DT	O
2.2-fold	JJ	O
drop	NN	O
in	IN	O
potency	NN	O
relative	NN	O
to	TO	O
2c	CD	O
.	.	O
The	DT	O
introduction	NN	O
of	IN	O
the	DT	O
strongly	RB	O
electron-withdrawing	JJ	O
difluoromethylene	NN	O
group	NN	O
can	MD	O
significantly	RB	O
remove	VB	O
the	DT	O
positive	JJ	O
charge	NN	O
on	IN	O
the	DT	O
amino	NN	O
group	NN	O
in	IN	O
the	DT	O
lipophilic	JJ	O
tail	NN	O
,	,	O
which	WDT	O
decreases	VBZ	O
its	PRP$	O
ability	NN	O
for	IN	O
electrostatic	JJ	O
interaction	NN	O
with	IN	O
the	DT	O
heme	NN	O
carboxylate	NN	O
.	.	O
However	RB	O
,	,	O
inhibitor	NN	O
2d	CD	O
still	RB	O
showed	VBD	O
very	RB	O
good	JJ	O
selectivity	NN	O
for	IN	O
nNOS	NN	O
over	IN	O
eNOS	NN	O
and	CC	O
iNOS	NN	O
.	.	O
From	IN	O
the	DT	O
foregoing	NN	O
,	,	O
the	DT	O
three	CD	O
best	JJS	O
inhibitors	NNS	O
(	(	O
2b	CD	O
,	,	O
2c	CD	O
,	,	O
and	CC	O
2d	CD	O
)	)	O
from	IN	O
this	DT	O
group	NN	O
of	IN	O
embodiments	NNS	O
were	VBD	O
chosen	VBN	O
,	,	O
together	RB	O
with	IN	O
compound	NN	O
(	(	O
I	PRP	O
)	)	O
,	,	O
to	TO	O
test	VB	O
their	PRP$	O
potency	NN	O
in	IN	O
a	DT	O
cell-based	JJ	O
assay	NN	O
.	.	O
This	DT	O
assay	NN	O
can	MD	O
provide	VB	O
valuable	JJ	O
data	NNS	O
about	IN	O
membrane	NN	O
permeability	NN	O
.	.	O
The	DT	O
results	NNS	O
are	VBP	O
summarized	VBN	O
in	IN	O
Table	JJ	O
3	CD	O
.	.	O
The	DT	O
IC50	NNP	O
values	NNS	O
of	IN	O
inhibitors	NNS	O
2b	CD	O
,	,	O
2c	CD	O
,	,	O
and	CC	O
2d	CD	O
are	VBP	O
comparable	JJ	O
to	TO	O
that	DT	O
of	IN	O
compound	NN	O
1	CD	O
.	.	O
The	DT	O
ratios	NNS	O
of	IN	O
inhibition	NN	O
of	IN	O
purified	JJ	O
nNOS	JJ	O
versus	IN	O
the	DT	O
cell-based	JJ	O
assay	NN	O
(	(	O
IC50/IC50	NNP	O
(	(	O
cell	NN	O
)	)	O
)	)	O
were	VBD	O
calculated	VBN	O
,	,	O
which	WDT	O
indicate	VBP	O
the	DT	O
relative	JJ	O
membrane	NN	O
permeability	NN	O
of	IN	O
different	JJ	O
inhibitors	NNS	O
(	(	O
Table	JJ	O
3	CD	O
)	)	O
.	.	O
The	DT	O
IC50/IC50	NNP	O
(	(	O
cell	NN	O
)	)	O
values	NNS	O
of	IN	O
all	DT	O
three	CD	O
low	JJ	O
pKa	NN	O
inhibitors	NNS	O
are	VBP	O
higher	JJR	O
than	IN	O
compound	NN	O
1	CD	O
,	,	O
which	WDT	O
indicates	VBZ	O
that	IN	O
by	IN	O
partially	RB	O
removing	VBG	O
the	DT	O
positive	JJ	O
charge	NN	O
on	IN	O
the	DT	O
amino	NN	O
group	NN	O
in	IN	O
1	CD	O
,	,	O
inhibitors	NNS	O
with	IN	O
improved	JJ	O
cell	NN	O
permeability	NN	O
can	MD	O
be	VB	O
achieved	VBN	O
.	.	O
Specifically	RB	O
,	,	O
inhibitor	NN	O
2b	CD	O
shows	VBZ	O
a	DT	O
2.4-fold	JJ	O
increase	NN	O
through	IN	O
cells	NNS	O
membrane	JJ	O
permeation	NN	O
relative	NN	O
to	TO	O
1	CD	O
,	,	O
while	IN	O
inhibitors	NNS	O
2c	CD	O
and	CC	O
2d	CD	O
exhibited	VBN	O
1.7-fold	JJ	O
and	CC	O
2.0-fold	JJ	O
increased	JJ	O
penetration	NN	O
,	,	O
respectively	RB	O
.	.	O
A	DT	O
comparison	NN	O
of	IN	O
the	DT	O
IC50/IC50	NNP	O
(	(	O
cell	NN	O
)	)	O
values	VBZ	O
between	IN	O
2c	CD	O
and	CC	O
2d	CD	O
demonstrates	NNS	O
that	IN	O
the	DT	O
stronger	JJR	O
difluoromethylene	JJ	O
electron-withdrawing	JJ	O
group	NN	O
,	,	O
which	WDT	O
significantly	RB	O
decreased	VBD	O
the	DT	O
pKa	NN	O
compared	VBN	O
to	TO	O
the	DT	O
monofluoromethylene	NN	O
group	NN	O
,	,	O
greatly	RB	O
improved	VBN	O
cell	NN	O
permeability	NN	O
.	.	O
Inhibitory	NNP	O
Assays	NNP	O
and	CC	O
Structure-Based	JJ	O
Evaluation	NN	O
To	TO	O
continue	VB	O
the	DT	O
study	NN	O
,	,	O
inhibitors	NNS	O
2da-2dd	CD	O
and	CC	O
2e-2f	CD	O
were	VBD	O
evaluated	VBN	O
for	IN	O
in	IN	O
vitro	JJ	O
inhibition	NN	O
activities	NNS	O
against	IN	O
three	CD	O
isozymes	NNS	O
of	IN	O
NOSs	NNP	O
including	VBG	O
rat	NN	O
nNOS	NN	O
,	,	O
bovine	JJ	O
eNOS	NN	O
and	CC	O
murine	NN	O
iNOS	NN	O
(	(	O
see	VB	O
,	,	O
Havel	NNP	O
,	,	O
supra	NN	O
)	)	O
as	IN	O
summarized	VBN	O
in	IN	O
Table	JJ	O
4	CD	O
.	.	O
Compared	VBN	O
to	TO	O
the	DT	O
racemic	JJ	O
compound	NN	O
2d	CD	O
,	,	O
the	DT	O
(	(	O
S	NNP	O
,	,	O
S	NNP	O
)	)	O
enantiomer	VBP	O
2da	CD	O
is	VBZ	O
a	DT	O
weak	JJ	O
inhibitor	NN	O
for	IN	O
nNOS	NN	O
with	IN	O
the	DT	O
Ki	NNP	O
values	NNS	O
of	IN	O
390	CD	O
nM	NNS	O
,	,	O
which	WDT	O
is	VBZ	O
five-fold	JJ	O
less	RBR	O
potent	JJ	O
than	IN	O
2d	CD	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
the	DT	O
selectivity	NN	O
of	IN	O
this	DT	O
inhibitor	NN	O
for	IN	O
nNOS	NN	O
over	IN	O
eNOS	NN	O
and	CC	O
iNOS	NN	O
also	RB	O
decreases	VBZ	O
by	IN	O
3-fold	JJ	O
and	CC	O
2-fold	JJ	O
,	,	O
respectively	RB	O
.	.	O
The	DT	O
(	(	O
R	NNP	O
,	,	O
R	NNP	O
)	)	O
enantiomer	VBD	O
2db	CD	O
,	,	O
however	RB	O
,	,	O
shows	VBZ	O
excellent	JJ	O
potency	NN	O
for	IN	O
nNOS	NN	O
(	(	O
Ki=36	NNP	O
nM	RB	O
)	)	O
and	CC	O
remarkable	JJ	O
selectivity	NN	O
over	IN	O
eNOS	NN	O
(	(	O
3800-fold	JJ	O
)	)	O
and	CC	O
iNOS	JJ	O
(	(	O
1400-fold	JJ	O
)	)	O
.	.	O
These	DT	O
results	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
chirality	NN	O
around	IN	O
the	DT	O
cis-chiral	JJ	O
pyrrolidine	NN	O
core	NN	O
plays	VBZ	O
a	DT	O
key	JJ	O
role	NN	O
in	IN	O
determining	VBG	O
the	DT	O
potency	NN	O
and	CC	O
selectivity	NN	O
of	IN	O
inhibitors	NNS	O
,	,	O
as	IN	O
we	PRP	O
have	VBP	O
observed	VBN	O
for	IN	O
another	DT	O
series	NN	O
of	IN	O
trans-	JJ	O
or	CC	O
cis-chiral	JJ	O
pyrrolidine	NN	O
inhibitors	NNS	O
(	(	O
1	CD	O
)	)	O
.	.	O
The	DT	O
potency	NN	O
and	CC	O
selectivity	NN	O
shown	VBN	O
with	IN	O
the	DT	O
racemic	JJ	O
compound	NN	O
2d	CD	O
can	MD	O
be	VB	O
attributed	VBN	O
mainly	RB	O
to	TO	O
the	DT	O
(	(	O
R	NNP	O
,	,	O
R	NNP	O
)	)	O
component	NN	O
2db	CD	O
.	.	O
We	PRP	O
now	RB	O
know	VBP	O
that	IN	O
a	DT	O
large	JJ	O
difference	NN	O
in	IN	O
binding	VBG	O
affinity	NN	O
between	IN	O
2da	CD	O
and	CC	O
2db	CD	O
originates	NNS	O
from	IN	O
two	CD	O
different	JJ	O
binding	VBG	O
modes	NNS	O
.	.	O
(	(	O
1	CD	O
)	)	O
The	DT	O
flipped	JJ	O
binding	NN	O
mode	NN	O
of	IN	O
2db	CD	O
relative	JJ	O
to	TO	O
2da	CD	O
allows	NNS	O
both	DT	O
aminopyridine	NN	O
and	CC	O
pyrrolidine	NN	O
nitrogen	NN	O
atoms	NNS	O
to	TO	O
make	VB	O
extensive	JJ	O
hydrogen	NN	O
bonds	NNS	O
with	IN	O
the	DT	O
heme	NN	O
and	CC	O
H4B	NNP	O
(	(	O
FIG	NNP	O
.	.	O
2B	CD	O
)	)	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
as	IN	O
we	PRP	O
have	VBP	O
argued	VBN	O
elsewhere	RB	O
,	,	O
(	(	O
1	CD	O
)	)	O
the	DT	O
conformation	NN	O
of	IN	O
2da	CD	O
when	WRB	O
bound	NN	O
to	TO	O
NOS	NNP	O
places	VBZ	O
the	DT	O
pyrrolidine	NN	O
N	NNP	O
atom	VBZ	O
very	RB	O
close	RB	O
to	TO	O
the	DT	O
aminopyridine	NN	O
and	CC	O
owing	VBG	O
to	TO	O
electrostatic	JJ	O
repulsion	NN	O
,	,	O
this	DT	O
aminopyridine	NN	O
is	VBZ	O
only	RB	O
partially	RB	O
protonated	VBN	O
.	.	O
However	RB	O
,	,	O
in	IN	O
the	DT	O
2db	CD	O
flipped	VBD	O
orientation	NN	O
the	DT	O
aminopyridine	NN	O
is	VBZ	O
farther	RB	O
from	IN	O
the	DT	O
pyrrolidine	NN	O
N	NNP	O
atom	NN	O
and	CC	O
remains	VBZ	O
fully	RB	O
protonated	VBN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
2db	CD	O
conformation	NN	O
provides	VBZ	O
greater	JJR	O
electrostatic	JJ	O
stabilization	NN	O
than	IN	O
the	DT	O
2da	CD	O
conformation	NN	O
which	WDT	O
accounts	VBZ	O
for	IN	O
the	DT	O
10-fold	JJ	O
lower	JJR	O
K	NNP	O
,	,	O
of	IN	O
2db	CD	O
than	IN	O
2da	CD	O
.	.	O
As	IN	O
a	DT	O
p-fluorophenyl	JJ	O
derivative	NN	O
of	IN	O
2db	CD	O
,	,	O
inhibitor	NN	O
2dc	CD	O
shows	VBZ	O
a	DT	O
significant	JJ	O
drop	NN	O
in	IN	O
potency	NN	O
for	IN	O
nNOS	NN	O
(	(	O
Ki=160	NNP	O
nM	RB	O
)	)	O
,	,	O
which	WDT	O
is	VBZ	O
4.5-fold	JJ	O
less	RBR	O
potent	JJ	O
than	IN	O
2db	CD	O
.	.	O
More	RBR	O
interestingly	RB	O
,	,	O
2dc	CD	O
also	RB	O
loses	VBZ	O
most	JJS	O
of	IN	O
the	DT	O
selectivity	NN	O
over	IN	O
eNOS	NN	O
and	CC	O
iNOS	NN	O
of	IN	O
2db	CD	O
by	IN	O
moving	VBG	O
one	CD	O
single	JJ	O
F	NNP	O
atom	NN	O
from	IN	O
the	DT	O
m-position	NN	O
to	TO	O
the	DT	O
p-position	NN	O
of	IN	O
the	DT	O
phenyl	NN	O
tail	NN	O
.	.	O
The	DT	O
new	JJ	O
fluorine	JJ	O
position	NN	O
leads	VBZ	O
to	TO	O
a	DT	O
‘	JJ	O
difluorine-down	JJ	O
’	NN	O
binding	VBG	O
mode	NN	O
of	IN	O
the	DT	O
inhibitor	NN	O
's	POS	O
phenyl	JJ	O
tail	NN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
the	DT	O
hydrogen	NN	O
bond	NN	O
between	IN	O
the	DT	O
Glu592	NNP	O
side	NN	O
chain	NN	O
and	CC	O
the	DT	O
amino	NN	O
nitrogen	NN	O
in	IN	O
the	DT	O
tail	NN	O
seen	VBN	O
in	IN	O
2db	CD	O
has	VBZ	O
been	VBN	O
eliminated	VBN	O
,	,	O
which	WDT	O
may	MD	O
explain	VB	O
the	DT	O
weaker	JJR	O
potency	NN	O
of	IN	O
2dc	CD	O
.	.	O
Inhibitor	NN	O
2dd	CD	O
,	,	O
with	IN	O
the	DT	O
substituent	NN	O
F	NNP	O
atom	NN	O
removed	VBD	O
from	IN	O
the	DT	O
phenyl	NN	O
tail	NN	O
,	,	O
has	VBZ	O
restored	VBN	O
good	JJ	O
potency	NN	O
for	IN	O
nNOS	NN	O
(	(	O
Ki=85	NNP	O
nM	RB	O
)	)	O
and	CC	O
high	JJ	O
isozyme-selectivity	NN	O
(	(	O
1500-fold	JJ	O
over	IN	O
eNOS	JJ	O
and	CC	O
1000-fold	JJ	O
over	IN	O
iNOS	NN	O
)	)	O
.	.	O
This	DT	O
is	VBZ	O
because	RB	O
2dd	CD	O
has	VBZ	O
retained	VBN	O
the	DT	O
binding	VBG	O
mode	NN	O
of	IN	O
2db	CD	O
.	.	O
The	DT	O
only	JJ	O
difference	NN	O
is	VBZ	O
that	IN	O
without	IN	O
a	DT	O
fluorine	NN	O
on	IN	O
the	DT	O
phenyl	NN	O
ring	VBG	O
the	DT	O
van	NN	O
der	NN	O
Waals	NNP	O
contacts	VBZ	O
to	TO	O
the	DT	O
protein	NN	O
(	(	O
Pro565	NNP	O
,	,	O
Va1567	NNP	O
,	,	O
and	CC	O
Phe584	NNP	O
)	)	O
are	VBP	O
less	RBR	O
optimal	JJ	O
compared	VBN	O
to	TO	O
that	DT	O
for	IN	O
2db	CD	O
.	.	O
This	DT	O
results	NNS	O
in	IN	O
a	DT	O
bit	NN	O
less	JJR	O
potency	NN	O
and	CC	O
selectivity	NN	O
for	IN	O
2dd	CD	O
than	IN	O
2db	CD	O
.	.	O
The	DT	O
amidino	NN	O
inhibitor	NN	O
2e	CD	O
,	,	O
with	IN	O
the	DT	O
aromatic	JJ	O
system	NN	O
of	IN	O
the	DT	O
aminopyridine	JJ	O
fragment	NN	O
partially	RB	O
reduced	VBN	O
,	,	O
exhibits	VBZ	O
a	DT	O
2-fold	JJ	O
drop	NN	O
in	IN	O
potency	NN	O
against	IN	O
nNOS	RB	O
compared	VBN	O
to	TO	O
2dd	CD	O
.	.	O
This	DT	O
result	NN	O
demonstrates	VBZ	O
that	IN	O
π-π	JJ	O
stacking	NN	O
in	IN	O
2dd	CD	O
between	IN	O
the	DT	O
aromatic	JJ	O
aminopyridine	NN	O
ring	NN	O
and	CC	O
the	DT	O
Tyr706	NNP	O
side	NN	O
chain	NN	O
contributes	VBZ	O
to	TO	O
its	PRP$	O
tighter	NN	O
binding	NN	O
.	.	O
Moreover	RB	O
,	,	O
the	DT	O
removal	NN	O
of	IN	O
the	DT	O
aromatic	JJ	O
system	NN	O
of	IN	O
the	DT	O
aminopyridine	JJ	O
ring	NN	O
from	IN	O
inhibitor	NN	O
2dd	CD	O
makes	VBZ	O
2e	CD	O
binds	NNS	O
more	RBR	O
than	IN	O
3-fold	JJ	O
better	NN	O
to	TO	O
iNOS	VB	O
thus	RB	O
exhibiting	VBG	O
a	DT	O
much	RB	O
less	JJR	O
selectivity	NN	O
.	.	O
Finally	RB	O
,	,	O
inhibitor	NN	O
2f	CD	O
,	,	O
with	IN	O
a	DT	O
(	(	O
S	NNP	O
,	,	O
S	NNP	O
)	)	O
configuration	NN	O
of	IN	O
the	DT	O
pyrrolidine	NN	O
core	NN	O
and	CC	O
a	DT	O
piperidinyl	NN	O
tail	NN	O
,	,	O
showed	VBD	O
poor	JJ	O
inhibition	NN	O
activity	NN	O
and	CC	O
isozyme-selectivity	NN	O
.	.	O
Both	DT	O
2da	CD	O
and	CC	O
2f	CD	O
have	VBP	O
a	DT	O
similar	JJ	O
binding	NN	O
orientation	NN	O
and	CC	O
rather	RB	O
poor	JJ	O
potency	NN	O
among	IN	O
the	DT	O
inhibitors	NNS	O
reported	VBD	O
in	IN	O
this	DT	O
work	NN	O
.	.	O
This	DT	O
result	NN	O
emphasizes	VBZ	O
again	RB	O
that	IN	O
the	DT	O
chirality	NN	O
of	IN	O
the	DT	O
pyrrolidine	NN	O
core	NN	O
is	VBZ	O
the	DT	O
key	NN	O
to	TO	O
higher	JJR	O
inhibitory	JJ	O
activity	NN	O
with	IN	O
(	(	O
R	NNP	O
,	,	O
R	NNP	O
)	)	O
inhibitors	NNS	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
a	DT	O
less	JJR	O
polar	JJ	O
aromatic	JJ	O
ring	NN	O
such	JJ	O
as	IN	O
the	DT	O
fluoro-phenyl	JJ	O
group	NN	O
in	IN	O
2da	CD	O
seems	VBZ	O
to	TO	O
fit	VB	O
better	RBR	O
in	IN	O
to	TO	O
the	DT	O
pocket	NN	O
surrounded	VBN	O
by	IN	O
Met336	NNP	O
,	,	O
Leu337	NNP	O
,	,	O
and	CC	O
Tyr706	NNP	O
in	IN	O
nNOS	NN	O
than	IN	O
does	VBZ	O
the	DT	O
polar	JJ	O
piperidinyl	NN	O
ring	NN	O
in	IN	O
2f	CD	O
.	.	O
However	RB	O
,	,	O
both	DT	O
2da	CD	O
and	CC	O
2f	CD	O
bind	NN	O
to	TO	O
eNOS	VB	O
with	IN	O
similar	JJ	O
potency	NN	O
possibly	RB	O
because	IN	O
of	IN	O
the	DT	O
smaller	JJR	O
Va1106	NNP	O
side	NN	O
chain	NN	O
in	IN	O
the	DT	O
pocket	NN	O
in	IN	O
eNOS	NN	O
compared	VBN	O
to	TO	O
Met336	NNP	O
in	IN	O
nNOS	NN	O
.	.	O
Isoform	NNP	O
selection	NN	O
from	IN	O
the	DT	O
inhibitors	NNS	O
in	IN	O
Table	JJ	O
4	CD	O
is	VBZ	O
not	RB	O
a	DT	O
straightforward	JJ	O
structure-based	JJ	O
determination	NN	O
.	.	O
For	IN	O
instance	NN	O
,	,	O
for	IN	O
any	DT	O
particular	JJ	O
inhibitor	NN	O
among	IN	O
those	DT	O
reported	VBN	O
in	IN	O
Table	JJ	O
4	CD	O
the	DT	O
binding	NN	O
mode	NN	O
in	IN	O
eNOS	NN	O
is	VBZ	O
no	DT	O
different	JJ	O
from	IN	O
that	DT	O
seen	VBN	O
in	IN	O
nNOS	NN	O
.	.	O
As	IN	O
discussed	VBN	O
for	IN	O
another	DT	O
series	NN	O
of	IN	O
chiral	JJ	O
pyrrolidine	NN	O
containing	VBG	O
inhibitors	NNS	O
,	,	O
one	CD	O
of	IN	O
the	DT	O
potential	JJ	O
reasons	NNS	O
for	IN	O
the	DT	O
isoform	NN	O
selectivity	NN	O
shown	VBN	O
by	IN	O
2db	CD	O
is	VBZ	O
the	DT	O
difference	NN	O
in	IN	O
stacking	VBG	O
interaction	NN	O
between	IN	O
the	DT	O
aminopyridine	NN	O
and	CC	O
Tyr706	NNP	O
in	IN	O
nNOS	NN	O
(	(	O
or	CC	O
Tyr	NNP	O
477	CD	O
in	IN	O
eNOS	NN	O
)	)	O
.	.	O
It	PRP	O
has	VBZ	O
been	VBN	O
consistently	RB	O
observed	VBN	O
that	IN	O
tighter	JJR	O
interactions	NNS	O
between	IN	O
this	DT	O
Tyr	NNP	O
and	CC	O
the	DT	O
aminopyridine	NN	O
with	IN	O
nNOS	JJ	O
complexed	NN	O
with	IN	O
inhibitors	NNS	O
that	WDT	O
adopt	VBP	O
the	DT	O
2db	CD	O
flipped	VBD	O
orientation	NN	O
.	.	O
(	(	O
Data	NNP	O
not	RB	O
presented	VBD	O
herein	NN	O
.	.	O
)	)	O
In	IN	O
part	NN	O
,	,	O
as	IN	O
demonstrated	VBN	O
above	IN	O
,	,	O
the	DT	O
present	JJ	O
invention	NN	O
provides	VBZ	O
a	DT	O
new	JJ	O
series	NN	O
of	IN	O
selective	JJ	O
nNOS	NN	O
inhibitors	NNS	O
(	(	O
e.g.	NN	O
,	,	O
2da-2dd	JJ	O
and	CC	O
2e-2f	JJ	O
)	)	O
with	IN	O
monocationic	JJ	O
character	NN	O
and	CC	O
,	,	O
therefore	RB	O
,	,	O
better	JJR	O
bioavailability	NN	O
.	.	O
Biological	JJ	O
evaluation	NN	O
of	IN	O
these	DT	O
new	JJ	O
inhibitors	NNS	O
based	VBN	O
on	IN	O
crystal	JJ	O
structures	NNS	O
suggests	VBZ	O
,	,	O
for	IN	O
instance	NN	O
,	,	O
use	NN	O
of	IN	O
inhibitor	NN	O
2db	CD	O
,	,	O
which	WDT	O
not	RB	O
only	RB	O
retains	VBZ	O
most	JJS	O
of	IN	O
the	DT	O
inhibitory	JJ	O
activity	NN	O
of	IN	O
the	DT	O
compound	NN	O
2d	CD	O
,	,	O
but	CC	O
also	RB	O
shows	VBZ	O
remarkable	JJ	O
selectivity	NN	O
for	IN	O
nNOS	NN	O
over	IN	O
both	DT	O
eNOS	NNS	O
and	CC	O
iNOS	NN	O
.	.	O
Accordingly	RB	O
,	,	O
this	DT	O
invention	NN	O
represents	VBZ	O
an	DT	O
advancement	NN	O
toward	IN	O
the	DT	O
goal	NN	O
of	IN	O
developing	VBG	O
drugs	NNS	O
with	IN	O
therapeutic	JJ	O
potential	NN	O
in	IN	O
treatment	NN	O
of	IN	O
diseases	NNS	O
caused	VBN	O
by	IN	O
unregulated	JJ	O
NO	NNP	O
generation	NN	O
from	IN	O
nNOS	NN	O
.	.	O
EXAMPLES	NNS	O
OF	IN	O
THE	DT	O
INVENTION	NNP	O
The	DT	O
following	JJ	O
non-limiting	JJ	O
examples	NNS	O
and	CC	O
data	NNS	O
illustrate	VBP	O
various	JJ	O
aspects	NNS	O
and	CC	O
features	NNS	O
relating	VBG	O
to	TO	O
the	DT	O
compounds	NNS	O
,	,	O
compositions	NNS	O
and/or	VBP	O
methods	NNS	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
,	,	O
including	VBG	O
the	DT	O
preparation	NN	O
and	CC	O
use	NN	O
of	IN	O
various	JJ	O
selective	JJ	O
neuronal	JJ	O
nitric	JJ	O
oxide	IN	O
synthase	NN	O
inhibitors	NNS	O
,	,	O
as	IN	O
are	VBP	O
available	JJ	O
through	IN	O
the	DT	O
synthetic	JJ	O
methodologies	NNS	O
described	VBD	O
herein	NN	O
.	.	O
In	IN	O
comparison	NN	O
with	IN	O
the	DT	O
prior	JJ	O
art	NN	O
,	,	O
the	DT	O
present	JJ	O
compounds	NNS	O
,	,	O
compositions	NNS	O
and/or	VBP	O
methods	NNS	O
provide	VBP	O
results	NNS	O
and	CC	O
data	NNS	O
which	WDT	O
are	VBP	O
surprising	JJ	O
,	,	O
unexpected	JJ	O
and	CC	O
contrary	JJ	O
thereto	NN	O
.	.	O
While	IN	O
the	DT	O
utility	NN	O
of	IN	O
this	DT	O
invention	NN	O
is	VBZ	O
illustrated	VBN	O
through	IN	O
use	NN	O
of	IN	O
several	JJ	O
compounds	NNS	O
and	CC	O
moieties	NNS	O
,	,	O
groups	NNS	O
or	CC	O
substituents	NNS	O
(	(	O
e.g.	NN	O
,	,	O
halide	NN	O
,	,	O
alkyl	NN	O
,	,	O
etc	FW	O
.	.	O
)	)	O
thereof	NN	O
,	,	O
it	PRP	O
will	MD	O
be	VB	O
understood	VBN	O
by	IN	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
that	WDT	O
comparable	JJ	O
results	NNS	O
are	VBP	O
obtainable	JJ	O
with	IN	O
various	JJ	O
other	JJ	O
compounds	NNS	O
and	CC	O
moieties/groups/substituents	NNS	O
(	(	O
e.g.	NN	O
,	,	O
substituted	VBD	O
alkyl	NN	O
,	,	O
etc	FW	O
.	.	O
)	)	O
,	,	O
as	IN	O
are	VBP	O
commensurate	JJ	O
with	IN	O
the	DT	O
scope	NN	O
of	IN	O
this	DT	O
invention	NN	O
and	CC	O
would	MD	O
be	VB	O
understood	VBN	O
by	IN	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
and	CC	O
made	VBD	O
aware	NN	O
of	IN	O
this	DT	O
invention—using	JJ	O
synthetic	JJ	O
techniques	NNS	O
of	IN	O
the	DT	O
sort	NN	O
described	VBD	O
herein	NN	O
or	CC	O
in	IN	O
the	DT	O
incorporated	JJ	O
references	NNS	O
or	CC	O
straight-forward	JJ	O
modifications	NNS	O
thereof	NN	O
,	,	O
such	JJ	O
techniques	NNS	O
limited	VBN	O
only	RB	O
by	IN	O
available	JJ	O
reagents	NNS	O
and	CC	O
starting	VBG	O
materials	NNS	O
.	.	O
All	DT	O
syntheses	NNS	O
were	VBD	O
conducted	VBN	O
under	IN	O
anhydrous	JJ	O
conditions	NNS	O
in	IN	O
an	DT	O
atmosphere	NN	O
of	IN	O
argon	NN	O
,	,	O
using	VBG	O
flame-dried	JJ	O
apparatus	NN	O
and	CC	O
employing	VBG	O
standard	JJ	O
techniques	NNS	O
in	IN	O
handling	VBG	O
air	NN	O
sensitive	JJ	O
materials	NNS	O
.	.	O
All	DT	O
solvents	NNS	O
were	VBD	O
distilled	VBN	O
and	CC	O
stored	VBN	O
under	IN	O
an	DT	O
argon	NN	O
or	CC	O
nitrogen	NN	O
atmosphere	RB	O
before	IN	O
using	VBG	O
.	.	O
All	DT	O
reagents	NNS	O
were	VBD	O
used	VBN	O
as	IN	O
received	VBN	O
.	.	O
Aqueous	JJ	O
solutions	NNS	O
of	IN	O
sodium	NN	O
bicarbonate	NN	O
,	,	O
sodium	NN	O
chloride	NN	O
(	(	O
brine	NN	O
)	)	O
,	,	O
and	CC	O
ammonium	NN	O
chloride	NN	O
were	VBD	O
saturated	VBN	O
.	.	O
Analytical	NNP	O
thin	JJ	O
layer	NN	O
chromatography	NN	O
was	VBD	O
visualized	VBN	O
by	IN	O
ultraviolet	NN	O
,	,	O
ninhydrin	NN	O
,	,	O
or	CC	O
phosphomolybdic	JJ	O
acid	NN	O
(	(	O
PMA	NNP	O
)	)	O
.	.	O
Flash	NNP	O
column	NN	O
chromatography	NN	O
was	VBD	O
carried	VBN	O
out	RP	O
under	IN	O
a	DT	O
positive	JJ	O
pressure	NN	O
of	IN	O
nitrogen	NN	O
.	.	O
1H	CD	O
NMR	NNP	O
spectra	NN	O
were	VBD	O
recorded	VBN	O
on	IN	O
500	CD	O
MHz	NNP	O
spectrometers	NNS	O
.	.	O
Data	NNS	O
are	VBP	O
presented	VBN	O
as	IN	O
follows	VBZ	O
:	:	O
chemical	NN	O
shift	NN	O
(	(	O
in	IN	O
ppm	NN	O
on	IN	O
the	DT	O
δ	NNP	O
scale	NN	O
relative	NN	O
to	TO	O
δ=0.00	VB	O
ppm	NN	O
for	IN	O
the	DT	O
protons	NNS	O
in	IN	O
TMS	NNP	O
)	)	O
,	,	O
integration	NN	O
,	,	O
multiplicity	NN	O
(	(	O
s=singlet	NN	O
,	,	O
d=doublet	NN	O
,	,	O
t=triplet	NN	O
,	,	O
q=quartet	NN	O
,	,	O
m=multiplet	NN	O
,	,	O
br=broad	NN	O
)	)	O
,	,	O
coupling	VBG	O
constant	JJ	O
(	(	O
J/Hz	NNP	O
)	)	O
.	.	O
Coupling	VBG	O
constants	NNS	O
were	VBD	O
taken	VBN	O
directly	RB	O
from	IN	O
the	DT	O
spectra	NN	O
and	CC	O
are	VBP	O
uncorrected	VBN	O
.	.	O
13C	CD	O
NMR	NNP	O
spectra	NN	O
were	VBD	O
recorded	VBN	O
at	IN	O
125	CD	O
MHz	NNP	O
,	,	O
and	CC	O
all	DT	O
chemical	NN	O
shift	NN	O
values	NNS	O
are	VBP	O
reported	VBN	O
in	IN	O
ppm	NN	O
on	IN	O
the	DT	O
δ	NNP	O
scale	NN	O
,	,	O
with	IN	O
an	DT	O
internal	JJ	O
reference	NN	O
of	IN	O
δ	$	O
77.0	CD	O
or	CC	O
49.0	CD	O
for	IN	O
CDCl3	NNP	O
or	CC	O
MeOD	NNP	O
,	,	O
respectively	RB	O
.	.	O
High-resolution	NNP	O
mass	NN	O
spectra	NN	O
were	VBD	O
measured	VBN	O
on	IN	O
liquid	NN	O
chromatography/time	NN	O
of	IN	O
flight	NN	O
mass	NN	O
spectrometry	NN	O
(	(	O
LC-TOF	NNP	O
)	)	O
.	.	O
Characterization	NN	O
of	IN	O
New	NNP	O
Compounds	NNP	O
Example	NNP	O
1	CD	O
(	(	O
E	NNP	O
)	)	O
-Methyl	VBZ	O
3-	JJ	O
(	(	O
3-fluorophenyl	JJ	O
)	)	O
acrylate	NN	O
(	(	O
6	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
(	(	O
E	NNP	O
)	)	O
-3-	NN	O
(	(	O
3-fluorophenyl	JJ	O
)	)	O
acrylic	JJ	O
acid	NN	O
(	(	O
5	CD	O
,	,	O
6.0	CD	O
g	NN	O
,	,	O
32.7	CD	O
mmol	NN	O
)	)	O
in	IN	O
MeOH	NNP	O
(	(	O
150	CD	O
mL	NN	O
)	)	O
at	IN	O
0°	CD	O
C.	NNP	O
was	VBD	O
added	VBN	O
concentrated	JJ	O
H2SO4	NNP	O
(	(	O
3.0	CD	O
mL	NN	O
)	)	O
slowly	RB	O
.	.	O
The	DT	O
reaction	NN	O
was	VBD	O
heated	VBN	O
under	IN	O
reflux	NN	O
for	IN	O
24	CD	O
h	NN	O
then	RB	O
cooled	VBD	O
to	TO	O
room	NN	O
temperature	NN	O
and	CC	O
neutralized	VBN	O
with	IN	O
Na2CO3	NNP	O
(	(	O
1.0	CD	O
g	NN	O
)	)	O
.	.	O
The	DT	O
solvent	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
and	CC	O
the	DT	O
resulting	VBG	O
yellow	JJ	O
oil	NN	O
partitioned	VBN	O
between	IN	O
EtOAc	NNP	O
(	(	O
300	CD	O
mL	NN	O
)	)	O
and	CC	O
saturated	VBN	O
NaHCO3	NNP	O
(	(	O
300	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
aqueous	JJ	O
layer	NN	O
was	VBD	O
extracted	VBN	O
with	IN	O
EtOAc	NNP	O
(	(	O
2×100	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
combined	JJ	O
organic	JJ	O
layers	NNS	O
were	VBD	O
washed	VBN	O
with	IN	O
brine	NN	O
(	(	O
200	CD	O
mL	NN	O
)	)	O
and	CC	O
dried	VBN	O
over	IN	O
Na2SO4	NNP	O
.	.	O
The	DT	O
solvent	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
to	TO	O
yield	VB	O
6	CD	O
as	IN	O
a	DT	O
low	JJ	O
melting	NN	O
(	(	O
<	JJ	O
25°	CD	O
C.	NNP	O
)	)	O
white	JJ	O
solid	JJ	O
(	(	O
32.0	CD	O
mmol	NN	O
,	,	O
99	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
3.79	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
6.39-6.43	JJ	O
(	(	O
d	NN	O
,	,	O
J=16.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.04-7.07	JJ	O
(	(	O
dt	NN	O
,	,	O
J=2.0	NNP	O
,	,	O
8.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.18-7.20	JJ	O
(	(	O
d	NN	O
,	,	O
J=9.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.25-7.26	JJ	O
(	(	O
d	NN	O
,	,	O
J=8.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.30-7.35	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.60-7.64	JJ	O
(	(	O
d	NN	O
,	,	O
J=16.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
52.0	CD	O
,	,	O
114.4	CD	O
,	,	O
114.6	CD	O
,	,	O
117.3	CD	O
,	,	O
117.4	CD	O
,	,	O
119.4	CD	O
,	,	O
124.29	CD	O
,	,	O
124.32	CD	O
,	,	O
130.6	CD	O
,	,	O
130.7	CD	O
,	,	O
136.8	CD	O
,	,	O
136.9	CD	O
,	,	O
143.6	CD	O
,	,	O
143.7	CD	O
,	,	O
162.2	CD	O
,	,	O
164.2	CD	O
,	,	O
167.2	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C10H10FO2	NNP	O
181.	CD	O
found	VBD	O
181	CD	O
.	.	O
Example	RB	O
2	CD	O
Methyl	NNP	O
2-	JJ	O
(	(	O
3-fluorophenyl	JJ	O
)	)	O
cyclopropanecarboxylate	NN	O
(	(	O
7	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
KOH	NNP	O
(	(	O
2.5	CD	O
g	NN	O
,	,	O
45	CD	O
mmol	NN	O
)	)	O
in	IN	O
H2O	NNP	O
(	(	O
4	CD	O
mL	NN	O
)	)	O
in	IN	O
a	DT	O
Mini	NNP	O
Diazald	NNP	O
apparatus	NN	O
(	(	O
Aldrich	NNP	O
Z108898	NNP	O
)	)	O
was	VBD	O
added	VBN	O
dropwise	NN	O
2-	JJ	O
(	(	O
2-ethoxyethoxy	JJ	O
)	)	O
ethanol	NN	O
(	(	O
14.0	CD	O
mL	NN	O
)	)	O
and	CC	O
ether	$	O
(	(	O
8.0	CD	O
mL	NN	O
)	)	O
.	.	O
To	TO	O
the	DT	O
condenser	NN	O
of	IN	O
the	DT	O
apparatus	NN	O
was	VBD	O
attached	VBN	O
a	DT	O
round-bottom	JJ	O
receiving	NN	O
flask	NN	O
(	(	O
Caution	NN	O
:	:	O
this	DT	O
flask	NN	O
must	MD	O
have	VB	O
a	DT	O
clear-seal	JJ	O
joint	NN	O
)	)	O
.	.	O
The	DT	O
receiving	NN	O
flask	NN	O
was	VBD	O
put	VBN	O
in	IN	O
a	DT	O
Dry	NNP	O
Ice-acetone	NNP	O
bath	NN	O
.	.	O
A	DT	O
glass	NN	O
tube	NN	O
(	(	O
Caution	NN	O
:	:	O
this	DT	O
tube	NN	O
must	MD	O
have	VB	O
fire-polished	JJ	O
ends	NNS	O
)	)	O
was	VBD	O
attached	VBN	O
to	TO	O
the	DT	O
side	NN	O
arm	NN	O
of	IN	O
the	DT	O
apparatus	NN	O
,	,	O
which	WDT	O
ended	VBD	O
in	IN	O
an	DT	O
ether	NN	O
(	(	O
˜5	NNP	O
mL	NN	O
)	)	O
trap	NN	O
in	IN	O
a	DT	O
Dry	NNP	O
Ice-acetone	NNP	O
bath	NN	O
.	.	O
A	DT	O
separate	JJ	O
clear-seal-joint	NN	O
funnel	NN	O
was	VBD	O
placed	VBN	O
over	IN	O
the	DT	O
reaction	NN	O
vessel	NN	O
.	.	O
This	DT	O
funnel	NN	O
was	VBD	O
charged	VBN	O
with	IN	O
a	DT	O
solution	NN	O
of	IN	O
Diazald	NNP	O
(	(	O
5.0	CD	O
g	NN	O
,	,	O
23	CD	O
mmol	NN	O
)	)	O
in	IN	O
ether	NN	O
(	(	O
30	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
vessel	NN	O
was	VBD	O
warmed	VBN	O
slowly	RB	O
to	TO	O
65°	CD	O
C.	NNP	O
The	DT	O
Diazald	NNP	O
solution	NN	O
was	VBD	O
added	VBN	O
slowly	RB	O
to	TO	O
the	DT	O
reaction	NN	O
vessel	NN	O
over	IN	O
a	DT	O
period	NN	O
of	IN	O
20	CD	O
min	NN	O
.	.	O
Afterward	RB	O
,	,	O
additional	JJ	O
ether	NN	O
(	(	O
10	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
to	TO	O
the	DT	O
reaction	NN	O
vessel	NN	O
through	IN	O
the	DT	O
top	JJ	O
funnel	NN	O
at	IN	O
the	DT	O
same	JJ	O
temperature	NN	O
.	.	O
The	DT	O
distillation	NN	O
was	VBD	O
continued	VBN	O
until	IN	O
the	DT	O
yellow	JJ	O
distillate	NN	O
became	VBD	O
colorless	NN	O
.	.	O
To	TO	O
a	DT	O
flame-dried	JJ	O
round-bottom	JJ	O
flask	NN	O
containing	VBG	O
ether	NN	O
(	(	O
50	CD	O
mL	NN	O
)	)	O
and	CC	O
CH2Cl2	NNP	O
(	(	O
150	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
6	CD	O
(	(	O
900	CD	O
mg	NN	O
,	,	O
5.0	CD	O
mmol	NN	O
)	)	O
and	CC	O
Pd	NNP	O
(	(	O
OAc	NNP	O
)	)	O
2	CD	O
(	(	O
5.80	CD	O
mg	NN	O
)	)	O
at	IN	O
0°	CD	O
C.	NNP	O
To	TO	O
this	DT	O
flask	NN	O
was	VBD	O
added	VBN	O
the	DT	O
freshly	RB	O
prepared	JJ	O
diazomethane	NN	O
solution	NN	O
through	IN	O
a	DT	O
cannula	NN	O
,	,	O
and	CC	O
then	RB	O
the	DT	O
reaction	NN	O
solution	NN	O
was	VBD	O
slowly	RB	O
warmed	VBN	O
to	TO	O
room	NN	O
temperature	NN	O
over	IN	O
a	DT	O
period	NN	O
of	IN	O
30	CD	O
min	NN	O
and	CC	O
allowed	VBN	O
to	TO	O
stir	VB	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
an	DT	O
additional	JJ	O
2	CD	O
h.	PDT	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
washed	VBN	O
with	IN	O
H2O	NNP	O
(	(	O
150	CD	O
mL	NN	O
)	)	O
and	CC	O
brine	NN	O
(	(	O
150	CD	O
mL	NN	O
)	)	O
and	CC	O
dried	VBN	O
over	IN	O
NaSO4	NNP	O
.	.	O
The	DT	O
solvent	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
to	TO	O
yield	VB	O
7	CD	O
as	IN	O
a	DT	O
colorless	NN	O
oil	NN	O
(	(	O
965	CD	O
mg	NN	O
,	,	O
5.0	CD	O
mmol	NN	O
,	,	O
100	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.30-1.35	JJ	O
(	(	O
ddd	NN	O
,	,	O
J=5.0	NNP	O
,	,	O
7.0	CD	O
,	,	O
8.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.60-1.66	JJ	O
(	(	O
dt	NN	O
,	,	O
J=5.0	NNP	O
,	,	O
10.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.90-1.94	JJ	O
(	(	O
ddd	NN	O
,	,	O
J=4.0	NNP	O
,	,	O
5.0	CD	O
,	,	O
8.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.51-2.54	JJ	O
(	(	O
dt	NN	O
,	,	O
J=2.5	NNP	O
,	,	O
5.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.74	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
6.70-6.80	JJ	O
(	(	O
td	JJ	O
,	,	O
J=2.0	NNP	O
,	,	O
10.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.90-6.95	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.23-7.28	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
17.4	CD	O
,	,	O
24.4	CD	O
,	,	O
26.1	CD	O
,	,	O
52.3	CD	O
,	,	O
113.2	CD	O
,	,	O
113.4	CD	O
,	,	O
113.6	CD	O
,	,	O
113.8	CD	O
,	,	O
122.2	CD	O
,	,	O
130.1	CD	O
,	,	O
130.2	CD	O
,	,	O
142.9	CD	O
,	,	O
143.0	CD	O
,	,	O
164.2	CD	O
,	,	O
173.8	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C11H12FO2	NNP	O
195.	CD	O
found	VBD	O
195	CD	O
.	.	O
Example	JJ	O
3	CD	O
2-	JJ	O
(	(	O
3-Fluorophenyl	JJ	O
)	)	O
cyclopropanecarboxylic	JJ	O
acid	NN	O
(	(	O
8	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
7	CD	O
(	(	O
390	CD	O
mg	NN	O
,	,	O
2.0	CD	O
mmol	NN	O
)	)	O
in	IN	O
MeOH	NNP	O
(	(	O
5	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
2N	CD	O
NaOH	NNP	O
(	(	O
5	CD	O
mL	NN	O
)	)	O
slowly	RB	O
.	.	O
The	DT	O
reaction	NN	O
solution	NN	O
was	VBD	O
stirred	VBN	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
2	CD	O
h	NN	O
then	RB	O
diluted	VBD	O
with	IN	O
H2O	NNP	O
(	(	O
25	CD	O
mL	NN	O
)	)	O
.	.	O
After	IN	O
extraction	NN	O
with	IN	O
ether	NN	O
(	(	O
20	CD	O
mL	NN	O
)	)	O
,	,	O
the	DT	O
aqueous	JJ	O
layer	NN	O
was	VBD	O
acidified	VBN	O
with	IN	O
2N	CD	O
HCl	NNP	O
(	(	O
2.1	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
resulting	VBG	O
solution	NN	O
was	VBD	O
extracted	VBN	O
with	IN	O
ether	NN	O
(	(	O
3×40	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
combined	JJ	O
organic	JJ	O
layers	NNS	O
were	VBD	O
dried	VBN	O
over	IN	O
MgSO4	NNP	O
and	CC	O
concentrated	VBD	O
to	TO	O
give	VB	O
8	CD	O
(	(	O
325	CD	O
mg	NN	O
,	,	O
1.8	CD	O
mmol	NN	O
,	,	O
99	CD	O
%	NN	O
)	)	O
as	IN	O
a	DT	O
light	JJ	O
yellow	JJ	O
oil	NN	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
0.87-0.91	JJ	O
(	(	O
dd	NN	O
,	,	O
J=6.0	NNP	O
,	,	O
13.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.21-1.29	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.39-1.43	JJ	O
(	(	O
ddd	NN	O
,	,	O
J=5.0	NNP	O
,	,	O
6.5	CD	O
,	,	O
8.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.67-1.72	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.90-1.94	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.58-2.63	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.79-6.82	JJ	O
(	(	O
dd	NN	O
,	,	O
J=2.0	NNP	O
,	,	O
5.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.90-6.95	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.24-7.28	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
8.90-11.00	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
17.8	CD	O
,	,	O
24.4	CD	O
,	,	O
26.9	CD	O
,	,	O
31.8	CD	O
,	,	O
113.3	CD	O
,	,	O
113.5	CD	O
,	,	O
113.8	CD	O
,	,	O
114.0	CD	O
,	,	O
122.30	CD	O
,	,	O
122.32	CD	O
,	,	O
130.2	CD	O
,	,	O
130.3	CD	O
,	,	O
142.4	CD	O
,	,	O
142.5	CD	O
,	,	O
162.2	CD	O
,	,	O
164.2	CD	O
,	,	O
179.8	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M−H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C10H8FO2	NNP	O
179.	CD	O
found	VBD	O
179	CD	O
.	.	O
Example	JJ	O
4	CD	O
tent-Butyl	JJ	O
2-	JJ	O
(	(	O
3-fluorophenyl	JJ	O
)	)	O
cyclopropylcarbamate	NN	O
(	(	O
9	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
8	CD	O
(	(	O
300	CD	O
mg	NN	O
,	,	O
1.67	CD	O
mmol	NN	O
)	)	O
in	IN	O
dry	JJ	O
t-BuOH	NN	O
(	(	O
5.0	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
diphenyl	NN	O
phosphorazidate	NN	O
(	(	O
DPPA	NNP	O
,	,	O
400	CD	O
μL	NN	O
,	,	O
1.83	CD	O
mmol	NN	O
)	)	O
and	CC	O
triethylamine	NN	O
(	(	O
Et3N	NNP	O
,	,	O
350	CD	O
μL	NN	O
,	,	O
2.51	CD	O
mmol	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
solution	NN	O
was	VBD	O
allowed	VBN	O
to	TO	O
stir	VB	O
at	IN	O
85°	CD	O
C.	NNP	O
for	IN	O
two	CD	O
days	NNS	O
,	,	O
then	RB	O
cooled	VBD	O
to	TO	O
room	NN	O
temperature	NN	O
and	CC	O
concentrated	VBD	O
.	.	O
The	DT	O
resulting	VBG	O
solution	NN	O
was	VBD	O
partitioned	VBN	O
between	IN	O
ether	NN	O
(	(	O
30	CD	O
mL	NN	O
)	)	O
and	CC	O
saturated	VBN	O
NaHCO3	NNP	O
(	(	O
30	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
aqueous	JJ	O
layer	NN	O
was	VBD	O
extracted	VBN	O
with	IN	O
ether	NN	O
(	(	O
2×30	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
combined	JJ	O
organic	JJ	O
layers	NNS	O
were	VBD	O
dried	VBN	O
over	IN	O
Na2SO4	NNP	O
and	CC	O
concentrated	VBN	O
.	.	O
The	DT	O
crude	JJ	O
product	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	NN	O
chromatography	NN	O
to	TO	O
yield	VB	O
9	CD	O
(	(	O
325	CD	O
mg	NN	O
,	,	O
1.30	CD	O
mmol	NN	O
,	,	O
82	CD	O
%	NN	O
)	)	O
as	IN	O
a	DT	O
white	JJ	O
solid	JJ	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.10-1.25	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
1.40-1.55	JJ	O
(	(	O
m	NN	O
,	,	O
10H	CD	O
)	)	O
,	,	O
2.00-2.10	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.73	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
5.04	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.82-6.88	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.92-6.94	JJ	O
(	(	O
d	NN	O
,	,	O
J=7.5	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.20-7.25	JJ	O
(	(	O
dd	NN	O
,	,	O
J=7.5	NNP	O
,	,	O
14.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
16.6	CD	O
,	,	O
25.1	CD	O
,	,	O
28.6	CD	O
,	,	O
32.9	CD	O
,	,	O
113.0	CD	O
,	,	O
113.2	CD	O
,	,	O
113.4	CD	O
,	,	O
113.6	CD	O
,	,	O
122.4	CD	O
,	,	O
129.9	CD	O
,	,	O
130.0	CD	O
,	,	O
130.1	CD	O
,	,	O
143.77	CD	O
,	,	O
143.83	CD	O
,	,	O
162.2	CD	O
,	,	O
164.1	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C14H19FNO2	NNP	O
252.	CD	O
found	VBD	O
252	CD	O
.	.	O
2-	JJ	O
(	(	O
3-Fluorophenyl	JJ	O
)	)	O
cyclopropanamine	NN	O
trifluoroacetic	JJ	O
acid	NN	O
salt	NN	O
(	(	O
4b	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
9	CD	O
(	(	O
560	CD	O
mg	NN	O
,	,	O
2.2	CD	O
mmol	NN	O
)	)	O
in	IN	O
CH2Cl2	NNP	O
(	(	O
15	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
trifluoroacetic	JJ	O
acid	NN	O
(	(	O
15	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
stirred	VBN	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
30	CD	O
min	NN	O
.	.	O
The	DT	O
solvent	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
.	.	O
The	DT	O
yellow	JJ	O
oil	NN	O
was	VBD	O
put	VBN	O
under	IN	O
vacuum	NN	O
for	IN	O
24	CD	O
h	NN	O
to	TO	O
give	VB	O
crude	NN	O
amine	NN	O
4b	CD	O
(	(	O
579	CD	O
mg	NN	O
,	,	O
2.2	CD	O
mmol	NN	O
,	,	O
100	CD	O
%	NN	O
)	)	O
as	IN	O
a	DT	O
yellow	JJ	O
oil	NN	O
,	,	O
which	WDT	O
was	VBD	O
used	VBN	O
in	IN	O
the	DT	O
next	JJ	O
step	NN	O
without	IN	O
further	JJ	O
purification	NN	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.10-1.30	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.40-1.60	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.30-2.50	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.70-2.90	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.70-6.72	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.72-6.77	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.89-7.00	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.10-7.30	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.80-8.20	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
10.8-11.8	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
13.2	CD	O
,	,	O
21.5	CD	O
,	,	O
31.6	CD	O
,	,	O
113.5	CD	O
,	,	O
113.7	CD	O
,	,	O
114.2	CD	O
,	,	O
114.4	CD	O
,	,	O
122.29	CD	O
,	,	O
122.31	CD	O
,	,	O
130.4	CD	O
,	,	O
130.5	CD	O
,	,	O
140.1	CD	O
,	,	O
140.2	CD	O
,	,	O
162.2	CD	O
,	,	O
164.1	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C9H11FN	NNP	O
152.	CD	O
found	VBD	O
152	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C9H11FN	NNP	O
152.08755.	CD	O
found	VBD	O
152.08703	CD	O
.	.	O
Examples	NNS	O
5-29	NNS	O
can	MD	O
be	VB	O
considered	VBN	O
in	IN	O
the	DT	O
context	NN	O
of	IN	O
Schemes	NNP	O
1b-1e	JJ	O
,	,	O
above	IN	O
.	.	O
Example	RB	O
5	CD	O
General	NNP	O
Method	NNP	O
(	(	O
A	NNP	O
)	)	O
for	IN	O
Rhodium	NNP	O
(	(	O
II	NNP	O
)	)	O
-catalyzed	VBD	O
cyclopropanation	NN	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
styrene	JJ	O
derivative	JJ	O
4a-c	JJ	O
(	(	O
20	CD	O
mmol	NN	O
)	)	O
in	IN	O
dry	JJ	O
toluene	NN	O
(	(	O
40	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
catalyst	NN	O
Rh2	NNP	O
(	(	O
OAc	NNP	O
)	)	O
4	CD	O
(	(	O
0.4	CD	O
mmol	NN	O
)	)	O
.	.	O
The	DT	O
resulting	JJ	O
mixture	NN	O
was	VBD	O
heated	VBN	O
at	IN	O
80°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
min	NNS	O
,	,	O
then	RB	O
EtO2CCHN2	NNP	O
(	(	O
10	CD	O
mmol	NN	O
)	)	O
was	VBD	O
added	VBN	O
dropwise	NN	O
at	IN	O
the	DT	O
same	JJ	O
temperature	NN	O
over	IN	O
a	DT	O
period	NN	O
of	IN	O
1	CD	O
h.	NN	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
allowed	VBN	O
to	TO	O
stir	VB	O
at	IN	O
85°	CD	O
C.	NNP	O
for	IN	O
an	DT	O
additional	JJ	O
2	CD	O
h	NN	O
,	,	O
and	CC	O
then	RB	O
cooled	VBD	O
to	TO	O
room	NN	O
temperature	NN	O
.	.	O
The	DT	O
solvent	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
and	CC	O
the	DT	O
resulting	JJ	O
oil	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	NN	O
chromatography	NN	O
(	(	O
1-10	CD	O
%	NN	O
EtOAc	NNP	O
in	IN	O
hexanes	NNS	O
)	)	O
to	TO	O
generate	VB	O
5a-c	JJ	O
as	IN	O
mixtures	NNS	O
of	IN	O
cis/trans	NNS	O
isomers	NNS	O
.	.	O
Example	RB	O
6	CD	O
General	NNP	O
Method	NNP	O
(	(	O
B	NNP	O
)	)	O
for	IN	O
Epimerization	NN	O
and	CC	O
hydrolysis	NN	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
5a-c	NNP	O
(	(	O
10	CD	O
mmol	NN	O
)	)	O
in	IN	O
EtOH	NNP	O
(	(	O
10	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
NaOMe	NNP	O
(	(	O
40	CD	O
mL	NN	O
)	)	O
in	IN	O
portion	NN	O
.	.	O
The	DT	O
reaction	NN	O
solution	NN	O
was	VBD	O
heated	VBN	O
under	IN	O
reflux	NN	O
for	IN	O
40	CD	O
h	NN	O
,	,	O
and	CC	O
then	RB	O
concentrated	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
.	.	O
The	DT	O
resulting	VBG	O
residue	NN	O
was	VBD	O
partitioned	VBN	O
between	IN	O
DCM	NNP	O
(	(	O
200	CD	O
mL	NN	O
)	)	O
and	CC	O
H2O	NNP	O
(	(	O
100	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
aqueous	JJ	O
layer	NN	O
was	VBD	O
extracted	VBN	O
with	IN	O
DCM	NNP	O
(	(	O
2×100	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
combined	JJ	O
organic	JJ	O
layers	NNS	O
were	VBD	O
dried	VBN	O
over	IN	O
Na2SO4	NNP	O
and	CC	O
concentrated	VBN	O
.	.	O
The	DT	O
crude	NN	O
ethyl	NN	O
ester	NN	O
was	VBD	O
taken	VBN	O
up	RP	O
in	IN	O
MeOH	NNP	O
(	(	O
70	CD	O
mL	NN	O
)	)	O
,	,	O
to	TO	O
which	WDT	O
was	VBD	O
added	VBN	O
LiOH	NNP	O
(	(	O
345	CD	O
mg	NN	O
,	,	O
15	CD	O
mmol	NN	O
)	)	O
and	CC	O
H2O	NNP	O
(	(	O
70	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
was	VBD	O
heated	VBN	O
at	IN	O
70°	CD	O
C.	NNP	O
for	IN	O
16	CD	O
h.	NN	O
After	IN	O
cooling	VBG	O
to	TO	O
room	NN	O
temperature	NN	O
,	,	O
MeOH	NNP	O
was	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
.	.	O
The	DT	O
resulting	VBG	O
aqueous	JJ	O
solution	NN	O
was	VBD	O
acidified	VBN	O
by	IN	O
concentrated	JJ	O
HCl	NNP	O
to	TO	O
pH	VB	O
1	CD	O
,	,	O
which	WDT	O
was	VBD	O
extracted	VBN	O
with	IN	O
EtOAc	NNP	O
(	(	O
3×150	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
combined	JJ	O
organic	JJ	O
layers	NNS	O
were	VBD	O
dried	VBN	O
over	IN	O
Na2SO4	NNP	O
,	,	O
and	CC	O
concentrated	VBD	O
.	.	O
The	DT	O
crude	JJ	O
product	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	NN	O
chromatography	NN	O
to	TO	O
yield	VB	O
6a-c	JJ	O
(	(	O
75-80	CD	O
%	NN	O
)	)	O
as	IN	O
white	JJ	O
solids	NNS	O
.	.	O
Example	RB	O
7	CD	O
General	NNP	O
Method	NNP	O
(	(	O
C	NNP	O
)	)	O
for	IN	O
Curtius	NNP	O
rearrangement	NN	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
6a-c	NNP	O
(	(	O
2.0	CD	O
mmol	NN	O
)	)	O
in	IN	O
dry	JJ	O
t-BuOH	NN	O
(	(	O
0.3	CD	O
M	NNP	O
)	)	O
was	VBD	O
added	VBN	O
diphenyl	NN	O
phosphorazidate	NN	O
(	(	O
2.2	CD	O
mmol	NN	O
)	)	O
and	CC	O
TEA	NNP	O
(	(	O
3.0	CD	O
mmol	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
solution	NN	O
was	VBD	O
heated	VBN	O
at	IN	O
85°	CD	O
C.	NNP	O
for	IN	O
two	CD	O
days	NNS	O
,	,	O
then	RB	O
cooled	VBD	O
to	TO	O
room	NN	O
temperature	NN	O
and	CC	O
concentrated	VBD	O
.	.	O
The	DT	O
resulting	VBG	O
solution	NN	O
was	VBD	O
partitioned	VBN	O
between	IN	O
ether	NN	O
(	(	O
50	CD	O
mL	NN	O
)	)	O
and	CC	O
NaHCO3	NNP	O
(	(	O
50	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
aqueous	JJ	O
layer	NN	O
was	VBD	O
extracted	VBN	O
with	IN	O
ether	NN	O
(	(	O
2×50	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
combined	JJ	O
organic	JJ	O
layers	NNS	O
were	VBD	O
dried	VBN	O
over	IN	O
Na2SO4	NNP	O
and	CC	O
concentrated	VBN	O
.	.	O
The	DT	O
crude	JJ	O
product	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	NN	O
chromatography	NN	O
to	TO	O
yield	VB	O
7a-c	JJ	O
(	(	O
75-82	CD	O
%	NN	O
)	)	O
as	IN	O
white	JJ	O
solids	NNS	O
.	.	O
Example	RB	O
8	CD	O
General	NNP	O
Method	NNP	O
(	(	O
D	NNP	O
)	)	O
for	IN	O
Boc-deprotection	NNP	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
7a-c	NNP	O
(	(	O
1.0	CD	O
mmol	NN	O
)	)	O
in	IN	O
CH2Cl2	NNP	O
(	(	O
5	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
TFA	NNP	O
(	(	O
5	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
stirred	VBN	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
30	CD	O
min	NN	O
.	.	O
The	DT	O
solvent	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
.	.	O
The	DT	O
yellow	JJ	O
oil	NN	O
was	VBD	O
put	VBN	O
under	IN	O
vacuum	NN	O
for	IN	O
24	CD	O
h	NN	O
to	TO	O
give	VB	O
crude	JJ	O
amine	JJ	O
3a-c	JJ	O
as	IN	O
yellow	JJ	O
oils	NNS	O
,	,	O
which	WDT	O
was	VBD	O
used	VBN	O
in	IN	O
the	DT	O
next	JJ	O
step	NN	O
without	IN	O
further	JJ	O
purification	NN	O
.	.	O
Example	RB	O
9	CD	O
General	NNP	O
Method	NNP	O
(	(	O
E	NNP	O
)	)	O
for	IN	O
Reductive	JJ	O
amination	NN	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
aldehyde	NN	O
(	(	O
0.1	CD	O
mmol	NN	O
)	)	O
in	IN	O
DCM	NNP	O
(	(	O
3	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
amine	NN	O
(	(	O
0.11	CD	O
mmol	NN	O
)	)	O
,	,	O
followed	VBN	O
by	IN	O
TEA	NNP	O
(	(	O
0.2	CD	O
mmol	NN	O
)	)	O
,	,	O
and	CC	O
NaHB	NNP	O
(	(	O
OAc	NNP	O
)	)	O
3	CD	O
(	(	O
0.12	CD	O
mmol	NN	O
)	)	O
.	.	O
The	DT	O
mixture	NN	O
was	VBD	O
stirred	VBN	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
an	DT	O
additional	JJ	O
3	CD	O
h	NN	O
,	,	O
and	CC	O
then	RB	O
concentrated	VBD	O
.	.	O
The	DT	O
crude	JJ	O
product	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	JJ	O
column	NN	O
chromatography	NN	O
(	(	O
EtOAc/hexanes	NNPS	O
,	,	O
2:1-4:1	JJ	O
)	)	O
to	TO	O
give	VB	O
the	DT	O
product	NN	O
as	IN	O
colorless	JJ	O
oil	NN	O
.	.	O
Example	RB	O
10	CD	O
General	NNP	O
Method	NNP	O
(	(	O
F	NNP	O
)	)	O
for	IN	O
Boc-deprotection	NNP	O
of	IN	O
Inhibitor	NNP	O
Compound	NNP	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
tri-Boc-protected	JJ	O
inhibitor	NN	O
(	(	O
0.2	CD	O
mmol	NN	O
)	)	O
in	IN	O
MeOH	NNP	O
(	(	O
0.5	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
6	CD	O
N	NNP	O
HCl	NNP	O
(	(	O
1.0	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
sit	VBN	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
16	CD	O
h	NN	O
,	,	O
and	CC	O
then	RB	O
concentrated	VBD	O
.	.	O
The	DT	O
resulting	VBG	O
pale	JJ	O
yellow	JJ	O
oil	NN	O
was	VBD	O
put	VBN	O
under	IN	O
vacuum	NN	O
for	IN	O
30	CD	O
h	NN	O
to	TO	O
give	VB	O
final	JJ	O
inhibitors	NNS	O
(	(	O
95-99	CD	O
%	NN	O
)	)	O
.	.	O
Example	JJ	O
11	CD	O
2-m-Tolylcyclopropanecarboxylic	JJ	O
acid	NN	O
(	(	O
6a	CD	O
)	)	O
.	.	O
Compound	NN	O
6a	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
general	JJ	O
method	NN	O
A	NNP	O
and	CC	O
B	NNP	O
(	(	O
77	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.30-1.40	JJ	O
(	(	O
ddd	NN	O
,	,	O
J=4.5	NNP	O
,	,	O
7.0	CD	O
,	,	O
7.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.60-1.65	JJ	O
(	(	O
dd	NN	O
,	,	O
J=5.0	NNP	O
,	,	O
9.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.85-1.90	JJ	O
(	(	O
ddd	NN	O
,	,	O
J=4.5	NNP	O
,	,	O
5.0	CD	O
,	,	O
7.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.50-2.60	JJ	O
(	(	O
ddd	NN	O
,	,	O
J=4.5	NNP	O
,	,	O
7.0	CD	O
,	,	O
9.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.85-6.95	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.00-7.05	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.15-7.22	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
17.5	CD	O
,	,	O
21.4	CD	O
,	,	O
24.0	CD	O
,	,	O
27.1	CD	O
,	,	O
123.2	CD	O
,	,	O
127.0	CD	O
,	,	O
127.4	CD	O
,	,	O
128.4	CD	O
,	,	O
138.2	CD	O
,	,	O
139.4	CD	O
,	,	O
180.1	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M−H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C11H13O2	NNP	O
177.	CD	O
found	VBD	O
177	CD	O
.	.	O
Example	JJ	O
12	CD	O
2-	JJ	O
(	(	O
3-Clorophenyl	JJ	O
)	)	O
cyclopropanecarboxylic	JJ	O
acid	NN	O
(	(	O
6b	CD	O
)	)	O
.	.	O
Compound	NN	O
6b	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
general	JJ	O
method	NN	O
A	NNP	O
and	CC	O
B	NNP	O
(	(	O
80	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.30-1.40	JJ	O
(	(	O
ddd	NN	O
,	,	O
J=2.0	NNP	O
,	,	O
3.5	CD	O
,	,	O
7.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.60-1.65	JJ	O
(	(	O
dd	NN	O
,	,	O
J=5.0	NNP	O
,	,	O
9.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.85-1.91	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.50-2.60	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.85-7.02	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.05-7.10	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.15-7.22	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
17.8	CD	O
,	,	O
24.4	CD	O
,	,	O
26.9	CD	O
,	,	O
31.8	CD	O
,	,	O
113.3	CD	O
,	,	O
113.5	CD	O
,	,	O
113.8	CD	O
,	,	O
114.0	CD	O
,	,	O
122.30	CD	O
,	,	O
122.32	CD	O
,	,	O
130.2	CD	O
,	,	O
130.3	CD	O
,	,	O
142.4	CD	O
,	,	O
142.5	CD	O
,	,	O
162.2	CD	O
,	,	O
164.2	CD	O
,	,	O
179.8	CD	O
;	:	O
LC-MS	NNP	O
(	(	O
M−H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C10H10ClO2	NNP	O
197.	CD	O
found	VBD	O
197	CD	O
.	.	O
Example	JJ	O
13	CD	O
2-	JJ	O
(	(	O
3-Fluorophenyl	JJ	O
)	)	O
cyclopropanecarboxylic	JJ	O
acid	NN	O
(	(	O
6c	CD	O
)	)	O
.	.	O
Compound	NN	O
6c	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
general	JJ	O
method	NN	O
A	NNP	O
and	CC	O
B	NNP	O
(	(	O
75	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
0.87-0.91	JJ	O
(	(	O
dd	NN	O
,	,	O
J=6.0	NNP	O
,	,	O
13.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.21-1.29	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.39-1.43	JJ	O
(	(	O
ddd	NN	O
,	,	O
J=5.0	NNP	O
,	,	O
6.5	CD	O
,	,	O
8.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.67-1.72	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.90-1.94	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.58-2.63	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.79-6.82	JJ	O
(	(	O
dd	NN	O
,	,	O
J=2.0	NNP	O
,	,	O
5.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.90-6.95	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.24-7.28	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
8.90-11.00	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
17.8	CD	O
,	,	O
24.4	CD	O
,	,	O
26.9	CD	O
,	,	O
31.8	CD	O
,	,	O
113.3	CD	O
,	,	O
113.5	CD	O
,	,	O
113.8	CD	O
,	,	O
114.0	CD	O
,	,	O
122.30	CD	O
,	,	O
122.32	CD	O
,	,	O
130.2	CD	O
,	,	O
130.3	CD	O
,	,	O
142.4	CD	O
,	,	O
142.5	CD	O
,	,	O
162.2	CD	O
,	,	O
164.2	CD	O
,	,	O
179.8	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M−H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C10H8FO2	NNP	O
179.	CD	O
found	VBD	O
179	CD	O
.	.	O
Example	JJ	O
14	CD	O
tert-Butyl	JJ	O
2-m-tolylcyclopropylcarbamate	JJ	O
(	(	O
7a	CD	O
)	)	O
.	.	O
Compound	NN	O
7a	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
general	JJ	O
method	NN	O
C	NNP	O
(	(	O
82	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.00-1.20	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
1.46	CD	O
(	(	O
s	NN	O
,	,	O
9H	CD	O
)	)	O
,	,	O
1.95-2.05	JJ	O
(	(	O
ddd	NN	O
,	,	O
J=3.0	NNP	O
,	,	O
6.5	CD	O
,	,	O
9.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.31	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.74	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
4.85	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.91-6.93	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.97-6.99	JJ	O
(	(	O
d	NN	O
,	,	O
J=7.5	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.13-7.16	JJ	O
(	(	O
dd	NN	O
,	,	O
J=7.5	NNP	O
,	,	O
8.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
16.3	CD	O
,	,	O
21.4	CD	O
,	,	O
24.5	CD	O
,	,	O
28.4	CD	O
,	,	O
32.6	CD	O
,	,	O
120.2	CD	O
,	,	O
120.3	CD	O
,	,	O
123.4	CD	O
,	,	O
126.1	CD	O
,	,	O
126.8	CD	O
,	,	O
127.2	CD	O
,	,	O
128.2	CD	O
,	,	O
130.1	CD	O
,	,	O
137.9	CD	O
,	,	O
140.6	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C15H21NO2	NNP	O
248.	CD	O
found	VBD	O
248	CD	O
.	.	O
Example	JJ	O
15	CD	O
tert-Butyl	JJ	O
2-	JJ	O
(	(	O
3-chloroluorophenyl	JJ	O
)	)	O
cyclopropylcarbamate	NN	O
(	(	O
7b	CD	O
)	)	O
.	.	O
Compound	NN	O
7b	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
general	JJ	O
method	NN	O
C	NNP	O
(	(	O
77	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.14-1.17	JJ	O
(	(	O
dd	NN	O
,	,	O
J=6.5	NNP	O
,	,	O
7.0	CD	O
Hz	NNP	O
,	,	O
2H	CD	O
)	)	O
,	,	O
1.45	CD	O
(	(	O
s	NN	O
,	,	O
9H	CD	O
)	)	O
,	,	O
1.99-2.03	JJ	O
(	(	O
ddd	NN	O
,	,	O
J=2.5	NNP	O
,	,	O
7.5	CD	O
,	,	O
10.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.72	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
4.88	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.95-7.02	JJ	O
(	(	O
d	NN	O
,	,	O
J=7.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.10-7.25	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
16.3	CD	O
,	,	O
24.5	CD	O
,	,	O
28.4	CD	O
,	,	O
32.6	CD	O
,	,	O
120.1	CD	O
,	,	O
120.3	CD	O
,	,	O
124.8	CD	O
,	,	O
126.2	CD	O
,	,	O
126.6	CD	O
,	,	O
129.5	CD	O
,	,	O
129.9	CD	O
,	,	O
134.1	CD	O
,	,	O
142.9	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C14H19ClNO2	NNP	O
268.	CD	O
found	VBD	O
268	CD	O
.	.	O
Example	JJ	O
16	CD	O
tert-Butyl	JJ	O
2-	JJ	O
(	(	O
3-fluorophenyl	JJ	O
)	)	O
cyclopropylcarbamate	NN	O
(	(	O
7c	CD	O
)	)	O
.	.	O
Compound	NN	O
7c	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
general	JJ	O
method	NN	O
C	NNP	O
(	(	O
75	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.10-1.25	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
1.40-1.55	JJ	O
(	(	O
m	NN	O
,	,	O
10H	CD	O
)	)	O
,	,	O
2.00-2.10	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.73	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
5.04	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.82-6.88	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.92-6.94	JJ	O
(	(	O
d	NN	O
,	,	O
J=7.5	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.20-7.25	JJ	O
(	(	O
dd	NN	O
,	,	O
J=7.5	NNP	O
,	,	O
14.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
16.6	CD	O
,	,	O
25.1	CD	O
,	,	O
28.6	CD	O
,	,	O
32.9	CD	O
,	,	O
113.0	CD	O
,	,	O
113.2	CD	O
,	,	O
113.4	CD	O
,	,	O
113.6	CD	O
,	,	O
122.4	CD	O
,	,	O
129.9	CD	O
,	,	O
130.0	CD	O
,	,	O
130.1	CD	O
,	,	O
143.77	CD	O
,	,	O
143.83	CD	O
,	,	O
162.2	CD	O
,	,	O
164.1	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C14H19FNO2	NNP	O
252.	CD	O
found	VBD	O
252	CD	O
.	.	O
Example	RB	O
17	CD	O
Compounds	NNS	O
8a	CD	O
and	CC	O
8b	CD	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
amine	NN	O
3c	CD	O
(	(	O
450	CD	O
mg	NN	O
,	,	O
3.0	CD	O
mmol	NN	O
)	)	O
in	IN	O
DCM	NNP	O
was	VBD	O
added	VBN	O
camphanic	JJ	O
chloride	NN	O
(	(	O
650	CD	O
mg	NN	O
,	,	O
3.0	CD	O
mmol	NN	O
)	)	O
,	,	O
followed	VBN	O
by	IN	O
TEA	NNP	O
(	(	O
510	CD	O
μL	NN	O
,	,	O
3.75	CD	O
mmol	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
was	VBD	O
allowed	VBN	O
to	TO	O
stir	VB	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
30	CD	O
min	NN	O
,	,	O
and	CC	O
then	RB	O
concentrated	VBD	O
.	.	O
The	DT	O
resulting	JJ	O
oil	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	NN	O
chromatography	NN	O
(	(	O
EtOAc/Hexanes	NNP	O
,	,	O
1:4	CD	O
)	)	O
to	TO	O
generate	VB	O
8a	CD	O
(	(	O
445	CD	O
mg	NN	O
,	,	O
45	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
0.92	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
1.12	CD	O
(	(	O
s	NN	O
,	,	O
6H	CD	O
)	)	O
,	,	O
1.19-1.22	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.28-1.30	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
1.65-1.75	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.85-2.00	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.05-2.15	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.50-2.60	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.90-2.98	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.68	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.84-6.90	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.95-6.97	JJ	O
(	(	O
d	NN	O
,	,	O
J=7.5	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.21-7.25	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
9.7	CD	O
,	,	O
15.8	CD	O
,	,	O
16.5	CD	O
,	,	O
16.7	CD	O
,	,	O
24.67	CD	O
,	,	O
24.78	CD	O
,	,	O
29.0	CD	O
,	,	O
30.3	CD	O
,	,	O
31.6	CD	O
,	,	O
54.0	CD	O
,	,	O
55.3	CD	O
,	,	O
92.4	CD	O
,	,	O
113.1	CD	O
,	,	O
113.27	CD	O
,	,	O
113.32	CD	O
,	,	O
113.5	CD	O
,	,	O
122.30	CD	O
,	,	O
122.32	CD	O
,	,	O
129.8	CD	O
,	,	O
129.9	CD	O
,	,	O
142.6	CD	O
,	,	O
142.7	CD	O
,	,	O
162.0	CD	O
,	,	O
163.9	CD	O
,	,	O
168.3	CD	O
,	,	O
178.2	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C19H23FNO3	NNP	O
332.1662.	CD	O
found	VBD	O
332.1673	CD	O
;	:	O
and	CC	O
8b	CD	O
(	(	O
360	CD	O
mg	NN	O
,	,	O
36	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
0.91	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
1.11	CD	O
(	(	O
s	NN	O
,	,	O
6H	CD	O
)	)	O
,	,	O
1.20-1.35	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
1.65-1.75	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.85-2.00	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.00-2.10	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.50-2.58	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.89-2.95	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.67	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.84-6.90	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.95-6.97	JJ	O
(	(	O
d	NN	O
,	,	O
J=8.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.21-7.24	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
9.7	CD	O
,	,	O
16.0	CD	O
,	,	O
16.5	CD	O
,	,	O
16.7	CD	O
,	,	O
24.61	CD	O
,	,	O
24.63	CD	O
,	,	O
29.0	CD	O
,	,	O
30.3	CD	O
,	,	O
31.5	CD	O
,	,	O
54.0	CD	O
,	,	O
55.3	CD	O
,	,	O
92.38	CD	O
,	,	O
92.40	CD	O
,	,	O
113.1	CD	O
,	,	O
113.29	CD	O
,	,	O
113.32	CD	O
,	,	O
113.4	CD	O
113.5	CD	O
,	,	O
113.6	CD	O
,	,	O
122.30	CD	O
,	,	O
122.32	CD	O
,	,	O
129.8	CD	O
,	,	O
129.9	CD	O
,	,	O
142.66	CD	O
,	,	O
142.72	CD	O
,	,	O
162.0	CD	O
,	,	O
163.9	CD	O
,	,	O
168.2	CD	O
,	,	O
168.3	CD	O
,	,	O
178.2	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C19H23FNO3	NNP	O
332.1662.	CD	O
found	VBD	O
332.1677	CD	O
.	.	O
Example	JJ	O
18	CD	O
(	(	O
1S,2R	CD	O
)	)	O
-2-	NN	O
(	(	O
3-Fluorophenyl	JJ	O
)	)	O
cyclopropanamine	NN	O
(	(	O
3d	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
8a	CD	O
(	(	O
330	CD	O
mg	NN	O
,	,	O
1.0	CD	O
mmol	NN	O
)	)	O
in	IN	O
EtOH	NNP	O
(	(	O
5	CD	O
mL	NN	O
)	)	O
was	VBD	O
slowly	RB	O
added	JJ	O
12	CD	O
N	NNP	O
HCl	NNP	O
(	(	O
10	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
resulting	JJ	O
mixture	NN	O
was	VBD	O
heated	VBN	O
under	IN	O
reflux	NN	O
for	IN	O
72	CD	O
h	NN	O
and	CC	O
then	RB	O
cooled	VBD	O
to	TO	O
room	NN	O
temperature	NN	O
.	.	O
The	DT	O
solvent	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
,	,	O
and	CC	O
the	DT	O
resulting	JJ	O
crude	JJ	O
material	NN	O
was	VBD	O
purified	VBN	O
with	IN	O
flash	JJ	O
chromatography	NN	O
(	(	O
2-5	CD	O
%	NN	O
MeOH	NNP	O
in	IN	O
DCM	NNP	O
)	)	O
to	TO	O
give	VB	O
3d	CD	O
as	IN	O
a	DT	O
yellow	JJ	O
oil	NN	O
(	(	O
105	CD	O
mg	NN	O
,	,	O
70	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.10-1.30	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.40-1.60	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.30-2.50	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.70-2.90	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.70-6.72	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.72-6.77	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.89-7.00	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.10-7.30	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.80-8.20	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
2H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
13.2	CD	O
,	,	O
21.5	CD	O
,	,	O
31.6	CD	O
,	,	O
113.5	CD	O
,	,	O
113.7	CD	O
,	,	O
114.2	CD	O
,	,	O
114.4	CD	O
,	,	O
122.29	CD	O
,	,	O
122.31	CD	O
,	,	O
130.4	CD	O
,	,	O
130.5	CD	O
,	,	O
140.1	CD	O
,	,	O
140.2	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C9H11FN	NNP	O
152.0876.	CD	O
found	VBD	O
152.0870	CD	O
.	.	O
Example	JJ	O
19	CD	O
(	(	O
1R,2S	CD	O
)	)	O
-2-	NN	O
(	(	O
3-Fluorophenyl	JJ	O
)	)	O
cyclopropanamine	NN	O
(	(	O
3e	CD	O
)	)	O
.	.	O
3e	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
a	DT	O
similar	JJ	O
procedure	NN	O
to	TO	O
that	DT	O
of	IN	O
3d	CD	O
using	VBG	O
8b	CD	O
as	IN	O
a	DT	O
starting	VBG	O
material	NN	O
(	(	O
67	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.10-1.30	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.40-1.60	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.30-2.50	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.70-2.90	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.70-6.72	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.72-6.77	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.89-7.00	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.10-7.30	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.80-8.20	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
2H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
13.2	CD	O
,	,	O
21.5	CD	O
,	,	O
31.6	CD	O
,	,	O
113.5	CD	O
,	,	O
113.7	CD	O
,	,	O
114.2	CD	O
,	,	O
114.4	CD	O
,	,	O
122.29	CD	O
,	,	O
122.31	CD	O
,	,	O
130.4	CD	O
,	,	O
130.5	CD	O
,	,	O
140.1	CD	O
,	,	O
140.2	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C9H11FN	NNP	O
152.0876.	CD	O
found	VBD	O
152.0870	CD	O
.	.	O
Example	JJ	O
20	CD	O
(	(	O
3R,4R	CD	O
)	)	O
-tert-Butyl	CD	O
3-	JJ	O
(	(	O
(	(	O
6-	CD	O
(	(	O
bis	NN	O
(	(	O
tert-butoxycarbonyl	JJ	O
)	)	O
amino	NN	O
)	)	O
-4-methylpyridin-2-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
(	(	O
1S,2R/1R,2S	CD	O
)	)	O
-2-m-tolylcyclopropylamino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidine-1-carboxylate	NN	O
(	(	O
9a	CD	O
)	)	O
.	.	O
Compound	NN	O
9a	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
general	JJ	O
method	NN	O
D	NNP	O
(	(	O
87	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
0.90-0.97	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.00-1.05	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.40-1.45	JJ	O
(	(	O
m	NN	O
,	,	O
27H	CD	O
)	)	O
,	,	O
1.84-1.91	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.27-2.32	JJ	O
(	(	O
m	NN	O
,	,	O
6H	CD	O
)	)	O
,	,	O
2.33-2.40	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.60-2.75	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.75-2.83	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.85-2.93	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.95-3.00	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.05-3.15	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.25-3.30	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.31-3.34	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.35-3.55	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.57-3.74	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.75-3.85	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.85-6.95	JJ	O
(	(	O
m	NN	O
,	,	O
4H	CD	O
)	)	O
,	,	O
6.92-7.01	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.10-7.20	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
100	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
13.7	CD	O
,	,	O
14.1	CD	O
,	,	O
14.2	CD	O
,	,	O
17.2	CD	O
,	,	O
17.3	CD	O
,	,	O
17.4	CD	O
,	,	O
19.1	CD	O
,	,	O
20.9	CD	O
,	,	O
21.0	CD	O
,	,	O
21.1	CD	O
,	,	O
21.4	CD	O
,	,	O
22.2	CD	O
,	,	O
24.96	CD	O
,	,	O
24.99	CD	O
,	,	O
25.0	CD	O
,	,	O
25.5	CD	O
,	,	O
27.9	CD	O
,	,	O
28.5	CD	O
,	,	O
29.7	CD	O
,	,	O
30.6	CD	O
,	,	O
34.6	CD	O
,	,	O
34.7	CD	O
,	,	O
41.0	CD	O
,	,	O
41.1	CD	O
,	,	O
42.6	CD	O
,	,	O
43.2	CD	O
,	,	O
48.8	CD	O
,	,	O
48.9	CD	O
,	,	O
49.0	CD	O
,	,	O
49.1	CD	O
,	,	O
50.3	CD	O
,	,	O
60.4	CD	O
,	,	O
64.4	CD	O
,	,	O
68.4	CD	O
,	,	O
78.6	CD	O
,	,	O
79.2	CD	O
,	,	O
79.3	CD	O
,	,	O
79.4	CD	O
,	,	O
82.8	CD	O
,	,	O
82.9	CD	O
,	,	O
119.5	CD	O
,	,	O
119.6	CD	O
,	,	O
122.7	CD	O
,	,	O
122.8	CD	O
,	,	O
122.9	CD	O
,	,	O
126.3	CD	O
,	,	O
126.5	CD	O
,	,	O
126.6	CD	O
,	,	O
126.7	CD	O
,	,	O
126.8	CD	O
,	,	O
128.17	CD	O
,	,	O
128.24	CD	O
,	,	O
128.3	CD	O
,	,	O
128.5	CD	O
,	,	O
128.6	CD	O
,	,	O
132.0	CD	O
,	,	O
132.1	CD	O
,	,	O
137.8	CD	O
,	,	O
137.9	CD	O
,	,	O
141.3	CD	O
,	,	O
142.3	CD	O
,	,	O
149.6	CD	O
,	,	O
151.4	CD	O
,	,	O
151.5	CD	O
,	,	O
151.8	CD	O
,	,	O
154.8	CD	O
,	,	O
159.1	CD	O
,	,	O
159.2	CD	O
,	,	O
171.2	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C38H57N4O7	NNP	O
681.4227.	CD	O
found	VBD	O
681.4224	CD	O
.	.	O
Example	JJ	O
21	CD	O
(	(	O
3R,4R	CD	O
)	)	O
-tert-Butyl	CD	O
3-	JJ	O
(	(	O
(	(	O
6-	CD	O
(	(	O
bis	NN	O
(	(	O
tert-butoxycarbonyl	JJ	O
)	)	O
amino	NN	O
)	)	O
-4-methylpyridin-2-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
(	(	O
1S,2R/1R,2S	CD	O
)	)	O
-2-	NN	O
(	(	O
3-clorophenyl	JJ	O
)	)	O
cyclopropylamino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidine-1-carboxylate	NN	O
(	(	O
9b	CD	O
)	)	O
.	.	O
Compound	NN	O
9b	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
general	JJ	O
method	NN	O
D	NNP	O
(	(	O
87	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
0.92-0.99	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.07-1.11	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.40-1.45	JJ	O
(	(	O
m	NN	O
,	,	O
27H	CD	O
)	)	O
,	,	O
1.85-1.90	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.29-2.33	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.34-2.38	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.60-2.75	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.76-2.83	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.85-2.93	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.95-3.00	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.05-3.15	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.25-3.30	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.31-3.34	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.35-3.52	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.57-3.74	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.75-3.85	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.85-6.92	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.93-7.05	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.08-7.20	JJ	O
(	(	O
m	NN	O
,	,	O
4H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
100	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
17.4	CD	O
,	,	O
17.5	CD	O
,	,	O
17.6	CD	O
,	,	O
18.7	CD	O
,	,	O
20.9	CD	O
,	,	O
21.0	CD	O
,	,	O
22.2	CD	O
,	,	O
24.9	CD	O
,	,	O
25.0	CD	O
,	,	O
25.3	CD	O
,	,	O
26.2	CD	O
,	,	O
27.9	CD	O
,	,	O
28.5	CD	O
,	,	O
34.6	CD	O
,	,	O
34.7	CD	O
,	,	O
35.6	CD	O
,	,	O
41.3	CD	O
,	,	O
41.4	CD	O
,	,	O
41.5	CD	O
,	,	O
41.6	CD	O
,	,	O
42.5	CD	O
,	,	O
43.1	CD	O
,	,	O
48.7	CD	O
,	,	O
48.8	CD	O
,	,	O
49.1	CD	O
,	,	O
50.3	CD	O
,	,	O
52.0	CD	O
,	,	O
68.4	CD	O
,	,	O
68.5	CD	O
,	,	O
76.7	CD	O
,	,	O
78.6	CD	O
,	,	O
79.2	CD	O
,	,	O
79.3	CD	O
,	,	O
79.4	CD	O
,	,	O
82.8	CD	O
,	,	O
82.9	CD	O
,	,	O
119.5	CD	O
,	,	O
119.6	CD	O
,	,	O
122.7	CD	O
,	,	O
124.0	CD	O
,	,	O
124.07	CD	O
,	,	O
124.10	CD	O
,	,	O
124.12	CD	O
,	,	O
124.3	CD	O
,	,	O
125.5	CD	O
,	,	O
125.6	CD	O
,	,	O
125.7	CD	O
,	,	O
125.81	CD	O
,	,	O
125.83	CD	O
,	,	O
125.86	CD	O
,	,	O
125.94	CD	O
,	,	O
128.5	CD	O
,	,	O
128.6	CD	O
,	,	O
129.4	CD	O
,	,	O
129.5	CD	O
,	,	O
129.6	CD	O
,	,	O
132.0	CD	O
,	,	O
132.1	CD	O
,	,	O
134.1	CD	O
,	,	O
134.2	CD	O
,	,	O
143.6	CD	O
,	,	O
144.6	CD	O
,	,	O
144.7	CD	O
,	,	O
149.6	CD	O
,	,	O
151.47	CD	O
,	,	O
151.53	CD	O
,	,	O
151.8	CD	O
,	,	O
154.8	CD	O
,	,	O
159.7	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C37H53ClN4O7	NNP	O
701.3681.	CD	O
found	VBD	O
701.3884	CD	O
.	.	O
Example	JJ	O
22	CD	O
(	(	O
3R,4R	CD	O
)	)	O
-tert-Butyl	CD	O
3-	JJ	O
(	(	O
(	(	O
6-	CD	O
(	(	O
bis	NN	O
(	(	O
tert-butoxycarbonyl	JJ	O
)	)	O
amino	NN	O
)	)	O
-4-methylpyridin-2-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
(	(	O
1S,2R/1R,2S	CD	O
)	)	O
-2-	NN	O
(	(	O
3-fluorophenyl	JJ	O
)	)	O
cyclopropylamino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidine-1-carboxylate	NN	O
(	(	O
9c	CD	O
)	)	O
.	.	O
Compound	NN	O
9c	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
general	JJ	O
method	NN	O
D	NNP	O
(	(	O
81	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
0.95-1.00	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.06-1.10	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.40-1.46	JJ	O
(	(	O
m	NN	O
,	,	O
27H	CD	O
)	)	O
,	,	O
1.86-1.90	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.26-2.33	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.35-2.40	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.60-2.75	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.76-2.85	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.86-2.92	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.95-2.98	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.05-3.13	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.24-3.30	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.30-3.35	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.36-3.51	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.57-3.75	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.77-3.85	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.85-6.92	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.93-7.20	JJ	O
(	(	O
m	NN	O
,	,	O
4H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
100	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
17.4	CD	O
,	,	O
17.5	CD	O
,	,	O
17.6	CD	O
,	,	O
18.7	CD	O
,	,	O
20.9	CD	O
,	,	O
21.0	CD	O
,	,	O
22.2	CD	O
,	,	O
24.9	CD	O
,	,	O
25.0	CD	O
,	,	O
25.3	CD	O
,	,	O
26.2	CD	O
,	,	O
27.9	CD	O
,	,	O
28.5	CD	O
,	,	O
34.6	CD	O
,	,	O
34.7	CD	O
,	,	O
35.6	CD	O
,	,	O
41.3	CD	O
,	,	O
41.4	CD	O
,	,	O
41.5	CD	O
,	,	O
41.6	CD	O
,	,	O
42.5	CD	O
,	,	O
43.1	CD	O
,	,	O
48.7	CD	O
,	,	O
48.8	CD	O
,	,	O
49.1	CD	O
,	,	O
50.3	CD	O
,	,	O
52.0	CD	O
,	,	O
68.4	CD	O
,	,	O
68.5	CD	O
,	,	O
76.7	CD	O
,	,	O
78.6	CD	O
,	,	O
79.2	CD	O
,	,	O
79.3	CD	O
,	,	O
79.4	CD	O
,	,	O
82.8	CD	O
,	,	O
82.9	CD	O
,	,	O
119.5	CD	O
,	,	O
119.6	CD	O
,	,	O
122.7	CD	O
,	,	O
124.0	CD	O
,	,	O
124.07	CD	O
,	,	O
124.10	CD	O
,	,	O
124.12	CD	O
,	,	O
124.3	CD	O
,	,	O
125.5	CD	O
,	,	O
125.6	CD	O
,	,	O
125.7	CD	O
,	,	O
125.81	CD	O
,	,	O
125.83	CD	O
,	,	O
125.86	CD	O
,	,	O
125.94	CD	O
,	,	O
128.5	CD	O
,	,	O
128.6	CD	O
,	,	O
129.4	CD	O
,	,	O
129.5	CD	O
,	,	O
129.6	CD	O
,	,	O
132.0	CD	O
,	,	O
132.1	CD	O
,	,	O
134.1	CD	O
,	,	O
134.2	CD	O
,	,	O
143.6	CD	O
,	,	O
144.6	CD	O
,	,	O
144.7	CD	O
,	,	O
149.6	CD	O
,	,	O
151.47	CD	O
,	,	O
151.53	CD	O
,	,	O
151.8	CD	O
,	,	O
154.8	CD	O
,	,	O
159.7	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C43H60F3N4O8	NNP	O
685.3977.	CD	O
found	VBD	O
685.3991	CD	O
.	.	O
Example	JJ	O
23	CD	O
(	(	O
3R,4R	CD	O
)	)	O
-tert-Butyl	CD	O
3-	JJ	O
(	(	O
(	(	O
6-	CD	O
(	(	O
bis	NN	O
(	(	O
tert-butoxycarbonyl	JJ	O
)	)	O
amino	NN	O
)	)	O
-4-methylpyridin-2-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
(	(	O
1S,2R	CD	O
)	)	O
-2-	NN	O
(	(	O
3-fluorophenyl	JJ	O
)	)	O
cyclopropylamino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidine-1-carboxylate	NN	O
(	(	O
9d	CD	O
)	)	O
.	.	O
Compound	NN	O
9d	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
general	JJ	O
method	NN	O
D	NNP	O
(	(	O
82	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
0.95-1.01	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.10-1.15	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.40-1.45	JJ	O
(	(	O
m	NN	O
,	,	O
27H	CD	O
)	)	O
,	,	O
1.89-1.92	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.28-2.32	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.33-2.37	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.60-2.75	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.76-2.83	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.85-2.93	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.95-3.00	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.05-3.15	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.27-3.31	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.32-3.34	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.35-3.55	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.57-3.74	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.75-3.85	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.65-6.72	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.80-6.89	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.90-6.95	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.15-7.20	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
100	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
14.2	CD	O
,	,	O
17.4	CD	O
,	,	O
17.5	CD	O
,	,	O
21.0	CD	O
,	,	O
22.7	CD	O
,	,	O
24.7	CD	O
,	,	O
24.8	CD	O
,	,	O
27.9	CD	O
,	,	O
28.5	CD	O
,	,	O
29.7	CD	O
,	,	O
31.6	CD	O
,	,	O
34.6	CD	O
,	,	O
34.7	CD	O
,	,	O
36.6	CD	O
,	,	O
41.4	CD	O
,	,	O
41.5	CD	O
,	,	O
42.5	CD	O
,	,	O
43.1	CD	O
,	,	O
44.7	CD	O
,	,	O
48.7	CD	O
,	,	O
48.8	CD	O
,	,	O
49.1	CD	O
,	,	O
50.3	CD	O
,	,	O
50.9	CD	O
,	,	O
60.4	CD	O
,	,	O
68.3	CD	O
,	,	O
78.6	CD	O
,	,	O
79.2	CD	O
,	,	O
79.3	CD	O
,	,	O
79.4	CD	O
,	,	O
82.8	CD	O
,	,	O
82.9	CD	O
,	,	O
112.2	CD	O
,	,	O
112.4	CD	O
,	,	O
112.6	CD	O
,	,	O
119.5	CD	O
,	,	O
119.6	CD	O
,	,	O
121.6	CD	O
,	,	O
122.7	CD	O
,	,	O
128.5	CD	O
,	,	O
128.6	CD	O
,	,	O
129.6	CD	O
,	,	O
129.7	CD	O
,	,	O
131.9	CD	O
,	,	O
132.0	CD	O
,	,	O
132.1	CD	O
,	,	O
132.2	CD	O
,	,	O
149.6	CD	O
,	,	O
151.5	CD	O
,	,	O
151.8	CD	O
,	,	O
154.6	CD	O
,	,	O
154.8	CD	O
,	,	O
159.0	CD	O
,	,	O
159.1	CD	O
,	,	O
162.0	CD	O
,	,	O
163.9	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C37H54FN4O7	NNP	O
685.3977.	CD	O
found	VBD	O
685.3979	CD	O
.	.	O
Example	JJ	O
24	CD	O
4-Methyl-6-	JJ	O
(	(	O
(	(	O
(	(	O
3R,4R	CD	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
(	(	O
1S,2R/1R,2S	CD	O
)	)	O
-2-m-tolylcyclopropylamino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidin-3-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
pyridin-2-amine	NN	O
(	(	O
2a	CD	O
)	)	O
.	.	O
Inhibitor	NN	O
2a	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
general	JJ	O
method	NN	O
E	NNP	O
as	IN	O
a	DT	O
mixture	NN	O
of	IN	O
two	CD	O
diastereomers	NNS	O
(	(	O
90	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
1.10-1.30	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.35-1.45	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.10-2.15	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.15-2.20	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.20-2.50	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.50-2.80	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.81-3.00	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.19-3.25	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.30-3.40	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.47-3.52	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.55-3.70	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.71-3.85	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
4.00-4.15	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.35-6.60	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.85-6.90	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.91-7.15	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
12.2	CD	O
,	,	O
12.3	CD	O
,	,	O
15.1	CD	O
,	,	O
20.2	CD	O
,	,	O
20.4	CD	O
,	,	O
20.5	CD	O
,	,	O
20.6	CD	O
,	,	O
20.7	CD	O
,	,	O
21.0	CD	O
,	,	O
21.6	CD	O
,	,	O
23.2	CD	O
,	,	O
28.8	CD	O
,	,	O
28.9	CD	O
,	,	O
30.1	CD	O
,	,	O
30.5	CD	O
,	,	O
31.8	CD	O
,	,	O
37.4	CD	O
,	,	O
38.5	CD	O
,	,	O
41.2	CD	O
,	,	O
41.3	CD	O
,	,	O
47.0	CD	O
,	,	O
47.2	CD	O
,	,	O
47.5	CD	O
,	,	O
49.2	CD	O
,	,	O
49.3	CD	O
,	,	O
63.6	CD	O
,	,	O
64.5	CD	O
,	,	O
78.1	CD	O
,	,	O
78.3	CD	O
,	,	O
110.2	CD	O
,	,	O
110.3	CD	O
,	,	O
113.9	CD	O
,	,	O
114.0	CD	O
,	,	O
122.9	CD	O
,	,	O
123.1	CD	O
,	,	O
123.3	CD	O
,	,	O
126.3	CD	O
,	,	O
126.5	CD	O
,	,	O
126.6	CD	O
,	,	O
126.7	CD	O
,	,	O
126.8	CD	O
,	,	O
127.5	CD	O
,	,	O
127.6	CD	O
,	,	O
127.7	CD	O
,	,	O
128.6	CD	O
,	,	O
128.7	CD	O
,	,	O
128.78	CD	O
,	,	O
128.82	CD	O
,	,	O
128.9	CD	O
,	,	O
129.0	CD	O
,	,	O
131.8	CD	O
,	,	O
131.9	CD	O
,	,	O
137.9	CD	O
,	,	O
138.1	CD	O
,	,	O
138.7	CD	O
,	,	O
138.9	CD	O
,	,	O
139.0	CD	O
,	,	O
145.59	CD	O
,	,	O
145.62	CD	O
,	,	O
153.8	CD	O
,	,	O
158.1	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C21H30FN4O2	NNP	O
381.2654.	CD	O
found	VBD	O
381.2653	CD	O
.	.	O
Example	JJ	O
25	CD	O
6-	JJ	O
(	(	O
(	(	O
(	(	O
3R,4R	CD	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
(	(	O
1S,2R/1R,2S	CD	O
)	)	O
-2-	NN	O
(	(	O
3-Clorophenyl	JJ	O
)	)	O
cyclopropylamino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidin-3-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-methylpyridin-2-amine	NN	O
(	(	O
2b	CD	O
)	)	O
.	.	O
Compound	NN	O
2b	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
general	JJ	O
method	NN	O
E	NNP	O
as	IN	O
a	DT	O
mixture	NN	O
of	IN	O
two	CD	O
diastereomers	NNS	O
(	(	O
91	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
1.10-1.30	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.35-1.50	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.15-2.20	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.25-2.30	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.35-2.50	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.55-2.70	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.70-2.77	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.81-3.00	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.19-3.25	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.30-3.40	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.49-3.52	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.55-3.70	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.75-3.85	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
4.05	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
4.12	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
6.34	CD	O
(	(	O
s	NN	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
6.39	CD	O
(	(	O
s	NN	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
6.51	CD	O
(	(	O
s	NN	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
6.53	CD	O
(	(	O
s	NN	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
6.95-7.01	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.05-7.20	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
12.3	CD	O
,	,	O
12.4	CD	O
,	,	O
12.6	CD	O
,	,	O
20.3	CD	O
,	,	O
20.4	CD	O
,	,	O
20.5	CD	O
,	,	O
21.1	CD	O
,	,	O
28.8	CD	O
,	,	O
28.9	CD	O
,	,	O
30.6	CD	O
,	,	O
37.4	CD	O
,	,	O
38.6	CD	O
,	,	O
41.2	CD	O
,	,	O
41.3	CD	O
,	,	O
47.0	CD	O
,	,	O
47.1	CD	O
,	,	O
47.2	CD	O
,	,	O
47.5	CD	O
,	,	O
49.2	CD	O
,	,	O
49.3	CD	O
,	,	O
63.5	CD	O
,	,	O
64.5	CD	O
,	,	O
78.2	CD	O
,	,	O
78.4	CD	O
,	,	O
110.31	CD	O
,	,	O
110.34	CD	O
,	,	O
113.9	CD	O
,	,	O
114.0	CD	O
,	,	O
124.7	CD	O
,	,	O
124.75	CD	O
,	,	O
124.82	CD	O
,	,	O
126.1	CD	O
,	,	O
126.16	CD	O
,	,	O
126.23	CD	O
,	,	O
126.7	CD	O
,	,	O
126.9	CD	O
,	,	O
127.0	CD	O
,	,	O
130.0	CD	O
,	,	O
130.1	CD	O
,	,	O
130.2	CD	O
,	,	O
133.8	CD	O
,	,	O
133.9	CD	O
,	,	O
134.0	CD	O
,	,	O
140.2	CD	O
,	,	O
140.7	CD	O
,	,	O
145.52	CD	O
,	,	O
145.54	CD	O
,	,	O
153.8	CD	O
,	,	O
158.1	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C22H30ClN4O	NNP	O
401.2108.	CD	O
found	VBD	O
401.2093	CD	O
.	.	O
Example	JJ	O
26	CD	O
6-	JJ	O
(	(	O
(	(	O
(	(	O
3R,4R	CD	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
(	(	O
1S,2R/1R,2S	CD	O
)	)	O
-2-	NN	O
(	(	O
3-Fluorophenyl	JJ	O
)	)	O
cyclopropylamino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidin-3-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-methylpyridin-2-amine	NN	O
(	(	O
2c	CD	O
)	)	O
.	.	O
Compound	NN	O
2c	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
general	JJ	O
method	NN	O
E	NNP	O
as	IN	O
a	DT	O
mixture	NN	O
of	IN	O
two	CD	O
diastereomers	NNS	O
(	(	O
99	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
1.30-1.40	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.41-1.48	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.10-2.20	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.30-2.50	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.51-2.77	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.80-2.90	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.91-3.03	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.04-3.40	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.41-3.72	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.73-3.88	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.90-4.11	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
4.40-4.50	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.30-6.60	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.70-6.90	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.00-7.20	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
12.6	CD	O
,	,	O
12.9	CD	O
,	,	O
20.7	CD	O
,	,	O
20.9	CD	O
,	,	O
21.2	CD	O
,	,	O
21.4	CD	O
,	,	O
29.1	CD	O
,	,	O
37.7	CD	O
,	,	O
37.8	CD	O
,	,	O
38.6	CD	O
,	,	O
41.5	CD	O
,	,	O
45.3	CD	O
,	,	O
47.3	CD	O
,	,	O
47.6	CD	O
,	,	O
47.7	CD	O
,	,	O
49.6	CD	O
,	,	O
63.8	CD	O
,	,	O
64.5	CD	O
,	,	O
78.3	CD	O
,	,	O
78.5	CD	O
,	,	O
109.0	CD	O
,	,	O
110.5	CD	O
,	,	O
113.2	CD	O
,	,	O
113.4	CD	O
,	,	O
113.8	CD	O
,	,	O
114.0	CD	O
,	,	O
114.3	CD	O
,	,	O
122.4	CD	O
,	,	O
127.2	CD	O
,	,	O
128.1	CD	O
,	,	O
129.2	CD	O
,	,	O
130.1	CD	O
,	,	O
136.4	CD	O
,	,	O
140.7	CD	O
,	,	O
140.9	CD	O
,	,	O
145.9	CD	O
,	,	O
146.6	CD	O
,	,	O
153.0	CD	O
,	,	O
154.0	CD	O
,	,	O
158.3	CD	O
,	,	O
161.8	CD	O
,	,	O
163.8	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C21H30FN4O2	NNP	O
385.2404.	CD	O
found	VBD	O
385.2393	CD	O
.	.	O
Example	JJ	O
27	CD	O
6-	JJ	O
(	(	O
(	(	O
(	(	O
3R,4R	CD	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
(	(	O
1S,2R	CD	O
)	)	O
-2-	NN	O
(	(	O
3-Fluorophenyl	JJ	O
)	)	O
cyclopropylamino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidin-3-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-methylpyridin-2-amine	NN	O
(	(	O
2d	CD	O
)	)	O
.	.	O
Compound	NN	O
2d	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
general	JJ	O
method	NN	O
E	NNP	O
(	(	O
95	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
1.30-1.40	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.41-1.46	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.18	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.19-2.20	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.40-2.50	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.55-2.70	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.81-3.00	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.19-3.23	JJ	O
(	(	O
dd	NN	O
,	,	O
J=3.5	NNP	O
,	,	O
13.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.30-3.40	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.49-3.52	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.55-3.61	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.75-3.85	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
4.06	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.38	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.54	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.80-6.95	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
7.15-7.25	JJ	O
(	(	O
dd	NN	O
,	,	O
J=5.5	NNP	O
,	,	O
10.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
12.6	CD	O
,	,	O
20.4	CD	O
,	,	O
21.0	CD	O
,	,	O
28.8	CD	O
,	,	O
30.1	CD	O
,	,	O
38.4	CD	O
,	,	O
41.3	CD	O
,	,	O
47.1	CD	O
,	,	O
47.5	CD	O
,	,	O
49.3	CD	O
,	,	O
64.3	CD	O
,	,	O
78.3	CD	O
,	,	O
110.3	CD	O
,	,	O
112.9	CD	O
,	,	O
113.1	CD	O
,	,	O
113.6	CD	O
,	,	O
113.8	CD	O
,	,	O
114.0	CD	O
,	,	O
122.1	CD	O
,	,	O
128.9	CD	O
,	,	O
129.0	CD	O
,	,	O
130.4	CD	O
,	,	O
130.5	CD	O
,	,	O
131.8	CD	O
,	,	O
131.9	CD	O
,	,	O
133.1	CD	O
,	,	O
140.6	CD	O
,	,	O
140.7	CD	O
,	,	O
145.6	CD	O
,	,	O
153.9	CD	O
,	,	O
158.1	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C21H30FN4O2	NNP	O
385.2404.	CD	O
found	VBD	O
385.2384	CD	O
.	.	O
Example	JJ	O
28	CD	O
(	(	O
3S,4S	CD	O
)	)	O
/	NN	O
(	(	O
3R,4R	CD	O
)	)	O
-tert-Butyl	CD	O
3-	JJ	O
(	(	O
(	(	O
6-	CD	O
(	(	O
benzyl	NN	O
(	(	O
tert-butoxycarbonyeamino	NN	O
)	)	O
-4-methylpyridin-2-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
tert-butoxycarbonyl	JJ	O
(	(	O
2-	JJ	O
(	(	O
3-fluorophenyl	JJ	O
)	)	O
cyclopropyl	NN	O
)	)	O
amino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidine-1-carboxylate	NN	O
(	(	O
12	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
aldehyde	JJ	O
11	CD	O
(	(	O
100	CD	O
mg	NN	O
,	,	O
0.18	CD	O
mmol	NN	O
)	)	O
in	IN	O
DCM	NNP	O
(	(	O
2	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
3e	CD	O
(	(	O
60	CD	O
mg	NN	O
,	,	O
0.37	CD	O
mmol	NN	O
)	)	O
,	,	O
followed	VBN	O
by	IN	O
TEA	NNP	O
(	(	O
125	CD	O
μL	NN	O
,	,	O
0.9	CD	O
mmol	NN	O
)	)	O
.	.	O
The	DT	O
mixture	NN	O
was	VBD	O
allowed	VBN	O
to	TO	O
stir	VB	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
5	CD	O
min	NN	O
before	IN	O
NaHB	NNP	O
(	(	O
OAc	NNP	O
)	)	O
3	CD	O
(	(	O
50	CD	O
mg	NN	O
,	,	O
0.23	CD	O
mmol	NN	O
)	)	O
was	VBD	O
added	VBN	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
stirred	VBN	O
for	IN	O
an	DT	O
additional	JJ	O
3	CD	O
h	NN	O
then	RB	O
partitioned	VBD	O
between	IN	O
EtOAc	NNP	O
(	(	O
50	CD	O
mL	NN	O
)	)	O
and	CC	O
brine	NN	O
(	(	O
25	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
organic	JJ	O
layer	NN	O
was	VBD	O
dried	VBN	O
over	IN	O
Na2SO4	NNP	O
and	CC	O
concentrated	VBN	O
to	TO	O
yield	VB	O
crude	JJ	O
secondary	JJ	O
amine	NN	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
the	DT	O
resulting	VBG	O
crude	JJ	O
amine	NN	O
in	IN	O
MeOH	NNP	O
(	(	O
1.5	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
(	(	O
Boc	NNP	O
)	)	O
2O	CD	O
(	(	O
120	CD	O
mg	NN	O
,	,	O
0.56	CD	O
mmol	NN	O
)	)	O
and	CC	O
Et3N	NNP	O
(	(	O
75	CD	O
μL	NN	O
,	,	O
0.56	CD	O
mmol	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
stirred	VBN	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
6	CD	O
h	NN	O
and	CC	O
then	RB	O
partitioned	VBD	O
between	IN	O
EtOAc	NNP	O
(	(	O
50	CD	O
mL	NN	O
)	)	O
and	CC	O
brine	NN	O
(	(	O
20	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
organic	JJ	O
layer	NN	O
was	VBD	O
dried	VBN	O
over	IN	O
Na2SO4	NNP	O
,	,	O
and	CC	O
the	DT	O
solvents	NNS	O
were	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
.	.	O
The	DT	O
resulting	VBG	O
material	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	JJ	O
column	NN	O
chromatography	NN	O
(	(	O
EtOAc/hexanes	NNPS	O
,	,	O
1:4-1:2	JJ	O
)	)	O
to	TO	O
yield	VB	O
12	CD	O
(	(	O
70	CD	O
mg	NN	O
,	,	O
60	CD	O
%	NN	O
)	)	O
as	IN	O
a	DT	O
colorless	NN	O
oil	NN	O
(	(	O
71	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.10-1.22	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
1.35-1.50	JJ	O
(	(	O
m	NN	O
,	,	O
28H	CD	O
)	)	O
,	,	O
1.65-1.80	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.10-2.20	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.20-2.35	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.40-2.80	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.80-2.95	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.97-3.10	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.16-3.21	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.22-3.44	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.45-3.70	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
4.04-4.10	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
5.10-5.25	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.55-6.65	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.65-6.95	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
7.10-7.27	JJ	O
(	(	O
m	NN	O
,	,	O
6H	CD	O
)	)	O
,	,	O
6.31-6.45	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
14.0	CD	O
,	,	O
14.4	CD	O
,	,	O
14.5	CD	O
,	,	O
19.4	CD	O
,	,	O
21.3	CD	O
,	,	O
21.4	CD	O
,	,	O
22.9	CD	O
,	,	O
28.4	CD	O
,	,	O
28.7	CD	O
,	,	O
28.8	CD	O
,	,	O
30.0	CD	O
,	,	O
30.9	CD	O
,	,	O
31.8	CD	O
,	,	O
34.8	CD	O
,	,	O
34.9	CD	O
,	,	O
40.0	CD	O
,	,	O
40.1	CD	O
,	,	O
42.9	CD	O
,	,	O
49.1	CD	O
,	,	O
49.5	CD	O
,	,	O
50.2	CD	O
,	,	O
50.5	CD	O
,	,	O
51.1	CD	O
,	,	O
60.7	CD	O
,	,	O
64.6	CD	O
,	,	O
78.2	CD	O
,	,	O
79.4	CD	O
,	,	O
79.7	CD	O
,	,	O
80.2	CD	O
,	,	O
81.4	CD	O
,	,	O
81.5	CD	O
,	,	O
112.9	CD	O
,	,	O
113.0	CD	O
,	,	O
117.2	CD	O
,	,	O
117.3	CD	O
,	,	O
120.2	CD	O
,	,	O
122.1	CD	O
,	,	O
126.8	CD	O
,	,	O
127.1	CD	O
,	,	O
127.2	CD	O
,	,	O
127.3	CD	O
,	,	O
128.3	CD	O
,	,	O
130.0	CD	O
,	,	O
140.1	CD	O
,	,	O
148.7	CD	O
,	,	O
148.8	CD	O
,	,	O
154.1	CD	O
,	,	O
154.6	CD	O
,	,	O
154.7	CD	O
,	,	O
155.0	CD	O
,	,	O
157.9	CD	O
,	,	O
162.2	CD	O
,	,	O
164.1	CD	O
,	,	O
171.4	CD	O
,	,	O
171.5	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C44H60FN4O7	NNP	O
775.4441.	CD	O
found	VBD	O
775.4441	CD	O
.	.	O
Example	JJ	O
29	CD	O
6-	JJ	O
(	(	O
(	(	O
(	(	O
3S,4S	CD	O
)	)	O
/	NN	O
(	(	O
3R,4R	CD	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
2-	JJ	O
(	(	O
3-Fluorophenyl	JJ	O
)	)	O
cyclopropylamino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidin-3-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-methylpyridin-2-amine	NN	O
(	(	O
10	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
12	CD	O
(	(	O
0.2	CD	O
mmol	NN	O
)	)	O
in	IN	O
EtOH	NNP	O
(	(	O
20	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
Pd	NNP	O
(	(	O
OH	NNP	O
)	)	O
2/C	CD	O
(	(	O
100	CD	O
mg	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
vessel	NN	O
was	VBD	O
charged	VBN	O
with	IN	O
H2	NNP	O
,	,	O
heated	VBD	O
at	IN	O
60°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
h	NN	O
,	,	O
then	RB	O
cooled	VBD	O
to	TO	O
room	NN	O
temperature	NN	O
.	.	O
The	DT	O
catalyst	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
filtration	NN	O
,	,	O
and	CC	O
the	DT	O
resulting	JJ	O
solution	NN	O
was	VBD	O
concentrated	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
.	.	O
The	DT	O
crude	JJ	O
material	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	JJ	O
column	NN	O
chromatography	NN	O
(	(	O
EtOAc/hexanes	NNPS	O
,	,	O
1:4-1:2	JJ	O
)	)	O
to	TO	O
yield	VB	O
13	CD	O
as	IN	O
a	DT	O
white	JJ	O
foamy	NN	O
solid	NN	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
the	DT	O
resulting	VBG	O
13	CD	O
in	IN	O
MeOH	NNP	O
(	(	O
0.5	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
6	CD	O
N	NNP	O
HCl	NNP	O
(	(	O
1.0	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
allowed	VBN	O
to	TO	O
sit	VB	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
16	CD	O
h.	PDT	O
The	DT	O
solvent	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
.	.	O
The	DT	O
crude	JJ	O
product	NN	O
was	VBD	O
recrystallized	VBN	O
using	VBG	O
cold	JJ	O
diethyl	NN	O
ether	NN	O
to	TO	O
provide	VB	O
10	CD	O
as	IN	O
a	DT	O
pale	JJ	O
yellow	JJ	O
solid	NN	O
(	(	O
20	CD	O
mg	NN	O
,	,	O
25	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
1.18-1.20	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.20	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.60-2.72	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.75-2.90	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.00-3.10	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.15-3.33	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.34-3.42	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.44-3.60	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.70-3.80	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
4.09	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.46-4.67	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.56	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.90-7.10	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
7.20-7.25	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
15.2	CD	O
,	,	O
15.5	CD	O
,	,	O
21.3	CD	O
,	,	O
29.2	CD	O
,	,	O
38.4	CD	O
,	,	O
38.5	CD	O
,	,	O
41.6	CD	O
,	,	O
41.7	CD	O
,	,	O
44.2	CD	O
,	,	O
44.4	CD	O
,	,	O
47.3	CD	O
,	,	O
49.5	CD	O
,	,	O
55.6	CD	O
,	,	O
64.0	CD	O
,	,	O
64.4	CD	O
,	,	O
78.4	CD	O
,	,	O
110.6	CD	O
,	,	O
114.3	CD	O
,	,	O
114.4	CD	O
,	,	O
114.5	CD	O
,	,	O
116.2	CD	O
,	,	O
116.4	CD	O
,	,	O
125.4	CD	O
,	,	O
125.6	CD	O
,	,	O
130.8	CD	O
,	,	O
130.9	CD	O
,	,	O
138.3	CD	O
,	,	O
145.9	CD	O
,	,	O
146.0	CD	O
,	,	O
154.1	CD	O
,	,	O
158.4	CD	O
,	,	O
161.9	CD	O
,	,	O
163.9	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C22H32FN4O	NNP	O
387.2560.	CD	O
found	VBD	O
385.2556	CD	O
.	.	O
Example	JJ	O
30	CD	O
1-	JJ	O
(	(	O
2-Bromo-1-fluoroethyl	JJ	O
)	)	O
-3-fluorobenzene	NN	O
(	(	O
11	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
3-fluorostyrene	NNP	O
(	(	O
10	CD	O
,	,	O
5.0	CD	O
g	NN	O
,	,	O
41	CD	O
mmol	NN	O
)	)	O
in	IN	O
CH2Cl2	NNP	O
at	IN	O
0°	CD	O
C.	NNP	O
was	VBD	O
added	VBN	O
NBS	NNP	O
(	(	O
8.8	CD	O
g	NN	O
,	,	O
49.2	CD	O
mmol	NN	O
)	)	O
.	.	O
After	IN	O
30	CD	O
min	NN	O
,	,	O
Et3N.3HF	NNP	O
(	(	O
20	CD	O
mL	NN	O
,	,	O
123	CD	O
mmol	NN	O
)	)	O
was	VBD	O
added	VBN	O
.	.	O
The	DT	O
reaction	NN	O
solution	NN	O
was	VBD	O
warmed	VBN	O
to	TO	O
room	NN	O
temperature	NN	O
and	CC	O
stirred	VBD	O
for	IN	O
16	CD	O
h.	PDT	O
The	DT	O
reaction	NN	O
was	VBD	O
quenched	VBN	O
with	IN	O
saturated	JJ	O
NaHCO3	NNP	O
then	RB	O
partitioned	VBD	O
between	IN	O
EtOAc	NNP	O
(	(	O
500	CD	O
mL	NN	O
)	)	O
and	CC	O
H2O	NNP	O
(	(	O
300	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
organic	JJ	O
layer	NN	O
was	VBD	O
washed	VBN	O
with	IN	O
brine	NN	O
(	(	O
300	CD	O
mL	NN	O
)	)	O
,	,	O
dried	VBN	O
over	IN	O
Na2SO4	NNP	O
,	,	O
and	CC	O
concentrated	VBD	O
.	.	O
The	DT	O
crude	JJ	O
product	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	JJ	O
column	NN	O
chromatography	NN	O
(	(	O
EtOAc/hexanes	NNPS	O
,	,	O
1:18-1:9	JJ	O
)	)	O
to	TO	O
yield	VB	O
11	CD	O
as	IN	O
a	DT	O
colorless	NN	O
liquid	NN	O
(	(	O
5.8	CD	O
g	NN	O
,	,	O
85	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
3.55-3.80	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
5.59-5.61	JJ	O
(	(	O
dd	NN	O
,	,	O
J=4.0	NNP	O
,	,	O
7.0	CD	O
Hz	NNP	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
5.68-5.70	JJ	O
(	(	O
dd	NN	O
,	,	O
J=4.5	NNP	O
,	,	O
7.5	CD	O
Hz	NNP	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
7.00-7.20	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
7.30-7.50	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
34.0	CD	O
,	,	O
34.3	CD	O
,	,	O
91.4	CD	O
,	,	O
91.4	CD	O
,	,	O
92.8	CD	O
,	,	O
113.0	CD	O
,	,	O
113.2	CD	O
,	,	O
116.3	CD	O
,	,	O
116.4	CD	O
,	,	O
116.5	CD	O
,	,	O
121.6	CD	O
,	,	O
121.7	CD	O
,	,	O
130.6	CD	O
,	,	O
130.7	CD	O
,	,	O
139.7	CD	O
,	,	O
139.8	CD	O
,	,	O
139.9	CD	O
,	,	O
162.1	CD	O
,	,	O
164.1	CD	O
;	:	O
GC-MS	NNP	O
calcd	NN	O
for	IN	O
C8H7BrF2	NNP	O
220.	CD	O
found	VBD	O
220	CD	O
.	.	O
Example	JJ	O
31	CD	O
1-	JJ	O
(	(	O
2-Azido-1-fluoroethyl	JJ	O
)	)	O
-3-fluorobenzene	NN	O
(	(	O
12	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
11	CD	O
(	(	O
2.3	CD	O
g	NN	O
,	,	O
10.5	CD	O
mmol	NN	O
)	)	O
in	IN	O
dry	JJ	O
DMSO	NNP	O
(	(	O
15	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
NaN3	NNP	O
(	(	O
1.0	CD	O
g	NN	O
,	,	O
15.7	CD	O
mmol	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
solution	NN	O
was	VBD	O
allowed	VBN	O
to	TO	O
stir	VB	O
at	IN	O
65°	CD	O
C.	NNP	O
for	IN	O
4	CD	O
h	NN	O
then	RB	O
cooled	VBD	O
to	TO	O
room	NN	O
temperature	NN	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
partitioned	VBN	O
between	IN	O
EtOAc	NNP	O
(	(	O
300	CD	O
mL	NN	O
)	)	O
and	CC	O
H2O	NNP	O
(	(	O
200	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
organic	JJ	O
layer	NN	O
was	VBD	O
washed	VBN	O
with	IN	O
H2O	NNP	O
(	(	O
200	CD	O
mL	NN	O
)	)	O
,	,	O
brine	NN	O
(	(	O
200	CD	O
mL	NN	O
)	)	O
,	,	O
and	CC	O
dried	VBD	O
over	IN	O
Na2SO4	NNP	O
.	.	O
The	DT	O
solvents	NNS	O
were	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
and	CC	O
the	DT	O
crude	JJ	O
product	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	JJ	O
column	NN	O
chromatography	NN	O
(	(	O
EtOAc/hexanes	NNPS	O
,	,	O
1:18-1:9	JJ	O
)	)	O
to	TO	O
yield	VB	O
12	CD	O
(	(	O
1.6	CD	O
g	NN	O
,	,	O
85	CD	O
%	NN	O
)	)	O
as	IN	O
a	DT	O
yellow	JJ	O
oil	NN	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
3.40-3.50	JJ	O
(	(	O
dd	NN	O
,	,	O
J=3.0	NNP	O
,	,	O
13.5	CD	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
3.50-3.60	JJ	O
(	(	O
dd	NN	O
,	,	O
J=3.0	NNP	O
,	,	O
13.5	CD	O
Hz	NNP	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
3.60-3.75	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
5.50-5.60	JJ	O
(	(	O
dd	NN	O
,	,	O
J=3.0	NNP	O
,	,	O
8.0	CD	O
Hz	NNP	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
5.65-5.80	JJ	O
(	(	O
dd	NN	O
,	,	O
J=3.0	NNP	O
,	,	O
8.0	CD	O
Hz	NNP	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
7.00-7.20	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
7.30-7.50	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
55.9	CD	O
,	,	O
56.1	CD	O
,	,	O
91.82	CD	O
,	,	O
91.84	CD	O
,	,	O
93.2	CD	O
,	,	O
93.3	CD	O
,	,	O
112.78	CD	O
,	,	O
112.84	CD	O
,	,	O
112.96	CD	O
,	,	O
113.03	CD	O
,	,	O
116.19	CD	O
,	,	O
116.20	CD	O
,	,	O
116.36	CD	O
,	,	O
116.38	CD	O
,	,	O
121.24	CD	O
,	,	O
121.27	CD	O
,	,	O
121.30	CD	O
,	,	O
121.33	CD	O
,	,	O
130.7	CD	O
,	,	O
130.8	CD	O
,	,	O
139.09	CD	O
,	,	O
139.15	CD	O
,	,	O
139.25	CD	O
,	,	O
139.31	CD	O
,	,	O
162.1	CD	O
,	,	O
164.1	CD	O
;	:	O
GC-MS	NNP	O
calcd	NN	O
for	IN	O
C8H7F2N3	NNP	O
183.	CD	O
found	VBD	O
183	CD	O
.	.	O
2-Fluoro-2-	JJ	O
(	(	O
3-fluorophenyl	JJ	O
)	)	O
ethanamine	NN	O
(	(	O
4c	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
azide	JJ	O
12	CD	O
(	(	O
1.8	CD	O
g	NN	O
,	,	O
Example	NNP	O
32	CD	O
10.0	CD	O
mmol	NN	O
)	)	O
in	IN	O
EtOH	NNP	O
(	(	O
30	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
1	CD	O
N	NNP	O
HCl	NNP	O
(	(	O
15	CD	O
mL	NN	O
)	)	O
and	CC	O
Pd	NNP	O
(	(	O
OH	NNP	O
)	)	O
2/C	CD	O
(	(	O
20	CD	O
%	NN	O
,	,	O
200	CD	O
mg	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
allowed	VBN	O
to	TO	O
stir	VB	O
under	IN	O
one	CD	O
atmosphere	NN	O
of	IN	O
H2	NNP	O
for	IN	O
24	CD	O
h.	PDT	O
The	DT	O
catalyst	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
filtration	NN	O
,	,	O
and	CC	O
the	DT	O
solvent	NN	O
was	VBD	O
evaporated	VBN	O
.	.	O
The	DT	O
resulting	VBG	O
yellowish	JJ	O
solid	NN	O
was	VBD	O
partitioned	VBN	O
between	IN	O
diethyl	NN	O
ether	NN	O
(	(	O
200	CD	O
mL	NN	O
)	)	O
and	CC	O
1	CD	O
N	NNP	O
HCl	NNP	O
(	(	O
200	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
aqueous	JJ	O
layer	NN	O
was	VBD	O
washed	VBN	O
with	IN	O
diethyl	NN	O
ether	NN	O
(	(	O
200	CD	O
mL	NN	O
)	)	O
then	RB	O
concentrated	VBD	O
to	TO	O
yield	VB	O
amine	JJ	O
4c	CD	O
as	IN	O
a	DT	O
hydrochloride	NN	O
salt	NN	O
(	(	O
1.69	CD	O
g	NN	O
,	,	O
8.8	CD	O
mmol	NN	O
,	,	O
98	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
3.33-3.35	JJ	O
(	(	O
dd	NN	O
,	,	O
J=3.5	NNP	O
,	,	O
4.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.36-3.39	JJ	O
(	(	O
dd	NN	O
,	,	O
J=3.5	NNP	O
,	,	O
4.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
5.71-5.74	JJ	O
(	(	O
dd	NN	O
,	,	O
J=5.0	NNP	O
,	,	O
6.0	CD	O
Hz	NNP	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
5.81-5.83	JJ	O
(	(	O
dd	NN	O
,	,	O
J=5.0	NNP	O
,	,	O
6.0	CD	O
Hz	NNP	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
7.05-7.13	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
7.33-7.48	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
44.0	CD	O
,	,	O
44.2	CD	O
,	,	O
89.3	CD	O
,	,	O
90.7	CD	O
,	,	O
112.67	CD	O
,	,	O
112.73	CD	O
,	,	O
112.85	CD	O
,	,	O
112.92	CD	O
,	,	O
116.5	CD	O
,	,	O
116.7	CD	O
,	,	O
121.57	CD	O
,	,	O
121.59	CD	O
,	,	O
121.63	CD	O
,	,	O
131.1	CD	O
,	,	O
131.2	CD	O
,	,	O
137.35	CD	O
,	,	O
137.45	CD	O
,	,	O
137.51	CD	O
,	,	O
161.8	CD	O
,	,	O
163.8	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C8H10F2N	NNP	O
158.	CD	O
found	VBD	O
158	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C8H10F2N	NNP	O
158.07758.	CD	O
found	VBD	O
158.07738	CD	O
.	.	O
Example	JJ	O
33	CD	O
1-	JJ	O
(	(	O
2-Bromo-1,1-difluoroethyl	JJ	O
)	)	O
-3-fluorobenzene	NN	O
(	(	O
14	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
flask	NN	O
containing	VBG	O
2-bromo-3′-fluoroacetophenone	CD	O
(	(	O
13	CD	O
,	,	O
2.15	CD	O
g	NN	O
,	,	O
10	CD	O
mmol	NN	O
)	)	O
was	VBD	O
added	VBN	O
DAST	NNP	O
(	(	O
1.38	CD	O
mL	NN	O
,	,	O
10.5	CD	O
mmol	NN	O
)	)	O
.	.	O
The	DT	O
flask	NN	O
was	VBD	O
sealed	VBN	O
and	CC	O
the	DT	O
reaction	NN	O
was	VBD	O
allowed	VBN	O
to	TO	O
proceed	VB	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
seven	CD	O
days	NNS	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
partitioned	VBN	O
between	IN	O
EtOAc	NNP	O
(	(	O
300	CD	O
mL	NN	O
)	)	O
and	CC	O
saturated	VBN	O
NaHCO3	NNP	O
(	(	O
300	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
organic	JJ	O
layer	NN	O
was	VBD	O
washed	VBN	O
with	IN	O
brine	NN	O
(	(	O
300	CD	O
mL	NN	O
)	)	O
and	CC	O
dried	VBN	O
over	IN	O
Na2SO4	NNP	O
.	.	O
The	DT	O
solvents	NNS	O
were	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
.	.	O
The	DT	O
crude	JJ	O
product	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	JJ	O
column	NN	O
chromatography	NN	O
(	(	O
EtOAc/hexanes	NNPS	O
,	,	O
1:18-1:9	JJ	O
)	)	O
to	TO	O
yield	VB	O
14	CD	O
(	(	O
1.65	CD	O
g	NN	O
,	,	O
70	CD	O
%	NN	O
)	)	O
as	IN	O
a	DT	O
brown	JJ	O
liquid	NN	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
3.74-3.80	JJ	O
(	(	O
t	JJ	O
,	,	O
J=14.0	NNP	O
Hz	NNP	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.18-7.27	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.31-7.34	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.44-7.48	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
33.2	CD	O
,	,	O
33.5	CD	O
,	,	O
33.8	CD	O
,	,	O
113.08	CD	O
,	,	O
113.13	CD	O
,	,	O
113.28	CD	O
,	,	O
113.33	CD	O
,	,	O
113.38	CD	O
,	,	O
117.87	CD	O
,	,	O
117.89	CD	O
,	,	O
118.04	CD	O
,	,	O
118.06	CD	O
,	,	O
118.07	CD	O
,	,	O
118.22	CD	O
,	,	O
118.24	CD	O
,	,	O
121.4	CD	O
,	,	O
121.5	CD	O
,	,	O
130.7	CD	O
,	,	O
130.8	CD	O
,	,	O
161.8	CD	O
,	,	O
183.8	CD	O
;	:	O
GC-MS	NNP	O
calcd	NN	O
for	IN	O
C8H6BrF3	NNP	O
238.	CD	O
found	VBD	O
238	CD	O
.	.	O
Example	JJ	O
34	CD	O
1-	JJ	O
(	(	O
2-Azido-1,1-difluoroethyl	JJ	O
)	)	O
-3-fluorobenzene	NN	O
(	(	O
15	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
14	CD	O
(	(	O
2.4	CD	O
g	NN	O
,	,	O
10	CD	O
mmol	NN	O
)	)	O
in	IN	O
anhydrous	JJ	O
DMSO	NNP	O
(	(	O
15	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
NaN3	NNP	O
(	(	O
1.0	CD	O
g	NN	O
,	,	O
15.7	CD	O
mmol	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
solution	NN	O
turned	VBD	O
purple	JJ	O
upon	IN	O
heating	NN	O
.	.	O
After	IN	O
being	VBG	O
stirred	VBN	O
at	IN	O
110°	CD	O
C.	NNP	O
for	IN	O
8	CD	O
h	NN	O
,	,	O
the	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
cooled	VBN	O
to	TO	O
room	NN	O
temperature	NN	O
and	CC	O
partitioned	VBD	O
between	IN	O
EtOAc	NNP	O
(	(	O
300	CD	O
mL	NN	O
)	)	O
and	CC	O
H2O	NNP	O
(	(	O
200	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
organic	JJ	O
layer	NN	O
was	VBD	O
washed	VBN	O
with	IN	O
H2O	NNP	O
(	(	O
200	CD	O
mL	NN	O
)	)	O
,	,	O
brine	NN	O
(	(	O
200	CD	O
mL	NN	O
)	)	O
,	,	O
and	CC	O
dried	VBD	O
over	IN	O
Na2SO4	NNP	O
.	.	O
The	DT	O
solvents	NNS	O
were	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
.	.	O
The	DT	O
crude	JJ	O
product	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	JJ	O
column	NN	O
chromatography	NN	O
(	(	O
EtOAc/hexanes	NNP	O
,	,	O
1:9	CD	O
)	)	O
to	TO	O
yield	VB	O
azide	RB	O
15	CD	O
(	(	O
1.7	CD	O
g	NN	O
,	,	O
88	CD	O
%	NN	O
)	)	O
as	IN	O
a	DT	O
yellow	JJ	O
oil	NN	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
3.60-3.75	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.00-7.15	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.15-7.35	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.40-7.60	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
55.8	CD	O
,	,	O
56.1	CD	O
,	,	O
56.4	CD	O
,	,	O
112.95	CD	O
,	,	O
113.01	CD	O
,	,	O
113.06	CD	O
,	,	O
113.14	CD	O
,	,	O
113.19	CD	O
,	,	O
113.25	CD	O
,	,	O
117.89	CD	O
,	,	O
117.90	CD	O
,	,	O
118.06	CD	O
,	,	O
118.07	CD	O
,	,	O
118.08	CD	O
,	,	O
119.78	CD	O
,	,	O
119.81	CD	O
,	,	O
121.25	CD	O
,	,	O
121.28	CD	O
,	,	O
121.30	CD	O
,	,	O
121.33	CD	O
,	,	O
121.35	CD	O
,	,	O
121.38	CD	O
,	,	O
130.8	CD	O
,	,	O
130.9	CD	O
,	,	O
136.7	CD	O
,	,	O
161.9	CD	O
,	,	O
163.9	CD	O
;	:	O
GC-MS	NNP	O
calcd	NN	O
for	IN	O
C8H6F3N3	NNP	O
201.	CD	O
found	VBD	O
201	CD	O
.	.	O
2,2-Fifluoro-2-	JJ	O
(	(	O
3-fluorophenyl	JJ	O
)	)	O
ethanamine	NN	O
(	(	O
4d	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
15	CD	O
(	(	O
2.0	CD	O
g	NN	O
,	,	O
10.0	CD	O
mmol	NN	O
)	)	O
in	IN	O
EtOH	NNP	O
(	(	O
30	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
1	CD	O
N	NNP	O
HCl	NNP	O
(	(	O
15	CD	O
mL	NN	O
)	)	O
and	CC	O
Pd	NNP	O
(	(	O
OH	NNP	O
)	)	O
2/C	CD	O
(	(	O
20	CD	O
%	NN	O
,	,	O
200	CD	O
mg	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
allowed	VBN	O
to	TO	O
stir	VB	O
under	IN	O
one	CD	O
atmosphere	NN	O
of	IN	O
H2	NNP	O
for	IN	O
24	CD	O
h.	PDT	O
The	DT	O
catalyst	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
filtration	NN	O
and	CC	O
the	DT	O
solvent	NN	O
was	VBD	O
evaporated	VBN	O
.	.	O
The	DT	O
resulting	VBG	O
yellowish	JJ	O
solid	NN	O
was	VBD	O
partitioned	VBN	O
between	IN	O
diethyl	NN	O
ether	NN	O
(	(	O
200	CD	O
mL	NN	O
)	)	O
and	CC	O
1	CD	O
N	NNP	O
HCl	NNP	O
(	(	O
200	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
aqueous	JJ	O
layer	NN	O
was	VBD	O
washed	VBN	O
with	IN	O
diethyl	NN	O
ether	NN	O
(	(	O
200	CD	O
mL	NN	O
)	)	O
then	RB	O
concentrated	VBD	O
to	TO	O
yield	VB	O
amine	JJ	O
4d	CD	O
as	IN	O
a	DT	O
white	JJ	O
solid	JJ	O
(	(	O
1.6	CD	O
g	NN	O
,	,	O
91	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
3.60-4.66	JJ	O
(	(	O
t	JJ	O
,	,	O
J=15.0	NNP	O
Hz	NNP	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.17-7.30	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
7.40-7.45	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
44.6	CD	O
,	,	O
44.8	CD	O
,	,	O
45.0	CD	O
,	,	O
112.6	CD	O
,	,	O
112.8	CD	O
,	,	O
118.5	CD	O
,	,	O
118.7	CD	O
,	,	O
121.3	CD	O
,	,	O
131.4	CD	O
,	,	O
131.5	CD	O
,	,	O
161.6	CD	O
,	,	O
163.6	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C8H9F3N	NNP	O
176.	CD	O
found	VBD	O
176	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C8H9F3N	NNP	O
176.06816.	CD	O
found	VBD	O
176.06843	CD	O
.	.	O
Example	JJ	O
35	CD	O
(	(	O
3S,4S	CD	O
)	)	O
/	NN	O
(	(	O
3R,4R	CD	O
)	)	O
-tert-Butyl-3-	NN	O
(	(	O
(	(	O
6-	CD	O
(	(	O
benzyl	NN	O
(	(	O
tert-butoxycarbonyl	JJ	O
)	)	O
amino	NN	O
)	)	O
-4-methylpyridin-2-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
tert-butoxycarbonyl	JJ	O
(	(	O
2-	JJ	O
(	(	O
3-fluorophenoxy	JJ	O
)	)	O
ethyl	NN	O
)	)	O
amino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidine-1-carboxylate	NN	O
(	(	O
17a	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
aldehyde	JJ	O
3	CD	O
(	(	O
50	CD	O
mg	NN	O
,	,	O
0.093	CD	O
mmol	NN	O
)	)	O
in	IN	O
THF	NNP	O
(	(	O
2	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
4a	CD	O
(	(	O
30	CD	O
mg	NN	O
,	,	O
0.186	CD	O
mmol	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
allowed	VBN	O
to	TO	O
stir	VB	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
10	CD	O
min	NN	O
before	IN	O
NaHB	NNP	O
(	(	O
OAc	NNP	O
)	)	O
3	CD	O
(	(	O
25	CD	O
mg	NN	O
,	,	O
0.116	CD	O
mmol	NN	O
)	)	O
was	VBD	O
added	VBN	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
stirred	VBN	O
for	IN	O
an	DT	O
additional	JJ	O
3	CD	O
h	NN	O
then	RB	O
partitioned	VBD	O
between	IN	O
EtOAc	NNP	O
(	(	O
50	CD	O
mL	NN	O
)	)	O
and	CC	O
brine	NN	O
(	(	O
25	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
organic	JJ	O
layer	NN	O
was	VBD	O
dried	VBN	O
over	IN	O
Na2SO4	NNP	O
and	CC	O
concentrated	VBN	O
to	TO	O
yield	VB	O
crude	JJ	O
16a	CD	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
crude	NN	O
16a	CD	O
in	IN	O
MeOH	NNP	O
(	(	O
1.5	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
(	(	O
Boc	NNP	O
)	)	O
2O	CD	O
(	(	O
30	CD	O
mg	NN	O
,	,	O
0.140	CD	O
mmol	NN	O
)	)	O
and	CC	O
Et3N	NNP	O
(	(	O
20	CD	O
μL	NN	O
,	,	O
0.140	CD	O
mmol	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
stirred	VBN	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
16	CD	O
h	NN	O
and	CC	O
then	RB	O
partitioned	VBD	O
between	IN	O
EtOAc	NNP	O
(	(	O
50	CD	O
mL	NN	O
)	)	O
and	CC	O
brine	NN	O
(	(	O
20	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
organic	JJ	O
layer	NN	O
was	VBD	O
dried	VBN	O
over	IN	O
Na2SO4	NNP	O
,	,	O
and	CC	O
the	DT	O
solvents	NNS	O
were	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
.	.	O
The	DT	O
resulting	VBG	O
material	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	JJ	O
column	NN	O
chromatography	NN	O
(	(	O
EtOAc/hexanes	NNPS	O
,	,	O
1:4-1:2	JJ	O
)	)	O
to	TO	O
yield	VB	O
17a	CD	O
(	(	O
35	CD	O
mg	NN	O
,	,	O
60	CD	O
%	NN	O
)	)	O
as	IN	O
a	DT	O
colorless	JJ	O
oil	NN	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.30-1.50	JJ	O
(	(	O
m	NN	O
,	,	O
27H	CD	O
)	)	O
,	,	O
2.20-2.40	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.45-2.60	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.60-2.80	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.80-3.00	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.00-3.15	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.16-3.80	JJ	O
(	(	O
m	NN	O
,	,	O
10H	CD	O
)	)	O
,	,	O
3.90-4.20	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
5.10-5.20	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.50-6.80	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
7.10-7.30	JJ	O
(	(	O
m	NN	O
,	,	O
5H	CD	O
)	)	O
,	,	O
7.35-7.50	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
100	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
21.4	CD	O
,	,	O
28.4	CD	O
,	,	O
28.6	CD	O
,	,	O
28.7	CD	O
,	,	O
34.7	CD	O
,	,	O
34.8	CD	O
,	,	O
42.3	CD	O
,	,	O
42.4	CD	O
,	,	O
42.8	CD	O
,	,	O
43.0	CD	O
,	,	O
47.7	CD	O
,	,	O
47.9	CD	O
,	,	O
48.1	CD	O
,	,	O
48.3	CD	O
,	,	O
48.9	CD	O
,	,	O
49.0	CD	O
,	,	O
49.4	CD	O
,	,	O
50.1	CD	O
,	,	O
50.4	CD	O
,	,	O
50.5	CD	O
,	,	O
51.0	CD	O
,	,	O
66.7	CD	O
,	,	O
67.1	CD	O
,	,	O
67.2	CD	O
,	,	O
68.2	CD	O
,	,	O
68.3	CD	O
,	,	O
79.0	CD	O
,	,	O
79.3	CD	O
,	,	O
79.4	CD	O
,	,	O
79.8	CD	O
,	,	O
80.1	CD	O
,	,	O
80.2	CD	O
,	,	O
81.3	CD	O
,	,	O
81.4	CD	O
,	,	O
102.2	CD	O
,	,	O
102.3	CD	O
,	,	O
102.4	CD	O
,	,	O
102.5	CD	O
,	,	O
107.7	CD	O
,	,	O
107.9	CD	O
,	,	O
110.3	CD	O
,	,	O
117.2	CD	O
,	,	O
117.3	CD	O
,	,	O
120.2	CD	O
,	,	O
126.7	CD	O
,	,	O
126.8	CD	O
,	,	O
127.1	CD	O
,	,	O
127.2	CD	O
,	,	O
128.3	CD	O
,	,	O
130.4	CD	O
,	,	O
130.5	CD	O
,	,	O
140.0	CD	O
,	,	O
148.8	CD	O
,	,	O
154.1	CD	O
,	,	O
154.5	CD	O
;	:	O
154.6	CD	O
,	,	O
154.7	CD	O
,	,	O
155.5	CD	O
,	,	O
157.8	CD	O
,	,	O
157.9	CD	O
,	,	O
160.2	CD	O
,	,	O
162.6	CD	O
,	,	O
165.0	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C43H60F3N4O8	NNP	O
779.	CD	O
found	VBD	O
779	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C43H60F3N4O8	NNP	O
779.43897.	CD	O
found	VBD	O
779.43823	CD	O
.	.	O
Example	JJ	O
36	CD	O
(	(	O
3S,4S	CD	O
)	)	O
/	NN	O
(	(	O
3R,4R	CD	O
)	)	O
-tert-Butyl	CD	O
3-	JJ	O
(	(	O
(	(	O
6-	CD	O
(	(	O
benzyl	NN	O
(	(	O
tert-butoxycarbonyl	JJ	O
)	)	O
amino	NN	O
)	)	O
-4-methylpyridin-2-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
tert-butoxycarbonyl	JJ	O
(	(	O
2-	JJ	O
(	(	O
3-fluorophenyl	JJ	O
)	)	O
cyclopropyl	NN	O
)	)	O
amino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidine-1-carboxylate	NN	O
(	(	O
17b	CD	O
)	)	O
.	.	O
17b	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
a	DT	O
procedure	NN	O
analogous	JJ	O
to	TO	O
that	DT	O
for	IN	O
17a	CD	O
(	(	O
51	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.10-1.22	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
1.35-1.50	JJ	O
(	(	O
m	NN	O
,	,	O
28H	CD	O
)	)	O
,	,	O
1.65-1.80	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.10-2.20	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.20-2.35	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.40-2.80	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.80-2.95	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.97-3.10	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.16-3.21	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.22-3.44	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.45-3.70	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
4.04-4.10	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
5.10-5.25	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.55-6.65	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.65-6.95	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
7.10-7.27	JJ	O
(	(	O
m	NN	O
,	,	O
6H	CD	O
)	)	O
,	,	O
6.31-6.45	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
14.0	CD	O
,	,	O
14.4	CD	O
,	,	O
14.5	CD	O
,	,	O
19.4	CD	O
,	,	O
21.3	CD	O
,	,	O
21.4	CD	O
,	,	O
22.9	CD	O
,	,	O
28.4	CD	O
,	,	O
28.7	CD	O
,	,	O
28.8	CD	O
,	,	O
30.0	CD	O
,	,	O
30.9	CD	O
,	,	O
31.8	CD	O
,	,	O
34.8	CD	O
,	,	O
34.9	CD	O
,	,	O
40.0	CD	O
,	,	O
40.1	CD	O
,	,	O
42.9	CD	O
,	,	O
49.1	CD	O
,	,	O
49.5	CD	O
,	,	O
50.2	CD	O
,	,	O
50.5	CD	O
,	,	O
51.1	CD	O
,	,	O
60.7	CD	O
,	,	O
64.6	CD	O
,	,	O
78.2	CD	O
,	,	O
79.4	CD	O
,	,	O
79.7	CD	O
,	,	O
80.2	CD	O
,	,	O
81.4	CD	O
,	,	O
81.5	CD	O
,	,	O
112.9	CD	O
,	,	O
113.0	CD	O
,	,	O
117.2	CD	O
,	,	O
117.3	CD	O
,	,	O
120.2	CD	O
,	,	O
122.1	CD	O
,	,	O
126.8	CD	O
,	,	O
127.1	CD	O
,	,	O
127.2	CD	O
,	,	O
127.3	CD	O
,	,	O
128.3	CD	O
,	,	O
130.0	CD	O
,	,	O
140.1	CD	O
,	,	O
148.7	CD	O
,	,	O
148.8	CD	O
,	,	O
154.1	CD	O
,	,	O
154.6	CD	O
,	,	O
154.7	CD	O
,	,	O
155.0	CD	O
,	,	O
157.9	CD	O
,	,	O
162.2	CD	O
,	,	O
164.1	CD	O
,	,	O
171.4	CD	O
,	,	O
171.5	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C44H60FN4O7	NNP	O
775.	CD	O
found	VBD	O
775	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C44H60FN4O7	NNP	O
775.44405.	CD	O
found	VBD	O
775.44418	CD	O
.	.	O
Example	JJ	O
37	CD	O
(	(	O
3S,4S	CD	O
)	)	O
/	NN	O
(	(	O
3R,4R	CD	O
)	)	O
-tert-Butyl	CD	O
3-	JJ	O
(	(	O
(	(	O
6-	CD	O
(	(	O
benzyl	NN	O
(	(	O
tert-butoxycarbonyl	JJ	O
)	)	O
amino	NN	O
)	)	O
-4-methylpyridin-2-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
tert-butoxycarbonyl	JJ	O
(	(	O
2-fluoro-2-	JJ	O
(	(	O
3-fluorophenypethypamino	JJ	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidine-1-carboxylate	NN	O
(	(	O
17c	CD	O
)	)	O
.	.	O
17c	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
a	DT	O
procedure	NN	O
analogous	JJ	O
to	TO	O
that	DT	O
for	IN	O
17a	CD	O
(	(	O
48	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.35-1.55	JJ	O
(	(	O
m	NN	O
,	,	O
27H	CD	O
)	)	O
,	,	O
2.20-2.35	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.50-2.80	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.80-2.95	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.00-3.22	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.23-3.90	JJ	O
(	(	O
m	NN	O
,	,	O
9H	CD	O
)	)	O
,	,	O
5.15-5.25	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
5.50-5.80	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.50-6.70	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.00-7.17	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
7.17-7.27	JJ	O
(	(	O
m	NN	O
,	,	O
6H	CD	O
)	)	O
,	,	O
7.30-7.50	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
14.4	CD	O
,	,	O
19.1	CD	O
,	,	O
21.3	CD	O
,	,	O
21.4	CD	O
,	,	O
28.1	CD	O
,	,	O
28.3	CD	O
,	,	O
28.4	CD	O
,	,	O
28.6	CD	O
,	,	O
28.7	CD	O
,	,	O
28.8	CD	O
,	,	O
29.9	CD	O
,	,	O
34.7	CD	O
,	,	O
42.5	CD	O
,	,	O
42.9	CD	O
,	,	O
49.1	CD	O
,	,	O
49.5	CD	O
,	,	O
50.1	CD	O
,	,	O
51.1	CD	O
,	,	O
54.7	CD	O
,	,	O
54.8	CD	O
,	,	O
60.6	CD	O
,	,	O
68.2	CD	O
,	,	O
78.9	CD	O
,	,	O
79.4	CD	O
,	,	O
79.9	CD	O
,	,	O
80.5	CD	O
,	,	O
81.4	CD	O
,	,	O
81.5	CD	O
,	,	O
92.1	CD	O
,	,	O
94.1	CD	O
,	,	O
112.5	CD	O
,	,	O
112.6	CD	O
,	,	O
112.7	CD	O
,	,	O
112.8	CD	O
,	,	O
115.5	CD	O
,	,	O
115.6	CD	O
,	,	O
115.7	CD	O
,	,	O
117.3	CD	O
,	,	O
120.2	CD	O
,	,	O
121.2	CD	O
,	,	O
126.6	CD	O
,	,	O
126.7	CD	O
,	,	O
126.8	CD	O
,	,	O
127.2	CD	O
,	,	O
127.3	CD	O
,	,	O
127.5	CD	O
,	,	O
128.3	CD	O
,	,	O
128.7	CD	O
,	,	O
130.4	CD	O
,	,	O
130.6	CD	O
,	,	O
132.6	CD	O
,	,	O
140.1	CD	O
,	,	O
140.6	CD	O
,	,	O
148.8	CD	O
,	,	O
154.1	CD	O
,	,	O
154.6	CD	O
,	,	O
154.7	CD	O
,	,	O
155.2	CD	O
,	,	O
155.6	CD	O
,	,	O
157.8	CD	O
,	,	O
162.1	CD	O
,	,	O
164.1	CD	O
,	,	O
171.4	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C43H59F2N4O7	NNP	O
781.	CD	O
found	VBD	O
781	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C43H59F2N4O7	NNP	O
781.43463.	CD	O
found	VBD	O
781.43446	CD	O
.	.	O
Example	JJ	O
38	CD	O
(	(	O
3S,4S	CD	O
)	)	O
/	NN	O
(	(	O
3R,4R	CD	O
)	)	O
-tert-Butyl	CD	O
3-	JJ	O
(	(	O
(	(	O
6-	CD	O
(	(	O
benzyl	NN	O
(	(	O
tert-butoxycarbonyl	JJ	O
)	)	O
amino	NN	O
)	)	O
-4-methylpyridin-2-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
tert-butoxycarbonyl	JJ	O
(	(	O
2,2-difluoro-2-	JJ	O
(	(	O
3-fluorophenypethypamino	JJ	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidine-1-carboxylate	NN	O
(	(	O
17d	CD	O
)	)	O
.	.	O
17d	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
a	DT	O
procedure	NN	O
analogous	JJ	O
to	TO	O
that	DT	O
for	IN	O
17a	CD	O
(	(	O
55	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.35-1.55	JJ	O
(	(	O
m	NN	O
,	,	O
27H	CD	O
)	)	O
,	,	O
2.20-2.40	JJ	O
(	(	O
s	JJ	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.50-2.80	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.80-2.95	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.00-3.21	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.30-3.79	JJ	O
(	(	O
m	NN	O
,	,	O
6H	CD	O
)	)	O
,	,	O
3.80-4.00	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
5.10-5.25	JJ	O
(	(	O
s	JJ	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.60-6.70	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.00-7.30	JJ	O
(	(	O
m	NN	O
,	,	O
8H	CD	O
)	)	O
,	,	O
7.31-7.60	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
14.4	CD	O
,	,	O
21.2	CD	O
,	,	O
21.3	CD	O
,	,	O
27.8	CD	O
,	,	O
28.1	CD	O
,	,	O
28.4	CD	O
,	,	O
28.5	CD	O
,	,	O
28.7	CD	O
,	,	O
29.9	CD	O
,	,	O
34.8	CD	O
,	,	O
42.3	CD	O
,	,	O
42.9	CD	O
,	,	O
47.5	CD	O
,	,	O
47.7	CD	O
,	,	O
49.0	CD	O
,	,	O
49.4	CD	O
,	,	O
50.1	CD	O
,	,	O
50.4	CD	O
,	,	O
50.9	CD	O
,	,	O
60.6	CD	O
,	,	O
67.9	CD	O
,	,	O
76.9	CD	O
,	,	O
78.9	CD	O
,	,	O
79.3	CD	O
,	,	O
79.7	CD	O
,	,	O
79.8	CD	O
,	,	O
80.6	CD	O
,	,	O
81.4	CD	O
,	,	O
113.0	CD	O
,	,	O
113.1	CD	O
,	,	O
117.2	CD	O
,	,	O
117.5	CD	O
,	,	O
120.1	CD	O
,	,	O
121.4	CD	O
,	,	O
126.7	CD	O
,	,	O
126.8	CD	O
,	,	O
126.9	CD	O
,	,	O
127.0	CD	O
,	,	O
127.1	CD	O
,	,	O
127.2	CD	O
,	,	O
127.5	CD	O
,	,	O
127.6	CD	O
,	,	O
128.3	CD	O
,	,	O
128.5	CD	O
,	,	O
128.6	CD	O
,	,	O
130.4	CD	O
,	,	O
140.0	CD	O
148.8	CD	O
,	,	O
154.1	CD	O
,	,	O
154.5	CD	O
,	,	O
154.9	CD	O
,	,	O
157.8	CD	O
,	,	O
161.5	CD	O
,	,	O
163.4	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C43H58F3N4O7	NNP	O
799.	CD	O
found	VBD	O
799	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C43H58F3N4O7	NNP	O
799.42521.	CD	O
found	VBD	O
799.42577	CD	O
.	.	O
Example	JJ	O
39	CD	O
6-	JJ	O
(	(	O
(	(	O
(	(	O
3S,4S	CD	O
)	)	O
/	NN	O
(	(	O
3R,4R	CD	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
2-	JJ	O
(	(	O
3-Fluorophenoxy	JJ	O
)	)	O
ethylamino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidin-3-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-methylpyridin-2-amine	NN	O
(	(	O
2a	CD	O
)	)	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
17a	CD	O
(	(	O
30	CD	O
mg	NN	O
,	,	O
39	CD	O
μmol	NN	O
)	)	O
in	IN	O
EtOH	NNP	O
(	(	O
5.0	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
a	DT	O
1:1	CD	O
mixture	NN	O
of	IN	O
EtOH/concentrated	NNP	O
HCl	NNP	O
(	(	O
10	CD	O
mL	NN	O
)	)	O
and	CC	O
Pd	NNP	O
(	(	O
OH	NNP	O
)	)	O
2/C	CD	O
(	(	O
20	CD	O
%	NN	O
,	,	O
30	CD	O
mg	NN	O
)	)	O
.	.	O
The	DT	O
mixture	NN	O
was	VBD	O
charged	VBN	O
with	IN	O
H2	NNP	O
under	IN	O
the	DT	O
pressure	NN	O
of	IN	O
500	CD	O
psi	NNS	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
allowed	VBN	O
to	TO	O
stir	VB	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
40	CD	O
h.	PDT	O
The	DT	O
catalyst	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
filtration	NN	O
through	IN	O
Celite	NNP	O
,	,	O
and	CC	O
the	DT	O
resulting	VBG	O
Celite	NNP	O
cake	NN	O
was	VBD	O
washed	VBN	O
with	IN	O
EtOH	NNP	O
(	(	O
4×3	CD	O
mL	NN	O
)	)	O
and	CC	O
2	CD	O
N	NNP	O
HCl	NNP	O
(	(	O
3	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
combined	JJ	O
filtrates	NNS	O
were	VBD	O
concentrated	VBN	O
to	TO	O
yield	VB	O
inhibitor	NN	O
2a	CD	O
,	,	O
a	DT	O
yellow	JJ	O
solid	NN	O
,	,	O
as	IN	O
a	DT	O
hydrochloride	NN	O
salt	NN	O
(	(	O
15	CD	O
mg	NN	O
,	,	O
85	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
2.08	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.60-2.63	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.70-2.80	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.97-3.03	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.13-3.16	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.17-3.37	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.38-3.50	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.54	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.73	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
4.05	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
4.17	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.33	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.44	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.50-6.55	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.58-6.70	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
7.06-7.08	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
21.3	CD	O
,	,	O
29.4	CD	O
,	,	O
41.7	CD	O
,	,	O
46.6	CD	O
,	,	O
47.0	CD	O
,	,	O
47.3	CD	O
,	,	O
49.5	CD	O
,	,	O
63.0	CD	O
,	,	O
64.0	CD	O
,	,	O
78.6	CD	O
,	,	O
108.4	CD	O
,	,	O
108.6	CD	O
,	,	O
108.7	CD	O
,	,	O
110.4	CD	O
,	,	O
110.5	CD	O
,	,	O
114.3	CD	O
,	,	O
130.9	CD	O
,	,	O
131.0	CD	O
,	,	O
145.8	CD	O
,	,	O
154.0	CD	O
,	,	O
158.3	CD	O
,	,	O
158.7	CD	O
,	,	O
158.8	CD	O
,	,	O
162.4	CD	O
,	,	O
164.4	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C21H30FN4O2	NNP	O
389.	CD	O
found	VBD	O
389	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C21H30FN4O2	NNP	O
389.23473.	CD	O
found	VBD	O
389.23444	CD	O
.	.	O
Example	JJ	O
40	CD	O
6-	JJ	O
(	(	O
(	(	O
(	(	O
3S,4S	CD	O
)	)	O
/	NN	O
(	(	O
3R,4R	CD	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
2-	JJ	O
(	(	O
3-Fluorophenyl	JJ	O
)	)	O
cyclopropylamino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidin-3-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-methylpyridin-2-amine	NN	O
(	(	O
2b	CD	O
)	)	O
.	.	O
Inhibitor	NN	O
2b	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
a	DT	O
procedure	NN	O
analogous	JJ	O
to	TO	O
that	DT	O
for	IN	O
2a	CD	O
(	(	O
91	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
1.18-1.20	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.20	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.60-2.72	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.75-2.90	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.00-3.10	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.15-3.33	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.34-3.42	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.44-3.60	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.70-3.80	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
4.09	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.46-4.67	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.56	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.90-7.10	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
7.20-7.25	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
15.2	CD	O
,	,	O
15.5	CD	O
,	,	O
21.3	CD	O
,	,	O
29.2	CD	O
,	,	O
38.4	CD	O
,	,	O
38.5	CD	O
,	,	O
41.6	CD	O
,	,	O
41.7	CD	O
,	,	O
44.2	CD	O
,	,	O
44.4	CD	O
,	,	O
47.3	CD	O
,	,	O
49.5	CD	O
,	,	O
55.6	CD	O
,	,	O
64.0	CD	O
,	,	O
64.4	CD	O
,	,	O
78.4	CD	O
,	,	O
110.6	CD	O
,	,	O
114.3	CD	O
,	,	O
114.4	CD	O
,	,	O
114.5	CD	O
,	,	O
116.2	CD	O
,	,	O
116.4	CD	O
,	,	O
125.4	CD	O
,	,	O
125.6	CD	O
,	,	O
130.8	CD	O
,	,	O
130.9	CD	O
,	,	O
138.3	CD	O
,	,	O
145.9	CD	O
,	,	O
146.0	CD	O
,	,	O
154.1	CD	O
,	,	O
158.4	CD	O
,	,	O
161.9	CD	O
,	,	O
163.9	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C22H30FN4O	NNP	O
385.	CD	O
found	VBD	O
385	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C22H30FN4O	NNP	O
385.24036.	CD	O
found	VBD	O
385.23933	CD	O
.	.	O
Example	JJ	O
41	CD	O
6-	JJ	O
(	(	O
(	(	O
(	(	O
3S,4S	CD	O
)	)	O
/	NN	O
(	(	O
3R,4R	CD	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
2-Fluoro-2-	JJ	O
(	(	O
3-fluorophenyl	JJ	O
)	)	O
propylamino	NN	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidin-3-yl	NN	O
)	)	O
methyl	NN	O
)	)	O
-4-methylpyridin-2-amine	NN	O
(	(	O
2c	CD	O
)	)	O
.	.	O
Inhibitor	NN	O
2c	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
a	DT	O
procedure	NN	O
analogous	JJ	O
to	TO	O
that	DT	O
for	IN	O
2a	CD	O
(	(	O
90	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
2.14	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.61-2.77	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.78-2.95	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.96-3.10	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.11-3.25	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.26-3.40	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.41-4.60	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.63-3.80	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
4.00-4.15	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
5.78-5.80	JJ	O
(	(	O
d	NN	O
,	,	O
J=9.0	NNP	O
Hz	NNP	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
5.81-5.90	JJ	O
(	(	O
d	NN	O
,	,	O
J=9.0	NNP	O
Hz	NNP	O
,	,	O
0.5H	CD	O
)	)	O
,	,	O
6.41-6.43	JJ	O
(	(	O
d	NN	O
,	,	O
J=7.5	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.50-6.55	JJ	O
(	(	O
d	NN	O
,	,	O
J=8.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.80-6.95	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.96-7.15	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.16-7.40	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
21.29	CD	O
,	,	O
21.34	CD	O
,	,	O
29.23	CD	O
,	,	O
29.28	CD	O
,	,	O
29.32	CD	O
,	,	O
29.8	CD	O
,	,	O
31.4	CD	O
,	,	O
41.6	CD	O
,	,	O
41.7	CD	O
,	,	O
47.1	CD	O
,	,	O
47.3	CD	O
,	,	O
47.6	CD	O
,	,	O
48.4	CD	O
,	,	O
49.5	CD	O
,	,	O
51.6	CD	O
,	,	O
52.1	CD	O
,	,	O
63.9	CD	O
,	,	O
64.0	CD	O
,	,	O
64.2	CD	O
,	,	O
78.4	CD	O
,	,	O
88.6	CD	O
,	,	O
89.9	CD	O
,	,	O
110.6	CD	O
,	,	O
112.8	CD	O
,	,	O
113.0	CD	O
,	,	O
114.2	CD	O
,	,	O
114.3	CD	O
,	,	O
114.4	CD	O
,	,	O
114.8	CD	O
,	,	O
115.6	CD	O
,	,	O
115.8	CD	O
,	,	O
116.7	CD	O
,	,	O
116.8	CD	O
,	,	O
121.8	CD	O
,	,	O
124.9	CD	O
,	,	O
126.9	CD	O
,	,	O
127.4	CD	O
,	,	O
128.9	CD	O
,	,	O
129.1	CD	O
,	,	O
130.8	CD	O
,	,	O
130.9	CD	O
,	,	O
131.1	CD	O
,	,	O
131.2	CD	O
,	,	O
137.1	CD	O
,	,	O
138.9	CD	O
,	,	O
139.0	CD	O
,	,	O
145.8	CD	O
,	,	O
145.9	CD	O
,	,	O
154.0	CD	O
,	,	O
158.4	CD	O
,	,	O
161.8	CD	O
,	,	O
161.9	CD	O
,	,	O
163.7	CD	O
,	,	O
163.8	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C21H29F2N4O	NNP	O
391.	CD	O
found	VBD	O
391	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C21H29F2N4O	NNP	O
391.23094.	CD	O
found	VBD	O
391.23012	CD	O
.	.	O
Example	JJ	O
42	CD	O
6-	JJ	O
(	(	O
(	(	O
(	(	O
3S,4S	CD	O
)	)	O
/	NN	O
(	(	O
3R,4R	CD	O
)	)	O
-4-	NN	O
(	(	O
2-	JJ	O
(	(	O
2,2-Difluoro-2-	JJ	O
(	(	O
3-fluorophenypethylamino	JJ	O
)	)	O
ethoxy	NN	O
)	)	O
pyrrolidin-3-yemethyl	NN	O
)	)	O
-4-methylpyridin-2-amine	NN	O
(	(	O
2d	CD	O
)	)	O
.	.	O
Inhibitor	NN	O
2d	CD	O
was	VBD	O
synthesized	VBN	O
using	VBG	O
a	DT	O
procedure	NN	O
analogous	JJ	O
to	TO	O
that	DT	O
for	IN	O
2a	CD	O
(	(	O
91	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
2.19	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.68-2.70	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.80-2.92	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.93-3.10	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.20-3.30	JJ	O
(	(	O
d	NN	O
,	,	O
J=13.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.38	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.50-3.60	JJ	O
(	(	O
d	NN	O
,	,	O
J=14.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.65	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.70-3.90	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
4.15	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.45	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.55	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.10-7.35	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
7.42	CD	O
(	(	O
br	NN	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
21.3	CD	O
,	,	O
29.3	CD	O
,	,	O
41.5	CD	O
,	,	O
47.3	CD	O
,	,	O
47.7	CD	O
,	,	O
47.8	CD	O
,	,	O
49.4	CD	O
,	,	O
51.9	CD	O
,	,	O
63.8	CD	O
,	,	O
78.5	CD	O
,	,	O
110.6	CD	O
,	,	O
112.5	CD	O
,	,	O
114.2	CD	O
,	,	O
118.6	CD	O
,	,	O
118.8	CD	O
,	,	O
121.2	CD	O
,	,	O
131.5	CD	O
,	,	O
145.8	CD	O
,	,	O
154.1	CD	O
,	,	O
158.4	CD	O
,	,	O
161.6	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C21H28F3N4O	NNP	O
409.	CD	O
found	VBD	O
409	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C21H28F3N4O	NNP	O
409.22152.	CD	O
found	VBD	O
409.22076	CD	O
.	.	O
Examples	NNS	O
43-57	CD	O
can	MD	O
be	VB	O
considered	VBN	O
in	IN	O
the	DT	O
context	NN	O
of	IN	O
Schemes	NNP	O
5-8	JJ	O
,	,	O
above	IN	O
.	.	O
Example	RB	O
43	CD	O
General	NNP	O
Method	NNP	O
(	(	O
A	NNP	O
)	)	O
for	IN	O
Reductive	JJ	O
Amination	NNP	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
aldehyde	JJ	O
8a	CD	O
or	CC	O
8b	CD	O
(	(	O
0.1	CD	O
mmol	NN	O
)	)	O
in	IN	O
THF	NNP	O
(	(	O
3	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
ethanamine	NN	O
(	(	O
0.2	CD	O
mmol	NN	O
)	)	O
,	,	O
followed	VBN	O
by	IN	O
NaHB	NNP	O
(	(	O
OAc	NNP	O
)	)	O
3	CD	O
(	(	O
0.12	CD	O
mmol	NN	O
)	)	O
.	.	O
The	DT	O
mixture	NN	O
was	VBD	O
stirred	VBN	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
an	DT	O
additional	JJ	O
3	CD	O
h	NN	O
,	,	O
and	CC	O
then	RB	O
concentrated	VBD	O
.	.	O
The	DT	O
crude	JJ	O
product	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	JJ	O
column	NN	O
chromatography	NN	O
(	(	O
EtOAc/hexanes	NNPS	O
,	,	O
2:1-4:1	JJ	O
)	)	O
to	TO	O
yield	VB	O
the	DT	O
corresponding	JJ	O
secondary	JJ	O
amines	NNS	O
as	IN	O
colorless	NN	O
oils	NNS	O
which	WDT	O
were	VBD	O
used	VBN	O
without	IN	O
further	JJ	O
purification	NN	O
.	.	O
Example	RB	O
44	CD	O
General	NNP	O
Method	NNP	O
(	(	O
B	NNP	O
)	)	O
for	IN	O
Boc-protection	NNP	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
secondary	JJ	O
amine	NN	O
(	(	O
0.5	CD	O
mmol	NN	O
)	)	O
in	IN	O
MeOH	NNP	O
(	(	O
10	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
(	(	O
Boc	NNP	O
)	)	O
2O	CD	O
(	(	O
164	CD	O
mg	NN	O
,	,	O
0.75	CD	O
mmol	NN	O
)	)	O
and	CC	O
TEA	NNP	O
(	(	O
140	CD	O
μL	NN	O
,	,	O
1.0	CD	O
mmol	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
allowed	VBN	O
to	TO	O
stir	VB	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
30	CD	O
min	NN	O
.	.	O
The	DT	O
solvent	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
,	,	O
and	CC	O
the	DT	O
resulting	VBG	O
material	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	JJ	O
column	NN	O
chromatography	NN	O
(	(	O
EtOAc/hexanes	NNPS	O
,	,	O
1:4-1:2	JJ	O
)	)	O
to	TO	O
yield	VB	O
9a-f	JJ	O
as	IN	O
a	DT	O
colorless	NN	O
oil	NN	O
.	.	O
Example	RB	O
45	CD	O
General	NNP	O
Method	NNP	O
(	(	O
C	NNP	O
)	)	O
for	IN	O
Catalytic	JJ	O
hydrogenation	NN	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
9a-f	NNP	O
(	(	O
0.2	CD	O
mmol	NN	O
)	)	O
in	IN	O
EtOH	NNP	O
(	(	O
20	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
Pd	NNP	O
(	(	O
OH	NNP	O
)	)	O
2/C	CD	O
(	(	O
100	CD	O
mg	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
vessel	NN	O
was	VBD	O
charged	VBN	O
with	IN	O
H2	NNP	O
,	,	O
heated	VBD	O
at	IN	O
60°	CD	O
C.	NNP	O
for	IN	O
24-48	JJ	O
h	NN	O
,	,	O
then	RB	O
cooled	VBD	O
to	TO	O
room	NN	O
temperature	NN	O
.	.	O
The	DT	O
catalyst	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
filtration	NN	O
,	,	O
and	CC	O
the	DT	O
resulting	JJ	O
solution	NN	O
was	VBD	O
concentrated	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
.	.	O
The	DT	O
crude	JJ	O
material	NN	O
was	VBD	O
purified	VBN	O
by	IN	O
flash	JJ	O
column	NN	O
chromatography	NN	O
(	(	O
EtOAc/hexanes	NNP	O
,	,	O
1:4	CD	O
1:2	CD	O
)	)	O
to	TO	O
yield	VB	O
10a-f	JJ	O
as	IN	O
a	DT	O
white	JJ	O
foamy	NN	O
solid	NN	O
.	.	O
Example	RB	O
46	CD	O
General	NNP	O
Method	NNP	O
(	(	O
D	NNP	O
)	)	O
for	IN	O
Boc-deprotection	NNP	O
.	.	O
To	TO	O
a	DT	O
solution	NN	O
of	IN	O
10a-f	JJ	O
(	(	O
50	CD	O
μmol	NN	O
)	)	O
in	IN	O
MeOH	NNP	O
(	(	O
0.5	CD	O
mL	NN	O
)	)	O
was	VBD	O
added	VBN	O
6	CD	O
N	NNP	O
HCl	NNP	O
(	(	O
1.0	CD	O
mL	NN	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
mixture	NN	O
was	VBD	O
allowed	VBN	O
to	TO	O
sit	VB	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
12	CD	O
h.	PDT	O
The	DT	O
solvent	NN	O
was	VBD	O
removed	VBN	O
by	IN	O
rotary	JJ	O
evaporation	NN	O
.	.	O
The	DT	O
crude	JJ	O
product	NN	O
was	VBD	O
recrystallized	VBN	O
using	VBG	O
cold	JJ	O
diethyl	NN	O
ether	NN	O
to	TO	O
provide	VB	O
2da-2dd	JJ	O
and	CC	O
2e-2f	JJ	O
as	IN	O
pale	JJ	O
yellow	JJ	O
solids	NNS	O
.	.	O
Example	RB	O
47	CD	O
9a	CD	O
was	VBD	O
synthesized	VBN	O
by	IN	O
general	JJ	O
methods	NNS	O
A	DT	O
and	CC	O
B	NNP	O
using	VBG	O
aldehyde	RB	O
8b	CD	O
as	IN	O
a	DT	O
starting	VBG	O
material	NN	O
(	(	O
55	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.35-1.55	JJ	O
(	(	O
m	NN	O
,	,	O
27H	CD	O
)	)	O
,	,	O
2.20-2.40	JJ	O
(	(	O
s	JJ	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.50-2.80	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.80-2.95	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.00-3.21	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.30-3.79	JJ	O
(	(	O
m	NN	O
,	,	O
6H	CD	O
)	)	O
,	,	O
3.80	CD	O
4.00	CD	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
5.10-5.25	JJ	O
(	(	O
s	JJ	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.60-6.70	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.00-7.30	JJ	O
(	(	O
m	NN	O
,	,	O
8H	CD	O
)	)	O
,	,	O
7.31	CD	O
7.60	CD	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
14.4	CD	O
,	,	O
21.2	CD	O
,	,	O
21.3	CD	O
,	,	O
27.8	CD	O
,	,	O
28.1	CD	O
,	,	O
28.4	CD	O
,	,	O
28.5	CD	O
,	,	O
28.7	CD	O
,	,	O
29.9	CD	O
,	,	O
34.8	CD	O
,	,	O
42.3	CD	O
,	,	O
42.9	CD	O
,	,	O
47.5	CD	O
,	,	O
47.7	CD	O
,	,	O
49.0	CD	O
,	,	O
49.4	CD	O
,	,	O
50.1	CD	O
,	,	O
50.4	CD	O
,	,	O
50.9	CD	O
,	,	O
60.6	CD	O
,	,	O
67.9	CD	O
,	,	O
76.9	CD	O
,	,	O
78.9	CD	O
,	,	O
79.3	CD	O
,	,	O
79.7	CD	O
,	,	O
79.8	CD	O
,	,	O
80.6	CD	O
,	,	O
81.4	CD	O
,	,	O
113.0	CD	O
,	,	O
113.1	CD	O
,	,	O
117.2	CD	O
,	,	O
117.5	CD	O
,	,	O
120.1	CD	O
,	,	O
121.4	CD	O
,	,	O
126.7	CD	O
,	,	O
126.8	CD	O
,	,	O
126.9	CD	O
,	,	O
127.0	CD	O
,	,	O
127.1	CD	O
,	,	O
127.2	CD	O
,	,	O
127.5	CD	O
,	,	O
127.6	CD	O
,	,	O
128.3	CD	O
,	,	O
128.5	CD	O
,	,	O
128.6	CD	O
,	,	O
130.4	CD	O
,	,	O
140.0	CD	O
148.8	CD	O
,	,	O
154.1	CD	O
,	,	O
154.5	CD	O
,	,	O
154.9	CD	O
,	,	O
157.8	CD	O
,	,	O
161.5	CD	O
,	,	O
163.4	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C43H58F3N4O7	NNP	O
799.	CD	O
found	VBD	O
799	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C43H58F3N4O7	NNP	O
799.4252.	CD	O
found	VBD	O
799.4258	CD	O
.	.	O
Example	RB	O
48	CD	O
9b	CD	O
was	VBD	O
synthesized	VBN	O
by	IN	O
general	JJ	O
methods	NNS	O
A	DT	O
and	CC	O
B	NNP	O
using	VBG	O
aldehyde	RB	O
8a	CD	O
as	IN	O
a	DT	O
starting	VBG	O
material	NN	O
(	(	O
55	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.35-1.55	JJ	O
(	(	O
m	NN	O
,	,	O
27H	CD	O
)	)	O
,	,	O
2.20-2.40	JJ	O
(	(	O
s	JJ	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.50-2.80	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.80-2.95	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.00-3.21	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
3.30-3.79	JJ	O
(	(	O
m	NN	O
,	,	O
6H	CD	O
)	)	O
,	,	O
3.80	CD	O
4.00	CD	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
5.10-5.25	JJ	O
(	(	O
s	JJ	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.60-6.70	JJ	O
(	(	O
br	JJ	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.00-7.30	JJ	O
(	(	O
m	NN	O
,	,	O
8H	CD	O
)	)	O
,	,	O
7.31-7.60	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
14.4	CD	O
,	,	O
21.2	CD	O
,	,	O
21.3	CD	O
,	,	O
27.8	CD	O
,	,	O
28.1	CD	O
,	,	O
28.4	CD	O
,	,	O
28.5	CD	O
,	,	O
28.7	CD	O
,	,	O
29.9	CD	O
,	,	O
34.8	CD	O
,	,	O
42.3	CD	O
,	,	O
42.9	CD	O
,	,	O
47.5	CD	O
,	,	O
47.7	CD	O
,	,	O
49.0	CD	O
,	,	O
49.4	CD	O
,	,	O
50.1	CD	O
,	,	O
50.4	CD	O
,	,	O
50.9	CD	O
,	,	O
60.6	CD	O
,	,	O
67.9	CD	O
,	,	O
76.9	CD	O
,	,	O
78.9	CD	O
,	,	O
79.3	CD	O
,	,	O
79.7	CD	O
,	,	O
79.8	CD	O
,	,	O
80.6	CD	O
,	,	O
81.4	CD	O
,	,	O
113.0	CD	O
,	,	O
113.1	CD	O
,	,	O
117.2	CD	O
,	,	O
117.5	CD	O
,	,	O
120.1	CD	O
,	,	O
121.4	CD	O
,	,	O
126.7	CD	O
,	,	O
126.8	CD	O
,	,	O
126.9	CD	O
,	,	O
127.0	CD	O
,	,	O
127.1	CD	O
,	,	O
127.2	CD	O
,	,	O
127.5	CD	O
,	,	O
127.6	CD	O
,	,	O
128.3	CD	O
,	,	O
128.5	CD	O
,	,	O
128.6	CD	O
,	,	O
130.4	CD	O
,	,	O
140.0	CD	O
148.8	CD	O
,	,	O
154.1	CD	O
,	,	O
154.5	CD	O
,	,	O
154.9	CD	O
,	,	O
157.8	CD	O
,	,	O
161.5	CD	O
,	,	O
163.4	CD	O
;	:	O
LCQ-MS	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C43H58F3N4O7	NNP	O
799.	CD	O
found	VBD	O
799	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C43H58F3N4O7	NNP	O
799.4252.	CD	O
found	VBD	O
799.4248	CD	O
Example	NNP	O
49	CD	O
9c	CD	O
was	VBD	O
synthesized	VBN	O
by	IN	O
general	JJ	O
methods	NNS	O
A	DT	O
and	CC	O
B	NNP	O
using	VBG	O
aldehyde	RB	O
8a	CD	O
as	IN	O
a	DT	O
starting	VBG	O
material	NN	O
(	(	O
55	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.20-1.50	JJ	O
(	(	O
m	NN	O
,	,	O
27H	CD	O
)	)	O
,	,	O
2.25	CD	O
2.35	CD	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.45-2.65	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.66-2.70	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.80-2.95	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.00-3.10	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.10-3.20	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.25-3.70	JJ	O
(	(	O
m	NN	O
,	,	O
7H	CD	O
)	)	O
,	,	O
3.80-4.00	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
5.10-5.20	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.60	CD	O
6.70	CD	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.00-7.15	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.16-7.20	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.21-7.27	JJ	O
(	(	O
m	NN	O
,	,	O
4H	CD	O
)	)	O
,	,	O
7.35-7.60	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
13.7	CD	O
,	,	O
14.2	CD	O
,	,	O
19.1	CD	O
,	,	O
21.0	CD	O
,	,	O
21.1	CD	O
,	,	O
24.7	CD	O
,	,	O
27.91	CD	O
,	,	O
27.96	CD	O
,	,	O
28.01	CD	O
,	,	O
28.2	CD	O
,	,	O
28.3	CD	O
,	,	O
28.5	CD	O
,	,	O
30.6	CD	O
,	,	O
34.4	CD	O
,	,	O
34.5	CD	O
,	,	O
34.6	CD	O
,	,	O
42.0	CD	O
,	,	O
42.1	CD	O
,	,	O
42.6	CD	O
,	,	O
42.7	CD	O
,	,	O
47.4	CD	O
,	,	O
47.5	CD	O
,	,	O
47.6	CD	O
,	,	O
47.8	CD	O
,	,	O
48.8	CD	O
,	,	O
49.3	CD	O
,	,	O
49.9	CD	O
,	,	O
50.1	CD	O
,	,	O
50.3	CD	O
,	,	O
50.8	CD	O
,	,	O
53.4	CD	O
,	,	O
53.8	CD	O
,	,	O
54.0	CD	O
,	,	O
60.4	CD	O
,	,	O
64.4	CD	O
,	,	O
67.7	CD	O
,	,	O
67.8	CD	O
,	,	O
68.0	CD	O
,	,	O
78.7	CD	O
,	,	O
78.8	CD	O
,	,	O
79.1	CD	O
,	,	O
79.2	CD	O
,	,	O
79.3	CD	O
,	,	O
79.6	CD	O
,	,	O
80.3	CD	O
,	,	O
81.17	CD	O
,	,	O
81.22	CD	O
,	,	O
115.2	CD	O
,	,	O
115.4	CD	O
,	,	O
115.6	CD	O
,	,	O
115.7	CD	O
,	,	O
117.0	CD	O
,	,	O
117.1	CD	O
,	,	O
119.9	CD	O
,	,	O
126.5	CD	O
,	,	O
126.6	CD	O
,	,	O
126.9	CD	O
,	,	O
127.0	CD	O
,	,	O
127.5	CD	O
,	,	O
128.1	CD	O
,	,	O
131.5	CD	O
,	,	O
139.7	CD	O
,	,	O
139.8	CD	O
,	,	O
148.6	CD	O
,	,	O
153.9	CD	O
,	,	O
154.3	CD	O
,	,	O
154.4	CD	O
,	,	O
154.5	CD	O
,	,	O
154.6	CD	O
,	,	O
154.7	CD	O
,	,	O
154.8	CD	O
,	,	O
155.1	CD	O
,	,	O
157.4	CD	O
,	,	O
157.5	CD	O
,	,	O
157.6	CD	O
,	,	O
162.7	CD	O
,	,	O
164.6	CD	O
,	,	O
171.2	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C43H58F3N4O7	NNP	O
799.4258.	CD	O
found	VBD	O
799.4237	CD	O
.	.	O
Example	RB	O
50	CD	O
9d	CD	O
was	VBD	O
synthesized	VBN	O
by	IN	O
general	JJ	O
methods	NNS	O
A	DT	O
and	CC	O
B	NNP	O
using	VBG	O
aldehyde	RB	O
8a	CD	O
as	IN	O
a	DT	O
starting	VBG	O
material	NN	O
(	(	O
55	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.20-1.50	JJ	O
(	(	O
m	NN	O
,	,	O
27H	CD	O
)	)	O
,	,	O
2.25	CD	O
2.35	CD	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.45-2.65	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.66-2.71	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.80-2.95	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.00-3.10	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.10-3.20	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.25-3.70	JJ	O
(	(	O
m	NN	O
,	,	O
7H	CD	O
)	)	O
,	,	O
3.80-4.00	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
5.10-5.20	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.60	CD	O
6.70	CD	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.00-7.60	JJ	O
(	(	O
m	NN	O
,	,	O
12H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
13.7	CD	O
,	,	O
14.2	CD	O
,	,	O
19.1	CD	O
,	,	O
21.0	CD	O
,	,	O
21.1	CD	O
,	,	O
24.7	CD	O
,	,	O
27.91	CD	O
,	,	O
27.96	CD	O
,	,	O
28.01	CD	O
,	,	O
28.2	CD	O
,	,	O
28.3	CD	O
,	,	O
28.5	CD	O
,	,	O
30.6	CD	O
,	,	O
34.4	CD	O
,	,	O
34.5	CD	O
,	,	O
34.6	CD	O
,	,	O
42.0	CD	O
,	,	O
42.1	CD	O
,	,	O
42.6	CD	O
,	,	O
42.7	CD	O
,	,	O
47.4	CD	O
,	,	O
47.5	CD	O
,	,	O
47.6	CD	O
,	,	O
47.8	CD	O
,	,	O
48.8	CD	O
,	,	O
49.3	CD	O
,	,	O
49.9	CD	O
,	,	O
50.1	CD	O
,	,	O
50.3	CD	O
,	,	O
50.8	CD	O
,	,	O
53.4	CD	O
,	,	O
53.8	CD	O
,	,	O
54.0	CD	O
,	,	O
60.4	CD	O
,	,	O
64.4	CD	O
,	,	O
67.7	CD	O
,	,	O
67.8	CD	O
,	,	O
68.0	CD	O
,	,	O
78.7	CD	O
,	,	O
78.8	CD	O
,	,	O
79.1	CD	O
,	,	O
79.2	CD	O
,	,	O
79.3	CD	O
,	,	O
79.6	CD	O
,	,	O
80.3	CD	O
,	,	O
81.17	CD	O
,	,	O
81.22	CD	O
,	,	O
115.2	CD	O
,	,	O
115.4	CD	O
,	,	O
115.6	CD	O
,	,	O
115.7	CD	O
,	,	O
117.0	CD	O
,	,	O
117.1	CD	O
,	,	O
119.9	CD	O
,	,	O
126.5	CD	O
,	,	O
126.6	CD	O
,	,	O
126.9	CD	O
,	,	O
127.0	CD	O
,	,	O
127.5	CD	O
,	,	O
128.1	CD	O
,	,	O
131.5	CD	O
,	,	O
139.7	CD	O
,	,	O
139.8	CD	O
,	,	O
148.6	CD	O
,	,	O
153.9	CD	O
,	,	O
154.3	CD	O
,	,	O
154.4	CD	O
,	,	O
154.5	CD	O
,	,	O
154.6	CD	O
,	,	O
154.7	CD	O
,	,	O
154.8	CD	O
,	,	O
155.1	CD	O
,	,	O
157.4	CD	O
,	,	O
157.5	CD	O
,	,	O
157.6	CD	O
,	,	O
162.7	CD	O
,	,	O
164.6	CD	O
,	,	O
171.2	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C43H59F2N4O7	NNP	O
781.4352.	CD	O
found	VBD	O
781.4366	CD	O
.	.	O
Example	RB	O
51	CD	O
9f	CD	O
was	VBD	O
synthesized	VBN	O
by	IN	O
general	JJ	O
methods	NNS	O
A	DT	O
and	CC	O
B	NNP	O
using	VBG	O
aldehyde	RB	O
8b	CD	O
as	IN	O
a	DT	O
starting	VBG	O
material	NN	O
(	(	O
55	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBZ	O
1.40-1.55	JJ	O
(	(	O
m	NN	O
,	,	O
27H	CD	O
)	)	O
,	,	O
2.27	CD	O
2.29	CD	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.45-2.67	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.68-2.75	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.85-2.95	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.00-3.11	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.12-3.20	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.30-3.45	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.46-3.65	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
4.05-4.20	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
5.16	CD	O
(	(	O
s	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
6.67	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.17-7.20	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.21-7.26	JJ	O
(	(	O
m	NN	O
,	,	O
4H	CD	O
)	)	O
,	,	O
7.30-7.45	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.50	CD	O
7.70	CD	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.75-7.85	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
8.60-8.71	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
CDCl3	NNP	O
)	)	O
δ	VBD	O
14.2	CD	O
,	,	O
21.11	CD	O
,	,	O
21.13	CD	O
,	,	O
24.7	CD	O
,	,	O
28.0	CD	O
,	,	O
28.1	CD	O
,	,	O
28.2	CD	O
,	,	O
28.3	CD	O
,	,	O
28.5	CD	O
,	,	O
29.7	CD	O
,	,	O
34.4	CD	O
,	,	O
34.5	CD	O
,	,	O
36.6	CD	O
,	,	O
42.2	CD	O
,	,	O
42.6	CD	O
,	,	O
42.7	CD	O
,	,	O
47.6	CD	O
,	,	O
47.7	CD	O
,	,	O
48.0	CD	O
,	,	O
48.8	CD	O
,	,	O
49.2	CD	O
,	,	O
49.89	CD	O
,	,	O
49.92	CD	O
,	,	O
50.1	CD	O
,	,	O
50.2	CD	O
,	,	O
50.8	CD	O
,	,	O
60.4	CD	O
,	,	O
67.5	CD	O
,	,	O
67.6	CD	O
,	,	O
67.7	CD	O
,	,	O
78.7	CD	O
,	,	O
79.1	CD	O
,	,	O
79.6	CD	O
,	,	O
80.2	CD	O
,	,	O
81.1	CD	O
,	,	O
81.2	CD	O
,	,	O
117.0	CD	O
,	,	O
117.1	CD	O
,	,	O
120.0	CD	O
,	,	O
120.4	CD	O
,	,	O
120.5	CD	O
,	,	O
124.76	CD	O
,	,	O
124.84	CD	O
,	,	O
126.4	CD	O
,	,	O
126.5	CD	O
,	,	O
126.6	CD	O
,	,	O
126.9	CD	O
,	,	O
127.0	CD	O
,	,	O
128.06	CD	O
,	,	O
128.11	CD	O
,	,	O
136.9	CD	O
,	,	O
137.0	CD	O
,	,	O
139.8	CD	O
,	,	O
139.9	CD	O
,	,	O
148.5	CD	O
,	,	O
149.3	CD	O
,	,	O
149.5	CD	O
,	,	O
153.8	CD	O
,	,	O
154.3	CD	O
,	,	O
154.4	CD	O
,	,	O
154.5	CD	O
,	,	O
154.7	CD	O
,	,	O
155.0	CD	O
,	,	O
155.4	CD	O
,	,	O
157.7	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C42H58F2N5O7	NNP	O
782.4304.	CD	O
found	VBD	O
782.4299	CD	O
.	.	O
Example	RB	O
52	CD	O
Inhibitor	NNP	O
compound	VBD	O
2da	CD	O
was	VBD	O
synthesized	VBN	O
by	IN	O
general	JJ	O
methods	NNS	O
C	NNP	O
and	CC	O
D	NNP	O
using	VBG	O
9a	CD	O
as	IN	O
a	DT	O
starting	VBG	O
material	NN	O
(	(	O
55	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
2.29	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.78-2.81	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.95	CD	O
3.05	CD	O
(	(	O
dd	NN	O
,	,	O
J=8.0	NNP	O
,	,	O
15.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.15-3.20	JJ	O
(	(	O
t	JJ	O
,	,	O
J=6.0	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.31-3.35	JJ	O
(	(	O
dd	NN	O
,	,	O
J=3.0	NNP	O
,	,	O
13.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.40-3.55	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.63-3.66	JJ	O
(	(	O
d	NN	O
,	,	O
J=13.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.71-3.79	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.87-3.95	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
4.24-4.26	JJ	O
(	(	O
t	JJ	O
,	,	O
J=3.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.55	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.64	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.25-7.29	JJ	O
(	(	O
dt	NN	O
,	,	O
J=2.5	NNP	O
,	,	O
8.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.34-7.36	JJ	O
(	(	O
dd	NN	O
,	,	O
J=2.5	NNP	O
,	,	O
14.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.38-7.40	JJ	O
(	(	O
dd	NN	O
,	,	O
J=2.5	NNP	O
,	,	O
8.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.49	CD	O
7.52	CD	O
(	(	O
dd	NN	O
,	,	O
J=6.0	NNP	O
,	,	O
8.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
21.0	CD	O
,	,	O
29.1	CD	O
,	,	O
41.3	CD	O
,	,	O
47.0	CD	O
,	,	O
47.5	CD	O
,	,	O
49.2	CD	O
,	,	O
51.5	CD	O
,	,	O
51.7	CD	O
,	,	O
51.9	CD	O
,	,	O
63.6	CD	O
,	,	O
78.3	CD	O
,	,	O
110.4	CD	O
,	,	O
112.3	CD	O
,	,	O
112.5	CD	O
,	,	O
114.0	CD	O
,	,	O
118.2	CD	O
,	,	O
118.4	CD	O
,	,	O
118.6	CD	O
,	,	O
121.0	CD	O
,	,	O
131.2	CD	O
,	,	O
131.3	CD	O
,	,	O
134.2	CD	O
,	,	O
145.5	CD	O
,	,	O
153.9	CD	O
,	,	O
158.1	CD	O
,	,	O
161.4	CD	O
,	,	O
163.3	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C21H28F3N4O	NNP	O
409.2215.	CD	O
found	VBD	O
409.2226	CD	O
.	.	O
Example	RB	O
53	CD	O
Inhibitor	NNP	O
compound	VBD	O
2db	CD	O
was	VBD	O
synthesized	VBN	O
by	IN	O
general	JJ	O
methods	NNS	O
C	NNP	O
and	CC	O
D	NNP	O
using	VBG	O
9b	CD	O
as	IN	O
a	DT	O
starting	VBG	O
material	NN	O
(	(	O
55	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
2.29	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.78-2.81	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.95	CD	O
3.05	CD	O
(	(	O
dd	NN	O
,	,	O
J=8.0	NNP	O
,	,	O
15.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.15-3.20	JJ	O
(	(	O
t	JJ	O
,	,	O
J=6.0	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.31-3.35	JJ	O
(	(	O
dd	NN	O
,	,	O
J=3.0	NNP	O
,	,	O
13.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.40-3.55	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.63-3.66	JJ	O
(	(	O
d	NN	O
,	,	O
J=13.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.71-3.79	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.87-3.95	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
4.24-4.26	JJ	O
(	(	O
t	JJ	O
,	,	O
J=3.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.55	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.64	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.25-7.29	JJ	O
(	(	O
dt	NN	O
,	,	O
J=2.5	NNP	O
,	,	O
8.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.34-7.36	JJ	O
(	(	O
dd	NN	O
,	,	O
J=2.5	NNP	O
,	,	O
14.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.38-7.40	JJ	O
(	(	O
dd	NN	O
,	,	O
J=2.5	NNP	O
,	,	O
8.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.49	CD	O
7.52	CD	O
(	(	O
dd	NN	O
,	,	O
J=6.0	NNP	O
,	,	O
8.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
21.0	CD	O
,	,	O
29.1	CD	O
,	,	O
41.3	CD	O
,	,	O
47.0	CD	O
,	,	O
47.5	CD	O
,	,	O
49.2	CD	O
,	,	O
51.5	CD	O
,	,	O
51.7	CD	O
,	,	O
51.9	CD	O
,	,	O
63.6	CD	O
,	,	O
78.3	CD	O
,	,	O
110.4	CD	O
,	,	O
112.3	CD	O
,	,	O
112.5	CD	O
,	,	O
114.0	CD	O
,	,	O
118.2	CD	O
,	,	O
118.4	CD	O
,	,	O
118.6	CD	O
,	,	O
121.0	CD	O
,	,	O
131.2	CD	O
,	,	O
131.3	CD	O
,	,	O
134.2	CD	O
,	,	O
145.5	CD	O
,	,	O
153.9	CD	O
,	,	O
158.1	CD	O
,	,	O
161.4	CD	O
,	,	O
163.3	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C21H28F3N4O	NNP	O
409.2215.	CD	O
found	VBD	O
409.2223	CD	O
.	.	O
Example	RB	O
54	CD	O
Inhibitor	NNP	O
compound	VBD	O
2dc	CD	O
was	VBD	O
synthesized	VBN	O
by	IN	O
general	JJ	O
methods	NNS	O
C	NNP	O
and	CC	O
D	NNP	O
using	VBG	O
9c	CD	O
as	IN	O
a	DT	O
starting	VBG	O
material	NN	O
(	(	O
55	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
2.30	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.78-2.81	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.95	CD	O
3.05	CD	O
(	(	O
dd	NN	O
,	,	O
J=8.0	NNP	O
,	,	O
15.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.15-3.20	JJ	O
(	(	O
t	JJ	O
,	,	O
J=6.0	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.31-3.35	JJ	O
(	(	O
dd	NN	O
,	,	O
J=3.0	NNP	O
,	,	O
13.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.40-3.55	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.63-3.66	JJ	O
(	(	O
d	NN	O
,	,	O
J=13.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.71-3.79	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.87-3.95	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
4.24-4.26	JJ	O
(	(	O
t	JJ	O
,	,	O
J=3.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.55	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.64	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.21-7.25	JJ	O
(	(	O
dd	NN	O
,	,	O
J=8.5	NNP	O
,	,	O
8.5	CD	O
Hz	NNP	O
,	,	O
2H	CD	O
)	)	O
,	,	O
7.59-7.62	JJ	O
(	(	O
dd	NN	O
,	,	O
J=5.0	NNP	O
,	,	O
8.5	CD	O
Hz	NNP	O
,	,	O
2H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
21.0	CD	O
,	,	O
29.0	CD	O
,	,	O
41.3	CD	O
,	,	O
47.0	CD	O
,	,	O
47.4	CD	O
,	,	O
49.2	CD	O
,	,	O
51.7	CD	O
,	,	O
51.9	CD	O
,	,	O
51.9	CD	O
,	,	O
63.6	CD	O
,	,	O
78.3	CD	O
,	,	O
110.4	CD	O
,	,	O
113.9	CD	O
,	,	O
116.0	CD	O
,	,	O
116.1	CD	O
,	,	O
118.7	CD	O
,	,	O
127.42	CD	O
,	,	O
127.47	CD	O
,	,	O
127.55	CD	O
,	,	O
127.59	CD	O
,	,	O
145.5	CD	O
,	,	O
153.9	CD	O
,	,	O
158.1	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C21H28F3N4O	NNP	O
409.2215.	CD	O
found	VBD	O
409.2230	CD	O
.	.	O
Example	RB	O
55	CD	O
Inhibitor	NNP	O
compound	VBD	O
2dd	CD	O
was	VBD	O
synthesized	VBN	O
by	IN	O
general	JJ	O
methods	NNS	O
C	NNP	O
and	CC	O
D	NNP	O
using	VBG	O
9d	CD	O
as	IN	O
a	DT	O
starting	VBG	O
material	NN	O
(	(	O
55	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
2.30	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.73-2.84	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
2.95	CD	O
3.05	CD	O
(	(	O
dd	NN	O
,	,	O
J=8.5	NNP	O
,	,	O
15.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.10-3.20	JJ	O
(	(	O
t	JJ	O
,	,	O
J=6.0	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.31-3.35	JJ	O
(	(	O
dd	NN	O
,	,	O
J=3.0	NNP	O
,	,	O
13.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.40-3.55	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
3.63-3.66	JJ	O
(	(	O
d	NN	O
,	,	O
J=13.5	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.71-3.79	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.87-3.95	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
4.24-4.26	JJ	O
(	(	O
t	JJ	O
,	,	O
J=3.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.55	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.64	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.45-7.65	JJ	O
(	(	O
m	NN	O
,	,	O
5H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
21.0	CD	O
,	,	O
29.0	CD	O
,	,	O
41.3	CD	O
,	,	O
47.0	CD	O
,	,	O
47.4	CD	O
,	,	O
49.2	CD	O
,	,	O
51.6	CD	O
,	,	O
51.8	CD	O
,	,	O
52.0	CD	O
,	,	O
63.6	CD	O
,	,	O
78.2	CD	O
,	,	O
110.4	CD	O
,	,	O
113.9	CD	O
,	,	O
119.0	CD	O
,	,	O
120.9	CD	O
,	,	O
124.81	CD	O
,	,	O
124.86	CD	O
,	,	O
124.91	CD	O
,	,	O
129.1	CD	O
,	,	O
131.6	CD	O
,	,	O
131.9	CD	O
,	,	O
132.1	CD	O
,	,	O
145.5	CD	O
,	,	O
153.9	CD	O
,	,	O
158.1	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C21H29F2N4O	NNP	O
391.2309.	CD	O
found	VBD	O
391.2337	CD	O
.	.	O
Example	RB	O
56	CD	O
Inhibitor	NNP	O
compound	VBD	O
2e	CD	O
was	VBD	O
synthesized	VBN	O
by	IN	O
general	JJ	O
methods	NNS	O
C	NNP	O
and	CC	O
D	NNP	O
using	VBG	O
9e	CD	O
as	IN	O
a	DT	O
starting	VBG	O
material	NN	O
(	(	O
55	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
0.85-0.95	JJ	O
(	(	O
d	NN	O
,	,	O
J=2.5	NNP	O
,	,	O
3H	CD	O
)	)	O
,	,	O
1.45	CD	O
1.55	CD	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.61-1.70	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.71-1.97	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.00-2.10	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.35-2.45	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.46	CD	O
2.57	CD	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.90-3.00	JJ	O
(	(	O
t	JJ	O
,	,	O
J=6.0	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.16-3.21	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.30-3.50	JJ	O
(	(	O
m	NN	O
,	,	O
4H	CD	O
)	)	O
,	,	O
3.51	CD	O
3.60	CD	O
(	(	O
d	NN	O
,	,	O
J=13.5	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.61-3.70	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.75-3.90	JJ	O
(	(	O
m	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
4.14s-4.16	JJ	O
(	(	O
t	JJ	O
,	,	O
J=3.0	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
7.45-7.65	JJ	O
(	(	O
m	NN	O
,	,	O
5H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
17.5	CD	O
,	,	O
17.6	CD	O
,	,	O
18.2	CD	O
,	,	O
26.8	CD	O
,	,	O
27.2	CD	O
,	,	O
27.3	CD	O
,	,	O
32.6	CD	O
,	,	O
32.9	CD	O
,	,	O
40.0	CD	O
,	,	O
40.2	CD	O
,	,	O
48.3	CD	O
,	,	O
48.9	CD	O
,	,	O
49.1	CD	O
,	,	O
49.6	CD	O
,	,	O
50.6	CD	O
,	,	O
52.2	CD	O
,	,	O
58.8	CD	O
,	,	O
65.2	CD	O
,	,	O
79.9	CD	O
,	,	O
80.0	CD	O
,	,	O
115.4	CD	O
,	,	O
115.6	CD	O
,	,	O
116.8	CD	O
,	,	O
117.0	CD	O
,	,	O
126.0	CD	O
,	,	O
132.1	CD	O
,	,	O
132.2	CD	O
,	,	O
140.2	CD	O
,	,	O
163.1	CD	O
,	,	O
165.0	CD	O
,	,	O
168.4	CD	O
;	:	O
LC	NNP	O
TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C21H33F2N4O	NNP	O
395.2622.	CD	O
found	VBD	O
395.2633	CD	O
.	.	O
Example	RB	O
57	CD	O
Inhibitor	NNP	O
compound	VBD	O
2f	CD	O
was	VBD	O
synthesized	VBN	O
by	IN	O
general	JJ	O
methods	NNS	O
C	NNP	O
and	CC	O
D	NNP	O
using	VBG	O
9f	CD	O
as	IN	O
a	DT	O
starting	VBG	O
material	NN	O
(	(	O
55	CD	O
%	NN	O
)	)	O
:	:	O
1H	CD	O
NMR	NNP	O
(	(	O
500	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBZ	O
1.40-1.50	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
1.51-1.60	JJ	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
1.79	CD	O
1.90	CD	O
(	(	O
m	NN	O
,	,	O
2H	CD	O
)	)	O
,	,	O
1.91-1.98	JJ	O
(	(	O
d	NN	O
,	,	O
J=13.5	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.20	CD	O
(	(	O
s	NN	O
,	,	O
3H	CD	O
)	)	O
,	,	O
2.65-2.75	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.79	CD	O
2.85	CD	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.94-2.96	JJ	O
(	(	O
d	NN	O
,	,	O
J=7.5	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
2.97-3.00	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.07-3.12	JJ	O
(	(	O
dd	NN	O
,	,	O
J=11.5	NNP	O
,	,	O
11.5	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.20-3.26	JJ	O
(	(	O
dd	NN	O
,	,	O
J=0.5	NNP	O
,	,	O
13.0	CD	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.31-3.47	JJ	O
(	(	O
m	NN	O
,	,	O
4H	CD	O
)	)	O
,	,	O
3.52-3.55	JJ	O
(	(	O
d	NN	O
,	,	O
J=13.5	NNP	O
Hz	NNP	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.61-3.64	JJ	O
(	(	O
m	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
3.74-3.82	JJ	O
(	(	O
m	NN	O
,	,	O
5H	CD	O
)	)	O
,	,	O
4.11	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.52	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
,	,	O
6.57	CD	O
(	(	O
s	NN	O
,	,	O
1H	CD	O
)	)	O
;	:	O
13C	CD	O
NMR	NNP	O
(	(	O
125	CD	O
MHz	NNP	O
,	,	O
D2O	NNP	O
)	)	O
δ	VBD	O
20.4	CD	O
,	,	O
21.05	CD	O
,	,	O
21.06	CD	O
,	,	O
22.4	CD	O
,	,	O
28.95	CD	O
,	,	O
29.01	CD	O
,	,	O
41.48	CD	O
,	,	O
41.51	CD	O
,	,	O
45.1	CD	O
,	,	O
47.0	CD	O
,	,	O
48.08	CD	O
,	,	O
48.14	CD	O
,	,	O
49.4	CD	O
,	,	O
57.7	CD	O
,	,	O
63.7	CD	O
,	,	O
63.9	CD	O
,	,	O
78.3	CD	O
,	,	O
78.4	CD	O
,	,	O
110.4	CD	O
,	,	O
114.09	CD	O
,	,	O
114.12	CD	O
,	,	O
145.7	CD	O
,	,	O
153.9	CD	O
,	,	O
158.1	CD	O
;	:	O
LC-TOF	NNP	O
(	(	O
M+H+	NNP	O
)	)	O
calcd	NN	O
for	IN	O
C20H34F2N5O	NNP	O
398.2742.	CD	O
found	VBD	O
398.2726	CD	O
.	.	O
Enzyme	NNP	O
Assays	NNP	O
Example	NNP	O
58	CD	O
IC50	NNP	O
values	NNS	O
for	IN	O
inhibitors	NNS	O
2a-d	CD	O
were	VBD	O
measured	VBN	O
for	IN	O
the	DT	O
three	CD	O
different	JJ	O
isoforms	NNS	O
of	IN	O
NOS	NNP	O
including	VBG	O
rat	NN	O
nNOS	NN	O
,	,	O
bovine	NN	O
eNOS	NN	O
,	,	O
and	CC	O
murine	JJ	O
macrophage	NN	O
iNOS	NN	O
using	VBG	O
L-arginine	NNP	O
as	IN	O
a	DT	O
substrate	NN	O
.	.	O
The	DT	O
three	CD	O
isozymes	NNS	O
were	VBD	O
recombinant	JJ	O
enzymes	NNS	O
,	,	O
which	WDT	O
were	VBD	O
overexpressed	VBN	O
(	(	O
in	IN	O
E.	NNP	O
coli	NNS	O
)	)	O
and	CC	O
isolated	VBN	O
as	IN	O
reported	VBN	O
.	.	O
The	DT	O
formation	NN	O
of	IN	O
nitric	JJ	O
oxide	NN	O
was	VBD	O
measured	VBN	O
using	VBG	O
a	DT	O
hemoglobin	JJ	O
capture	NN	O
assay	VBP	O
described	VBN	O
previously	RB	O
.	.	O
(	(	O
Hevel	NNP	O
,	,	O
supra	NN	O
.	.	O
)	)	O
All	DT	O
NOS	NNP	O
isozymes	NNS	O
were	VBD	O
assayed	VBN	O
at	IN	O
room	NN	O
temperature	NN	O
in	IN	O
a	DT	O
100	CD	O
mM	NN	O
Hepes	NNP	O
buffer	NN	O
(	(	O
pH	JJ	O
7.4	CD	O
)	)	O
containing	VBG	O
10	CD	O
μM	JJ	O
L-arginine	NNP	O
,	,	O
1.6	CD	O
mM	NN	O
CaCl2	NNP	O
,	,	O
11.6	CD	O
μg/mL	NNP	O
calmodulin	NN	O
,	,	O
100	CD	O
μM	NN	O
DTT	NNP	O
,	,	O
100	CD	O
μM	NN	O
NADPH	NNP	O
,	,	O
6.5	CD	O
μM	NN	O
H4B	NNP	O
,	,	O
3.0	CD	O
mM	NN	O
oxyhemoglobin	NN	O
(	(	O
for	IN	O
iNOS	NN	O
assays	NNS	O
,	,	O
no	DT	O
Ca2+	NNP	O
and	CC	O
calmodulin	NN	O
was	VBD	O
added	VBN	O
)	)	O
.	.	O
The	DT	O
assay	NN	O
was	VBD	O
initiated	VBN	O
by	IN	O
the	DT	O
addition	NN	O
of	IN	O
enzyme	NN	O
,	,	O
and	CC	O
the	DT	O
initial	JJ	O
rates	NNS	O
of	IN	O
the	DT	O
enzymatic	JJ	O
reactions	NNS	O
were	VBD	O
determined	VBN	O
by	IN	O
monitoring	VBG	O
the	DT	O
formation	NN	O
of	IN	O
NO-hemoglobin	NNP	O
complex	NN	O
at	IN	O
401	CD	O
nm	NN	O
from	IN	O
0	CD	O
to	TO	O
60	CD	O
s	NN	O
after	IN	O
.	.	O
The	DT	O
corresponding	JJ	O
Ki	NNP	O
values	NNS	O
of	IN	O
inhibitors	NNS	O
were	VBD	O
calculated	VBN	O
from	IN	O
the	DT	O
IC50	NNP	O
values	NNS	O
using	VBG	O
equation	NN	O
1	CD	O
with	IN	O
known	VBN	O
Km	NNP	O
values	NNS	O
(	(	O
rat	NN	O
nNOS	RB	O
,	,	O
1.3	CD	O
μM	NN	O
;	:	O
iNOS	NN	O
,	,	O
8.3	CD	O
μM	NN	O
;	:	O
eNOS	CC	O
,	,	O
1.7	CD	O
μM	NN	O
)	)	O
.Ki=IC50/	NN	O
(	(	O
1+	CD	O
[	NNP	O
S	NNP	O
]	NNP	O
/Km	NNP	O
)	)	O
(	(	O
1	CD	O
)	)	O
Example	NN	O
59	CD	O
IC50	NNP	O
values	NNS	O
for	IN	O
inhibitors	NNS	O
2da-2dd	JJ	O
and	CC	O
2e-f	JJ	O
were	VBD	O
measured	VBN	O
for	IN	O
the	DT	O
three	CD	O
different	JJ	O
isoforms	NNS	O
of	IN	O
NOS	NNP	O
including	VBG	O
rat	NN	O
nNOS	NN	O
,	,	O
bovine	NN	O
eNOS	NN	O
,	,	O
and	CC	O
murine	JJ	O
macrophage	NN	O
iNOS	NN	O
using	VBG	O
L-arginine	NNP	O
as	IN	O
a	DT	O
substrate	NN	O
.	.	O
The	DT	O
three	CD	O
isozymes	NNS	O
were	VBD	O
recombinant	JJ	O
enzymes	NNS	O
,	,	O
which	WDT	O
were	VBD	O
overexpressed	VBN	O
(	(	O
in	IN	O
E.	NNP	O
coli	NNS	O
)	)	O
and	CC	O
isolated	VBN	O
as	IN	O
reported	VBN	O
.	.	O
The	DT	O
formation	NN	O
of	IN	O
nitric	JJ	O
oxide	NN	O
was	VBD	O
measured	VBN	O
using	VBG	O
a	DT	O
hemoglobin	JJ	O
capture	NN	O
assay	VBP	O
described	VBN	O
previously	RB	O
.	.	O
All	DT	O
NOS	NNP	O
isozymes	NNS	O
were	VBD	O
assayed	VBN	O
at	IN	O
room	NN	O
temperature	NN	O
in	IN	O
a	DT	O
100	CD	O
mM	NN	O
Hepes	NNP	O
buffer	NN	O
(	(	O
pH	JJ	O
7.4	CD	O
)	)	O
containing	VBG	O
10	CD	O
μM	JJ	O
L-arginine	NNP	O
,	,	O
1.6	CD	O
mM	NN	O
CaCl2	NNP	O
,	,	O
11.6	CD	O
μg/mL	NNP	O
calmodulin	NN	O
,	,	O
100	CD	O
μM	NN	O
DTT	NNP	O
,	,	O
100	CD	O
μM	NN	O
NADPH	NNP	O
,	,	O
6.5	CD	O
μM	NN	O
H4B	NNP	O
,	,	O
3.0	CD	O
μM	NN	O
oxyhemoglobin	NN	O
(	(	O
for	IN	O
iNOS	NN	O
assays	NNS	O
,	,	O
no	DT	O
Ca2+	NNP	O
and	CC	O
calmodulin	NN	O
was	VBD	O
added	VBN	O
)	)	O
.	.	O
The	DT	O
assay	NN	O
was	VBD	O
initiated	VBN	O
by	IN	O
the	DT	O
addition	NN	O
of	IN	O
enzyme	NN	O
,	,	O
and	CC	O
the	DT	O
initial	JJ	O
rates	NNS	O
of	IN	O
the	DT	O
enzymatic	JJ	O
reactions	NNS	O
were	VBD	O
determined	VBN	O
by	IN	O
monitoring	VBG	O
the	DT	O
formation	NN	O
of	IN	O
NO-hemoglobin	NNP	O
complex	NN	O
at	IN	O
401	CD	O
nm	NN	O
for	IN	O
60	CD	O
s.	PDT	O
The	DT	O
corresponding	JJ	O
Ki	NNP	O
values	NNS	O
of	IN	O
inhibitors	NNS	O
were	VBD	O
calculated	VBN	O
from	IN	O
the	DT	O
IC50	NNP	O
values	NNS	O
using	VBG	O
equation	NN	O
1	CD	O
with	IN	O
known	VBN	O
Km	NNP	O
values	NNS	O
,	,	O
as	IN	O
above	IN	O
.	.	O
Inhibitor	NNP	O
Complex	NNP	O
Crystal	NNP	O
Preparation	NNP	O
Example	NNP	O
60	CD	O
The	DT	O
nNOS	NN	O
or	CC	O
eNOS	JJ	O
heme	NN	O
domain	NN	O
protein	NN	O
used	VBN	O
for	IN	O
crystallographic	JJ	O
studies	NNS	O
were	VBD	O
produced	VBN	O
by	IN	O
limited	JJ	O
trypsin	NN	O
digest	NN	O
from	IN	O
the	DT	O
corresponding	JJ	O
full	JJ	O
length	NN	O
enzymes	NNS	O
and	CC	O
further	JJ	O
purified	VBN	O
through	IN	O
a	DT	O
Superdex	NNP	O
200	CD	O
gel	NN	O
filtration	NN	O
column	NN	O
(	(	O
GE	NNP	O
Healthcare	NNP	O
)	)	O
as	IN	O
described	VBN	O
previously	RB	O
.	.	O
(	(	O
See	VB	O
,	,	O
Li	NNP	B
,	,	I
H.	NNP	I
;	:	I
Shimizu	NNP	I
,	,	I
H.	NNP	I
;	:	I
Flinspach	NNP	I
,	,	I
M.	NNP	I
;	:	I
Jamal	NNP	I
,	,	I
J.	NNP	I
;	:	I
Yang	NNP	I
,	,	I
W.	NNP	I
;	:	I
Xian	JJ	I
,	,	I
M.	NNP	I
;	:	I
Cai	NNP	I
,	,	I
T.	NNP	I
;	:	I
Wen	NNP	I
,	,	I
E.	NNP	I
Z.	NNP	I
;	:	I
Jia	NNP	I
,	,	I
Q.	NNP	I
;	:	I
Wang	NNP	I
,	,	I
P.	NNP	I
G.	NNP	I
;	:	I
Poulos	NNP	I
,	,	I
T.	NNP	I
L.	NNP	I
,	,	I
The	DT	I
novel	NN	I
binding	VBG	I
mode	NN	I
of	IN	I
N-alkyl-N′-hydroxyguanidine	NNP	I
to	TO	I
neuronal	JJ	I
nitric	JJ	I
oxide	JJ	I
synthase	NN	I
provides	VBZ	I
mechanistic	JJ	I
insights	NNS	I
into	IN	I
NO	DT	I
biosynthesis	NN	I
.	.	I
Biochemistry	NN	I
2002	CD	I
,	,	I
41	CD	I
,	,	I
13868-13875	JJ	I
;	:	O
and	CC	O
Flinspach	NNP	B
,	,	I
M.	NNP	I
L.	NNP	I
;	:	I
Li	NNP	I
,	,	I
H.	NNP	I
;	:	I
Jamal	NNP	I
,	,	I
J.	NNP	I
;	:	I
Yang	NNP	I
,	,	I
W.	NNP	I
;	:	I
Huang	NNP	I
,	,	I
H.	NNP	I
;	:	I
Hah	NNP	I
,	,	I
J.	NNP	I
M.	NNP	I
;	:	I
Gomez	NNP	I
Vidal	NNP	I
,	,	I
J	NNP	I
.	.	I
A.	NN	I
;	:	I
Litzinger	NNP	I
,	,	I
E.	NNP	I
A.	NN	I
;	:	I
Silverman	NNP	I
,	,	I
R.	NNP	I
B.	NNP	I
;	:	I
Poulos	NNP	I
,	,	I
T.	NNP	I
L.	NNP	I
,	,	I
Structural	NNP	I
basis	NN	I
for	IN	I
dipeptide	JJ	I
amide	IN	I
isoform-selective	JJ	I
inhibition	NN	I
of	IN	I
neuronal	JJ	I
nitric	JJ	I
oxide	NN	I
synthase	NN	I
.	.	I
Nat	NNP	I
Struct	NNP	I
Mol	NNP	I
Biol	NNP	I
2004	CD	I
,	,	I
11	CD	I
,	,	I
54-59	JJ	I
.	.	O
)	)	O
The	DT	O
enzyme-inhibitor	NN	O
complex	JJ	O
crystals	NNS	O
were	VBD	O
obtained	VBN	O
by	IN	O
soaking	VBG	O
rather	RB	O
than	IN	O
co-crystallization	NN	O
,	,	O
as	IN	O
reported	VBN	O
.	.	O
The	DT	O
nNOS	JJ	O
heme	NN	O
domain	NN	O
at	IN	O
7-9	JJ	O
mg/mL	NN	O
containing	VBG	O
20	CD	O
mM	JJ	O
histidine	NN	O
or	CC	O
the	DT	O
eNOS	JJ	O
heme	NN	O
domain	NN	O
at	IN	O
20	CD	O
mg/mL	NN	O
with	IN	O
2	CD	O
mM	NNS	O
imidazole	JJ	O
were	VBD	O
used	VBN	O
for	IN	O
the	DT	O
sitting	VBG	O
drop	NN	O
vapor	NN	O
diffusion	NN	O
crystallization	NN	O
setup	NN	O
under	IN	O
the	DT	O
conditions	NNS	O
previously	RB	O
reported	VBN	O
.	.	O
Fresh	JJ	O
crystals	NNS	O
(	(	O
1-2	JJ	O
day	NN	O
old	JJ	O
)	)	O
were	VBD	O
first	RB	O
passed	VBN	O
stepwise	NN	O
through	IN	O
cryo-protectant	JJ	O
solutions	NNS	O
described	VBN	O
and	CC	O
then	RB	O
soaked	VBD	O
with	IN	O
10	CD	O
mM	NNS	O
inhibitor	NN	O
for	IN	O
4-6	JJ	O
h	NN	O
at	IN	O
4°	CD	O
C.	NNP	O
before	IN	O
being	VBG	O
mount	NN	O
on	IN	O
nylon	JJ	O
loops	NNS	O
and	CC	O
flash	NN	O
cooled	VBN	O
by	IN	O
plunging	VBG	O
into	IN	O
liquid	JJ	O
nitrogen	NN	O
.	.	O
(	(	O
See	VB	O
,	,	O
Li	NNP	B
,	,	I
H.	NNP	I
;	:	I
Shimizu	NNP	I
,	,	I
H.	NNP	I
;	:	I
Flinspach	NNP	I
,	,	I
M.	NNP	I
;	:	I
Jamal	NNP	I
,	,	I
J.	NNP	I
;	:	I
Yang	NNP	I
,	,	I
W.	NNP	I
;	:	I
Xian	JJ	I
,	,	I
M.	NNP	I
;	:	I
Cai	NNP	I
,	,	I
T.	NNP	I
;	:	I
Wen	NNP	I
,	,	I
E.	NNP	I
Z.	NNP	I
;	:	I
Jia	NNP	I
,	,	I
Q.	NNP	I
;	:	I
Wang	NNP	I
,	,	I
P.	NNP	I
G.	NNP	I
;	:	I
Poulos	NNP	I
,	,	I
T.	NNP	I
L.	NNP	I
,	,	I
The	DT	I
novel	NN	I
binding	VBG	I
mode	NN	I
of	IN	I
N-alkyl-N′-hydroxyguanidine	NNP	I
to	TO	I
neuronal	JJ	I
nitric	JJ	I
oxide	JJ	I
synthase	NN	I
provides	VBZ	I
mechanistic	JJ	I
insights	NNS	I
into	IN	I
NO	DT	I
biosynthesis	NN	I
.	.	I
Biochemistry	NN	I
2002	CD	I
,	,	I
41	CD	I
,	,	I
13868-13875	CD	I
;	:	O
Flinspach	NNP	B
,	,	I
M.	NNP	I
L.	NNP	I
;	:	I
Li	NNP	I
,	,	I
H.	NNP	I
;	:	I
Jamal	NNP	I
,	,	I
J.	NNP	I
;	:	I
Yang	NNP	I
,	,	I
W.	NNP	I
;	:	I
Huang	NNP	I
,	,	I
H.	NNP	I
;	:	I
Hah	NNP	I
,	,	I
J.	NNP	I
M.	NNP	I
;	:	I
Gomez-Vidal	NNP	I
,	,	I
J	NNP	I
.	.	I
A.	NN	I
;	:	I
Litzinger	NNP	I
,	,	I
E.	NNP	I
A.	NN	I
;	:	I
Silverman	NNP	I
,	,	I
R.	NNP	I
B.	NNP	I
;	:	I
Poulos	NNP	I
,	,	I
T.	NNP	I
L.	NNP	I
,	,	I
Structural	NNP	I
basis	NN	I
for	IN	I
dipeptide	JJ	I
amide	IN	I
isoform-selective	JJ	I
inhibition	NN	I
of	IN	I
neuronal	JJ	I
nitric	JJ	I
oxide	NN	I
synthase	NN	I
.	.	I
Nat	NNP	I
Struct	NNP	I
Mol	NNP	I
Biol	NNP	I
2004	CD	I
,	,	I
11	CD	I
,	,	I
54-59	JJ	I
.	.	O
)	)	O
Crystals	NNS	O
were	VBD	O
stored	VBN	O
in	IN	O
liquid	JJ	O
nitrogen	NN	O
until	IN	O
data	NNS	O
collection	NN	O
.	.	O
X-ray	JJ	O
Diffraction	NNP	O
Data	NNP	O
Collection	NNP	O
,	,	O
Processing	NNP	O
,	,	O
and	CC	O
Structure	NNP	O
Refinement	NNP	O
Example	NNP	O
61	CD	O
The	DT	O
cryogenic	NN	O
(	(	O
100K	CD	O
)	)	O
x-ray	JJ	O
diffraction	NN	O
data	NNS	O
were	VBD	O
collected	VBN	O
remotely	RB	O
at	IN	O
various	JJ	O
beamlines	NNS	O
at	IN	O
Stanford	NNP	O
Synchrotron	NNP	O
Radiation	NNP	O
Lightsource	NNP	O
through	IN	O
the	DT	O
data	NNS	O
collection	NN	O
control	NN	O
software	NN	O
Blu-Ice	NNP	O
and	CC	O
the	DT	O
crystal	NN	O
mounting	VBG	O
robot	NN	O
.	.	O
(	(	O
McPhillips	NNP	B
,	,	I
T.	NNP	I
M.	NNP	I
;	:	I
McPhillips	NNP	I
,	,	I
S.	NNP	I
E.	NNP	I
;	:	I
Chiu	NNP	I
,	,	I
H.	NNP	I
J.	NNP	I
;	:	I
Cohen	NNP	I
,	,	I
A.	NNP	I
E.	NNP	I
;	:	I
Deacon	NNP	I
,	,	I
A.	NNP	I
M.	NNP	I
;	:	I
Ellis	NNP	I
,	,	I
P.	NNP	I
J.	NNP	I
;	:	I
Garman	NNP	I
,	,	I
E.	NNP	I
;	:	I
Gonzalez	NNP	I
,	,	I
A.	NNP	I
;	:	I
Sauter	NNP	I
,	,	I
N.	NNP	I
K.	NNP	I
;	:	I
Phizackerley	NNP	I
,	,	I
R.	NNP	I
P.	NNP	I
;	:	I
Soltis	NNP	I
,	,	I
S.	NNP	I
M.	NNP	I
;	:	I
Kuhn	NNP	I
,	,	I
P.	NNP	I
,	,	I
Blu-Ice	NNP	I
and	CC	I
the	DT	I
Distributed	NNP	I
Control	NNP	I
System	NNP	I
:	:	I
software	NN	I
for	IN	I
data	NNS	I
acquisition	NN	I
and	CC	I
instrument	NN	I
control	NN	I
at	IN	I
macromolecular	JJ	I
crystallography	NN	I
beamlines	NNS	I
.	.	I
J	NNP	I
Synchrotron	NNP	I
Radiat	NNP	I
2002	CD	I
,	,	I
9	CD	I
,	,	I
401-406	JJ	I
.	.	O
)	)	O
Raw	NNP	O
data	NNS	O
frames	NNS	O
were	VBD	O
indexed	JJ	O
,	,	O
integrated	VBN	O
,	,	O
and	CC	O
scaled	VBD	O
using	VBG	O
HKL2000	NNP	O
.	.	O
(	(	O
6	CD	O
)	)	O
Typically	RB	O
,	,	O
each	DT	O
data	NN	O
set	NN	O
consisted	VBD	O
of	IN	O
90	CD	O
to	TO	O
100	CD	O
degree	NN	O
of	IN	O
data	NNS	O
with	IN	O
0.5	CD	O
degree	NN	O
frame	NN	O
width	NN	O
for	IN	O
both	DT	O
nNOS	JJ	O
and	CC	O
eNOS	JJ	O
crystals	NNS	O
because	IN	O
of	IN	O
their	PRP$	O
identical	JJ	O
orthorhombic	NN	O
P212121	NNP	O
space	NN	O
group	NN	O
symmetry	NN	O
.	.	O
The	DT	O
binding	NN	O
of	IN	O
inhibitors	NNS	O
was	VBD	O
detected	VBN	O
by	IN	O
the	DT	O
initial	JJ	O
difference	NN	O
Fourier	NNP	O
maps	NNS	O
calculated	VBD	O
with	IN	O
REFMAC	NNP	O
.	.	O
(	(	O
Murshudov	NNP	B
,	,	I
G.	NNP	I
N.	NNP	I
;	:	I
Vagin	NNP	I
,	,	I
A	NNP	I
.	.	I
A.	NN	I
;	:	I
Dodson	NNP	I
,	,	I
E.	NNP	I
J.	NNP	I
,	,	I
Refinement	NNP	I
of	IN	I
Macromolecular	NNP	I
Structures	NNP	I
by	IN	I
the	DT	I
Maximum-Likelihood	NNP	I
Method	NNP	I
.	.	I
Acta	NNP	I
Cryst	NNP	I
.	.	I
1997	CD	I
,	,	I
D53	NNP	I
,	,	I
240	CD	I
255	CD	I
.	.	O
)	)	O
The	DT	O
inhibitor	NN	O
molecules	NNS	O
were	VBD	O
then	RB	O
modeled	VBN	O
in	IN	O
O	NNP	O
(	(	O
Jones	NNP	B
,	,	I
T.	NNP	I
A.	NN	I
;	:	I
Zou	NNP	I
,	,	I
J.-Y	NNP	I
.	.	I
;	:	I
Cowan	NNP	I
,	,	I
S.	NNP	I
W.	NNP	I
;	:	I
Kjeldgaarrd	NNP	I
,	,	I
M.	NNP	I
,	,	I
Improved	NNP	I
methods	NNS	I
for	IN	I
building	NN	I
models	NNS	I
in	IN	I
electron	JJ	I
density	NN	I
and	CC	I
the	DT	I
location	NN	I
of	IN	I
errors	NNS	I
in	IN	I
these	DT	I
models	NNS	I
.	.	I
Acta	NNP	I
Cryst	NNP	I
.	.	I
1991	CD	I
,	,	I
A47	NNP	I
,	,	I
110-119	JJ	I
)	)	O
or	CC	O
COOT	NNP	O
(	(	O
Emsley	NNP	B
,	,	I
P.	NNP	I
;	:	I
Cowtan	NNP	I
,	,	I
K.	NNP	I
,	,	I
Coot	NNP	I
:	:	I
model-building	JJ	I
tools	NNS	I
for	IN	I
molecular	JJ	I
graphics	NNS	I
.	.	I
Acta	NNP	I
Cryst	NNP	I
.	.	I
2004	CD	I
,	,	I
D60	NNP	I
,	,	I
2126-2132	JJ	I
)	)	O
and	CC	O
refined	VBN	O
using	VBG	O
REFMAC	NNP	O
.	.	O
Water	NNP	O
molecules	NNS	O
were	VBD	O
added	VBN	O
in	IN	O
REFMAC	NNP	O
and	CC	O
checked	VBN	O
by	IN	O
COOT	NNP	O
.	.	O
The	DT	O
TLS	NNP	O
protocol	NN	O
was	VBD	O
implemented	VBN	O
in	IN	O
the	DT	O
final	JJ	O
stage	NN	O
of	IN	O
refinements	NNS	O
with	IN	O
each	DT	O
subunit	NN	O
as	IN	O
one	CD	O
TLS	NNP	O
group	NN	O
.	.	O
(	(	O
Winn	NNP	B
,	,	I
M.	NNP	I
D.	NNP	I
;	:	I
Isupov	NNP	I
,	,	I
M.	NNP	I
N.	NNP	I
;	:	I
Murshudov	NNP	I
,	,	I
G.	NNP	I
N.	NNP	I
,	,	I
Use	NNP	I
of	IN	I
TLS	NNP	I
parameters	NNS	I
to	TO	I
model	VB	I
anisotropic	JJ	I
displacements	NNS	I
in	IN	I
macromolecular	JJ	I
refinement	NN	I
.	.	I
Acta	NNP	I
Cryst	NNP	I
.	.	I
2001	CD	I
,	,	I
D57	NNP	I
,	,	I
122-133	JJ	I
.	.	O
)	)	O
The	DT	O
refined	JJ	O
structures	NNS	O
were	VBD	O
validated	VBN	O
in	IN	O
COOT	NNP	O
before	IN	O
deposition	NN	O
to	TO	O
RCSB	NNP	O
protein	NNP	O
data	VBD	O
bank	NN	O
.	.	O
The	DT	O
crystallographic	JJ	O
data	NNS	O
collection	NN	O
and	CC	O
structure	NN	O
refinement	NN	O
statistics	NNS	O
are	VBP	O
summarized	VBN	O
in	IN	O
Table	JJ	O
5	CD	O
with	IN	O
PDB	NNP	O
accession	NN	O
codes	NNS	O
included	VBD	O
.	.	O
As	IN	O
demonstrated	VBN	O
by	IN	O
the	DT	O
foregoing	NN	O
,	,	O
this	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
new	JJ	O
series	NN	O
of	IN	O
selective	JJ	O
nNOS	JJ	O
inhibitors	NNS	O
.	.	O
Without	IN	O
limitation	NN	O
,	,	O
biological	JJ	O
evaluation	NN	O
of	IN	O
these	DT	O
new	JJ	O
inhibitors	NNS	O
led	VBD	O
to	TO	O
the	DT	O
discovery	NN	O
of	IN	O
several	JJ	O
inhibitors	NNS	O
,	,	O
which	WDT	O
not	RB	O
only	RB	O
retain	VBP	O
most	JJS	O
of	IN	O
the	DT	O
activity	NN	O
of	IN	O
compound	NN	O
1	CD	O
,	,	O
but	CC	O
also	RB	O
have	VBP	O
improved	VBN	O
membrane	JJ	O
permeability	NN	O
.	.	O
Claims	NNS	O
(	(	O
22	CD	O
)	)	O
Priority	NN	O
Applications	NNP	O
(	(	O
2	CD	O
)	)	O
Applications	NNPS	O
Claiming	NNP	O
Priority	NNP	O
(	(	O
1	CD	O
)	)	O
Publications	NNPS	O
(	(	O
2	CD	O
)	)	O
Family	RB	O
ID=42354458	NNP	O
Family	NNP	O
Applications	NNP	O
(	(	O
1	CD	O
)	)	O
Country	NN	O
Status	NNP	O
(	(	O
2	CD	O
)	)	O
Cited	VBN	O
By	IN	O
(	(	O
2	CD	O
)	)	O
Families	NNPS	O
Citing	VBG	O
this	DT	O
family	NN	O
(	(	O
14	CD	O
)	)	O
Citations	NNPS	O
(	(	O
3	CD	O
)	)	O
Patent	NN	O
Citations	NNP	O
(	(	O
4	CD	O
)	)	O
Non-Patent	JJ	O
Citations	NNP	O
(	(	O
17	CD	O
)	)	O
Cited	VBN	O
By	IN	O
(	(	O
7	CD	O
)	)	O
Also	RB	O
Published	VBN	O
As	IN	O
Similar	JJ	O
Documents	NNP	O
Legal	NNP	O
Events	NNP	O
Owner	NNP	O
name	NN	O
:	:	O
NATIONAL	NNP	O
INSTITUTES	NNP	O
OF	NNP	O
HEALTH	NNP	O
(	(	O
NIH	NNP	O
)	)	O
,	,	O
U.S.	NNP	O
DEPT	NNP	O
.	.	O
OF	IN	O
Free	NNP	O
format	NN	O
text	NN	O
:	:	O
CONFIRMATORY	NNP	O
LICENSE	NNP	O
;	:	O
ASSIGNOR	NNP	O
:	:	O
NORTHWESTERN	NNP	O
UNIVERSITY	NNP	O
;	:	O
REEL/FRAME:023871/0184	NNP	O
Effective	NNP	O
date	NN	O
:	:	O
20100127	CD	O
Owner	NNP	O
name	NN	O
:	:	O
NORTHWESTERN	NNP	O
UNIVERSITY	NNP	O
,	,	O
ILLINOIS	NNP	O
Free	NNP	O
format	NN	O
text	NN	O
:	:	O
ASSIGNMENT	NNP	O
OF	IN	O
ASSIGNORS	NNP	O
INTEREST	NNP	O
;	:	O
ASSIGNORS	NNP	O
:	:	O
SILVERMAN	NNP	O
,	,	O
RICHARD	NNP	O
B.	NNP	O
;	:	O
XUE	NNP	O
,	,	O
FENGTIAN	NNP	O
;	:	O
REEL/FRAME:024042/0085	NNP	O
Effective	NNP	O
date	NN	O
:	:	O
20100226	CD	O
Year	NN	O
of	IN	O
fee	JJ	O
payment	NN	O
:	:	O
4	CD	O
